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ABSTRACT 
Amy L. Schmidbauer 
MINING FOR CONSERVED MOTIFS AND 
SIGNIFICANT FUNCTIONS IN S. MANSONI 
CERCARIAL SECRETIONS 
 
Schistosomiasis is a disease caused by a parasitic flatworm of the genus Schistosoma.  It 
infects an estimated 200 million people and 165 million head of livestock worldwide.  
There is medical interest in characterizing the parasitic proteins that interact with the 
human host for either the development of vaccines or the identification of drug targets.  The 
cercarial secretome and adult tegument sub-proteome of S. mansoni have both been 
recently published (Knudsen, Medzihradszky et al. 2005) (van Balkom, van Gestel et al. 
2005).  As secretome proteins are secreted extracellularly, and tegument sub-proteome 
proteins are anchored in the cellular membrane, we hypothesize that both sets of proteins 
employ similar secretion machinery and mechanisms.  Motivated by the discovery in the 
malarian parasite, Plasmodium falciparum, of conserved sequence motifs that are required 
for export downstream of N-terminal signal sequences (Hiller, Bhattacharjee et al. 2004), S. 
mansoni secretory and tegumental proteins were analyzed for conserved motifs using 
recursive iterations of MEME and MAST.  To compliment the conserved motif analysis, an 
automated workflow to process InterProScan functional domain and GO annotation data, 
that employs statistical methods for determining significant functions, was developed.  A 
conserved motif, enriched in the mechanically-induced vesicle secretion proteins, was 
elucidated and insight was gained into both the functions of proteins found to contain the 
motif, as well as the effects of different cercarial secretion induction methods.  A 
hypothesis of the secretion model empoloyed by the invading parasite was generated. 
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GLOSSARY 
1D SDS PAGE- One dimensional sodium dodecyl sulphate polyacrylamide gel 
electrophoresis.  A technique for separating large numbers of proteins by loading them onto 
a gel and applying an electric current.   
2D gel electrophoresis- Two dimensional polyacrylamide gel electrophoresis.  A 
technique for separating large numbers of proteins by loading them onto a gel, applying an 
electric current to separate by isoelectric point,  then, in the perpendicular direction, 
separating them by molecular weight.  
acetabular glands- S. mansoni possesses 2 sets of acetabular glands, one set posterior and 
one set anterior to the acetabulum (ventral sucker), which produce mucus and enzymes that 
are important in skin penetration.  
acetabulum- Ventral sucker of S. mansoni.  Plays an active role in skin exploration and 
penetration. 
BAC-  Bacterial artificial chromosome.  A DNA construct, based on a fertility plasmid, 
used for transforming and cloning in bacteria, usually E. coli. Its usual insert size is 150 
kbp, with a range from 100 to 300 kbp.  
Bayes optimal classifier- Statistical classifier for predicting class membership 
probabilities, based on Bayesian theorem which uses prior and posterior probabilities. 
bioinformatics- The science of informatics as applied to biological research. Informatics is 
the management and analysis of data using advanced computing techniques. 
BLAST- Basic Local Alignment Search Tool.  An algorithm for performing similarity 
searches through local alignments. 
blood fluke- A term used to refer to Schistosoma, a trematode flatworm. 
 x 
cDNA- Complimentary DNA.  Single-stranded DNA that has been synthesized from an 
mRNA template by reverse transcriptase. 
centromere- The cinched "waist" of the chromosome essential for the division and the 
retention of the chromosome in the cell. Uniquely specialized region of the chromosome to 
which spindle fibers attach during cell division. 
cercariae (plural, singular = cercaria)- the invasive larval stage of the blood fluke. 
CLUSTALW- A general purpose program for performing multiple sequence alignments of 
DNA or protein sequences. 
contig- Short for contiguous.  Refers to a contiguous set of overlapping DNA sequences in 
the context of a sequencing project.  Also referred to as an EST assembly, tentative 
consensus sequence, or gene cluster. 
definitive host- The host in which the sexual reproduction of a parasite takes place 
erythrocytes- Blood cells. 
escape glands- schistosome cercarial glands that excrete their contents when the cercaria 
emerges from its snail host. 
EST- Expressed Sequence Tag.  Short, single-pass reads from mRNA that are usually 
produced in large numbers in the context of sequencing projects.  Represent portion of 
DNA that is expressed. 
EST assemblies- see “contig”. 
ESTScan- Program for detecting ORFs (open reading frames); able to find and correct 
sequence errors resulting in frame shifts within the coding sequence. 
e-value- Expectation value.  For a given score, (e.g. BLAST) the number of hits in a 
database search that are expected to be seen by chance.  Takes into account the size of the 
database. The lower the E-value, the more significant the score. 
 xi 
expectation maximization- A technique for estimating hidden parameters.  Used by 
MEME. 
fibrosis- Formation of scar-like tissue. 
FISH- Fluorescent In Situ Hybridization.  A laboratory technique used to determine how 
many copies of a specific segment of DNA are present or absent in a cell in which a special 
region of a chromosome is stained with a dye that emits colored light when exposed to 
ultraviolet light. 
FrameFinder- Program for detecting ORFs. 
gene clusters- See “contig”. 
Gibbs sampling strategy- Local multiple sequence alignment method that uses a 
stochastic algorithm. 
glycocalyx- A sticky layer of a cell wall that consists of proteins and/or polysaccharides 
and functions to maintain osmotic pressure in the organism. 
Golgi apparatus- Membrane-bound organelle in eukaryotic cells where the proteins and 
lipids made in the endoplasmic reticulum are modified and sorted. 
granuloma- The formation of a nodule as a result of inflammation. 
head gland- One of the glands of Schistosoma mansoni.  Postulated to contain secretory 
bodies of proteins that function in the adjustment of the schistosomulae post-penetration. 
HMM- Hidden Markov Model.  A statistical model where the system being modeled is 
assumed to be a Markov process (a simple stochastic process in which the distribution of 
future states depends only on the present state and not on how it arrived in the present 
state) with unknown parameters, and the challenge is to determine the hidden parameters, 
from the observable parameters, based on this assumption. The extracted model 
 xii 
parameters can then be used to perform further analysis, for example for pattern 
recognition applications. 
homology- Pertaining to phylogeny.  Particular features (e.g. genes or proteins) in different 
individuals that are descended from the same feature in a common ancestor. 
immunogenic- Possessing the ability to elicit an immune response. 
immunogenicity- The ability of an antigen or vaccine to stimulate an immune response. 
information content- Referring to the amount of information a particular motif found by 
MEME contains.  Highly conserved positions in the motif have high information; positions 
where all letters are equally likely have low information. 
intermediate host- Host that serves as a temporary but essential environment for the 
completion of a parasite’s life cycle. 
InterPro- A federated database of profiles, patterns, and HMMs for detecting protein 
domains. 
LC-MS/MS- Liquid Chromatography/Mass Spectrometry/Mass Spectrometry.  A 
technique that combines the solute separation power of HPLC, with the detection power of 
a mass spectrometer for identification of proteins. 
lumen- The cavity or channel within a tube or tubular organ such as a blood vessel or the 
intestine. 
malaria- An infective disease caused by a protozoan parasites that is transmitted through 
the bite of an infected Anopheles mosquito. 
MAST- Motif Alignment Search Tool.  A tool for searching sequence databases for motifs 
found by MEME. 
 xiii 
Matlab- A commercial package (The MathWorks) which operates as an interactive 
programming environment, especially good for mathematical operations and working with 
matrices. 
MEME- Multiple Expectation Maximization for Motif Elicitation.  A tool for finding 
sequence motifs. 
metazoan- Multicellular organism. 
miracidia (plural, singular = miracidium)- the small free-swimming larvae of S. mansoni 
that hatch from eggs present in host feces, swim to find their freshwater snail intermediate 
host, and penetrate snails tissues where they develop into sporocyts.   
MS/MS- Mass Spectrometry/Mass Spectrometry.  Tandem mass spectrometry.  A method 
by which peptide sequences are solved from the mass-to-charge (m/z) fragmentation 
patterns of ions produced from collision-induced-dissociation. 
multiple sequence alignment- A bioinformatics tool that compares multiple DNA or 
amino acid sequences and aligns them to highlight their similarities. 
oral sucker- The part of the S. mansoni cercaria that works its way into its host’s skin. 
ORESTES- Open Reading frame Expressed Sequence Tags.  A strategy for preferentially 
generating ESTs of the central, and thus most informative portion of the transcript.  Also 
frequently identifies less abundant mRNAs.  
parasitophorous vacuolar membrane- the membrane surrounding the vacuole that is 
created by plasmodia for survival within host erythrocyte cells. 
parasitophorous vacuole- The vacuole that is created by plasmodia for survival within 
host erythrocyte cells. 
pathogenicity- Capacity to cause disease. 
 xiv 
PEXEL motif- Plasmodium Export Element.  A five amino acid conserved sequence motif 
found in the malaria parasite, P. falciparum, that allows it to survive and multiply by 
exporting multiple remodeling and virulence proteins across the membrane of the 
parasitophorous vacuole into human erythrocytes.   
PfEMP1- Plasmodium falciparum erythrocyte membrane protein 1.  An important 
virulence protein in the malaria parasite. 
PSPM- Position Specific Probability Matrix.  Used by MEME to represent the observed 
frequency of each letter in any motif it finds.   Columns correspond to letters in the 
alphabet, rows correspond to position in the motif. 
PSSM- Position Specific Scoring Matrix.  A log-odds matrix calculated by taking 100 
times the log (base 2) of the ratio p/f at each position in the motif, where p is the probability 
of a particular letter at that position in the motif, and f is the background frequency of the 
letter.  Used by MAST to detect occurrences of the motif in sequence databases.  Columns 
correspond to letters in the alphabet, rows correspond to position in the motif. 
postacetabular glands- Part of S. mansoni’s cercarial morphology.  Three pairs of glands 
are located posterior to the acetabulum (ventral sucker).  Vesicle secretions produced by 
these glands contain various enzymes, including proteases and high levels of calcium, 
making them important in skin penetration. 
preacetabular glands- Part of S. mansoni’s cercarial morphology.  Two pairs of glands 
located anterior to the acetabulum (ventral sucker).  Produce mucus and help cercariae 
adhere to surfaces. 
PRINS- Primed In Situ Hybridization.  An alternative method to traditional in situ 
hybridization for the identification of chromosomes in metaphase spreads or interphase 
nuclei.  Denatured DNA is hybridized to short DNA fragments, or designed 
oligonucleotides and then primer extension is carried out with the appropriate polymerase 
in the presence of labeled nucleotides.  
 xv 
proteome- The total complement of proteins expressed by an organism. 
proteomics- The study of the proteome, employing methods that separate, quantify and 
identify proteins. 
protozoan- Single-celled eukaryote. 
PFGE- Pulsed Field Gel Electrophoresis.  A gel electrophoretic method for the separation 
of megabase fragments of DNA based on continuous alteration of the angle at which the 
electrical field is applied. 
p-value- The p-value indicates the probability that the result obtained in a statistical test is 
due to chance rather than a true relationship between measures. Small p-values indicate that 
it is very unlikely that the results were due to chance.   
reporter gene- A gene whose gene product is easily detected (e.g. through the use of 
fluorescent labeling). 
RT-PCR- Reverse Transcriptase Polymerase Chain Reaction.  Method for amplifying 
DNA or RNA segments using heat-resistant enzymes.  First, complementary DNA (cDNA) 
is made from an RNA template, using a reverse transcriptase enzyme, and then some of it 
is used in a PCR reaction to produce large quantities. 
schistosome:  The blood fluke or flatworm. 
schistosomiasis-  The disease caused by species of Schistosoma. 
schistosomula (plural, singular = schistosomules)- One of the life cycle stages of 
Schistosoma.  Cercaria are transformed into schistosomula after they penetrate the skin. 
secretome- The set of soluble proteins secreted into the extracellular environment of a cell. 
secretory vesicles- Membrane bound structure derived from the Golgi apparatus, 
containing material to be released from the cell. 
 xvi 
signal peptide- A short peptide sequence (15-60 amino acids long) that directs the post 
translational transport of a protein. Some signal peptides are cleaved from the protein by 
signal peptidase after the proteins are transported. Signal peptides may also be called 
targeting signals or signal sequences. 
signal sequence trap method- A method for selecting cDNAs encoding secreted and 
surface proteins with N-terminal signal peptides.  cDNAs are fused with a signal sequence-
deficient reporter gene with the expectation that those cDNAs containing a signal sequence 
will result in surface expression of the protein produced. 
SignalP- A program for predicting the presence of signal peptides and location of signal 
peptide cleavage sites in amino acid sequences from different organisms, based on pattern 
recognition of known motifs for signal peptidase I found in higher eukaryotes. 
singletons- ESTs that are not contained in an assembly. 
sporocysts- One of the life cycle stages of Schistosoma.  Miracidia transform into 
sporocysts after they penetrate the tissues of their intermediate host (the snail).  Sporocysts 
then multiply asexually to produce hundreds of thousands of cercariae.   
tegument- The outer membrane of the blood fluke.  The tegument in Schistosoma is 
uniquely 3-layered. 
tentative consensus sequences- See “contig”. 
Th1-type response- Two types of T-helper cells boost the immune attack.  Th1-type cells 
stimulate macrophages and natural killer cells, which directly attack microbes that replicate 
in the body’s cells. This type of response is called cellular immunity. 
Th2-type response- Two types of T-helper cells boost the immune attack.  Th2 cells attack 
foreign matter too large to be killed by macrophages or natural killer cells, by preferentially 
stimulating B cells to produce antibodies. This type of response is called humoral 
immunity. 
 xvii 
UNDP- United Nations Development Program. 
unsupervised learning- A method of machine learning where a model is fit to 
observations.  Does not involve any prior knowledge, unlike supervised learning.  A data 
set of input objects is gathered and treated as a set of random variables, for which a joint 
density model is then built. 
VTS- Vacuolar Transport Sequence.  An eleven amino acid conserved sequence motif 
found in the malaria parasite, P. falciparum, that allows it to survive and multiply by 
exporting multiple remodeling and virulence proteins across the membrane of the 
parasitophorous vacuole into human erythrocytes.  (The PEXEL motif is contained within 
the VTS.) 
ventral sucker-  See “acetabulum”. 
weight matrix- A flexible type of quantitative motif descriptor that contains weights or 
scores for each amino acid in every position. 
Weka- Data mining software written in Java.  Collection of machine learning algorithms 
for data mining tasks. 
WHO TDR- World Health Organization Special Program for Research and Training in 
Tropical Diseases. 
whole genome shotgun sequencing- A method of sequence where all the DNA is first 
broken into fragments and the fragments are then sequenced at random and assembled 
together by looking for overlaps. 
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I. INTRODUCTION 
A. Introduction of Subject 
Schistosoma mansoni is a parasitic flatworm that causes the disease schistosomiasis and 
infects an estimated 200 million people worldwide.  Schistosomiasis is generally 
considered to rank second behind malaria among parasitic/infectious diseases in global 
importance.  It is endemic to 76 countries, mostly underdeveloped, and is usually 
associated with water resource development projects that expand the habitat of the 
parasite’s intermediate host, the freshwater snail (Johnston, Blaxter et al. 1999). There is 
medical interest in characterizing the parasitic proteins that interact with the human host for 
either the development of vaccines or identification of drug targets.  The proteins that the 
larval stage of the parasite secretes extracellularly just prior to infection of the definitive 
human host have been recently isolated and identified (Knudsen, Medzihradszky et al. 
2005).  Proteins contained in the adult tegument, the metabolically active outer surface of 
the parasite, have also recently been isolated and identified (van Balkom, van Gestel et al. 
2005).   The recent discovery of highly conserved sequence motifs in proteins exported by 
the protozoan parasite Plasmodium falciparum, which causes malaria, were the motivation 
of this research (Hiller, Bhattacharjee et al. 2004).  We hypothesize that a conserved motif 
in proteins that are either secreted extracellularly or anchored into the tegument underlies a 
common export mechanism.  The goals of this project are to elucidate a conserved 
sequence motif across S. mansoni secreted proteins and to functionally annotate the 
proteins to hypothesize about the underlying mechanism of secretion used by the invading 
parasite. 
B. Importance of Subject 
According to the World Health Organization’s Tropical Disease Research Unit (WHO 
TDR), approximately 600 million people worldwide are at risk for schistosomiasis 
infection, 200 million people are currently infected, 20 million severely.  The majority of 
infections occur in under-developed countries (TDR 2002).  Reported mortality estimates 
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range from 11,000 per year (TDR 2002) to 500,000 per year (Johnston, Blaxter et al. 
1999).  It has been given a Category 2 rating by the World Health Organization, meaning 
that a control strategy exists but has not resulted in a persistent reduction in the disease 
burden (TDR 2002).  Reinfection is common and can lead to liver, intestine, and urinary 
tract damage and can stunt growth and cognitive development (Remme, Blas et al. 2002).  
The parasite also infects approximately 165 million head of livestock (Chitsulo, Engels et 
al. 2000).       
C. Knowledge Gap 
Two drugs introduced in the 1970s are still the only ones commercially available for the 
treatment of schistosomiasis:  praziquantel and oxaminquine (Cioli and Pica-Mattoccia 
2005).  Oxamniquine is only effective against S. mansoni, limiting its use to South America 
where S. mansoni is the only species present.  Praziquantel is a broader spectrum drug that 
has been used in other parts of the world.  Market competition has driven down the price of 
praziquantel, but not oxamniquine, due to its geographical limitations.  This has resulted in 
countries even in South America decreasing their use of oxamniquine in favor of 
praziquantel. This has effectively made praziquantel the only drug currently available 
against the disease (Cioli and Pica-Mattoccia 2005).  Praziquantel is effective in a single 
dose, but given that infections occur mainly in under-developed countries (85% in sub-
Saharan Africa) and that reinfection is common, the cost of $0.40 per treatment is 
prohibitive (Cioli and Pica-Mattoccia 2005).  Massive funding from the Gates Foundation 
is allowing implementation of a program called the “Schistosomiasis Control Initiative”, 
which will provide praziquantel treatments to a few select African nations, frequently to 
school-aged children (Cioli and Pica-Mattoccia 2005).  But full-blown resistance to 
praziquantel could occur at any time (Chitsulo 2005), so a schistosomiasis vaccine, as well 
as new lead chemotherapeutics, need to be pursued.   
Both drugs are chemotherapeutics whose modes of action are not completely understood.  
Both drugs result in selective toxicity to the adult worm.  Their structures are shown in 
Figure 1 below.  It is known that oxamniquine’s mode of action is dependent upon the 
presence of the hydroxymethyl group (Cioli and Pica-Mattoccia 2005).  Some interesting 
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features of oxamniquine activity include:  1) schistosomes have a delayed reaction to it (5-7 
days after a 30 minute in vitro exposure), 2) the length of exposure can be as short as 15 
minutes for the drug to be effective, 3) it is more effective against male worms than female 
worms, and 4) it has little activity against immature schistosomes (Cioli and Pica-Mattoccia 
2005).  Resistance to oxamniquine has been proven both in the laboratory (Rogers and 
Bueding 1971) and in the field (Katz, Dias et al. 1973) and it has shown to be complete 
(Pica-Mattoccia, Dias et al. 1993).  This resistance does not, however, spread throughout 
the population, as cases of it have been confined and random (Cioli and Pica-Mattoccia 
2005).  It has been proven that resistance to the drug is a recessive trait (Cioli, Pica-
Mattoccia et al. 1992), which has led to the suggestion that resistant schistosome are 
missing some function that activates the drug (Cioli and Pica-Mattoccia 2005).  This 
missing function has been proven to be the enzyme sulfotransferase (Cioli and Pica-
Mattoccia 2005).  It has been shown that a particular sulfotransferase is specific to S. 
mansoni, and is necessary to confer sensitivity to the drug oxamniquine.  Sulfotransferases 
function by transferring a sulfate group from a donor molecule (phosphoadenosine-
phosphosulfate, PAPS) to the hydroxyl group of an acceptor substrate, oxamniquine, in this 
case.  This creates an unstable sulfate ester which spontaneously dissociates, leading to an 
electrophile (positively charged molecule) capable of alkylating (forming covalent bonds 
with) other molecules, such as, in this case, schistosome DNA and other macromolecules.  
The sulfotransferase gene has not yet been cloned in S. mansoni.  Schistosomes without a 
functional sulfotransferase have a lower fitness, as indicated by various measure of the 
vitality of their life cycle.  This decreased fitness, in addition to the fact that the gene is 
recessive, is proposed as an explanation for why oxamniquine resistance does not spread 
throughout a population (Cioli and Pica-Mattoccia 2005). 
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Figure 1.  Praziquantel (left) and Oxamniquine (right) 
Praziquantel is effective not just against all species of schistosomes, but also against other 
trematodes and human and veterinary cestodes.  The effectiveness of the drug is 
significantly reduced in animals that are immune-compromised (Sabah, Fletcher et al. 
1985), though this has not yet been evidenced in humans (Karanja, Boyer et al. 1998).  The 
drug has little effect on immature schistosomes (Gonnert and Andrews 1977), and the 
height of effectiveness against mature schistosomes is reached at two points: very early, -1 
to +1 days from infection, and relatively late, 7 weeks post infection.  The biggest effect of 
the drug is a huge increase in the amount of intracellular calcium in the parasite (Pax, 
Bettett et al. 1978) if calcium is present in the medium.  The cause of this influx is not 
known, but it has been shown not be caused be alteration of either ATPases that pump 
calcium out of cells (Nechay, Hillman et al. 1980) or voltage-gated calcium channels 
(Fetterer, Pax et al. 1980).  This huge increase in calcium causes severe paralysis of the 
parasite’s musculature, causing the schistosome suckers to release their hold on the inner 
wall of blood vessels and the schistosome to migrate to the liver.  Another significant effect 
caused by praziquantel is massive alterations of the parasite’s tegument, also dependent on 
the presence of calcium.  This increases the number of schistosome antigens present at the 
parasite surface, some of which have been identified and characterized  (Doenhoff, Sabah 
et al. 1987) (Sauma and Strand 1990), which exposes antigens to the host immune 
response.   
A pyrazio-isoquinoline ring system containing an asymmetric carbon atom that leads to 
two enantiomers referred to as dextro- and laevo- praziquantel form the base of 
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praziquantel structure.  Despite the fact that the dextro- form is almost inactive while the 
laevo- form possesses most of the anti-schistosomal activity, most commercial preparations 
are a 50:50 mixture because isolating the laevo- form is an expensive process.  Hypotheses 
regarding the mode of action include that praziquantel interacts with membrane 
phospholipids to change the permeability of the lipid bilayer (Harder, Goossens et al. 1988) 
(Schepers, Brasseur et al. 1988), and that it interacts somehow with glutathione S-
transferase (GST) based on the presence of a pocket in the three-dimensional structure of 
GST that could fit praziquantel (McTigue, Williams et al. 1995).  These hypotheses have 
been disproven, however.  More recently it has been hypothesized that beta subunits of 
calcium-binding proteins are involved in praziquantel activity, based on them containing 
subsequences that are unique to schistosomes (Kohn, Anderson et al. 2001). 
There is currently no vaccine available for schistosomiasis.  Challenges involved in 
studying schistosomes include: 1) the lack of an animal model that adequately reflects the 
human response, 2) maintaining the life cycle of Schistosoma in the laboratory (S. mansoni 
is used most often because it is the easiest to maintain in the laboratory), 3) finding a 
vaccine  with broad spectrum activity against all five species of Schistosoma that infect 
human (or at least the three main species), and 4) the fact that the parasite goes through 
three life cycle changes within its human host means that the antigens presented to the host 
are always changing.  There is reason to believe that a vaccine can be developed, however, 
as there is ample evidence that humans acquire some level of resistance after recurrent 
schistosome infection (Bergquist 1998).  In the mid-90s the WHO selected six promising 
anti-larval or anti-worm vaccine candidate antigens for testing in mouse and rat including: 
glutathione-S-transferase (Sm28) and the muscle protein paramyosin (Sm97), both found in 
the schistosomula and adult stages; triose phosphate isomerase (TPI), a membrane antigen 
(Sm23), and myosin heavy chain (rIrV5), all found in all stages; and the antigenic 
membrane protein fatty acid-binding protein (Sm14), found only in the schistosomula stage 
(Mountford and Jenkins 2005).  The target of consistently inducing 40% protection was not 
reached, however, most likely due to instability of formulations (Bergquist 1998).  The 
ability to scale up production according to GMP standards has turned out to be an 
important criterion in assessing vaccine candidates (Bergquist 2004).   
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New candidate antigens are needed and “expectations of finding additional candidates 
through mining the expanding genomics databases and through proteomics analysis are 
justifiable” (Bergquist 2004).  The underlying mechanisms of human resistance to 
schistosomiasis and the immune responses elicited by the various life cycle stages or 
particular antigens are not well understood.  For example, some antigens have been shown 
to require a Th2-type response, others a Th1-type response (Bergquist 2004).  There is also 
disagreement in the research community about the desired type of immune response that a 
vaccine should achieve.  This lack of agreement and understanding has lead to different 
adjuvants being selected for delivery of antigens and the selected adjuvant itself has an 
effect on the immune responses elicited (Mountford and Jenkins 2005).  Control strategies 
now seem to be aiming towards development of vaccines that provide partial protection 
that  can be complemented with chemotherapeutic drugs (Bergquist 2004). 
II. BACKGROUND 
A. Related Research 
S. mansoni 
The Schistosoma Genome Network (SGN) is one of the Parasite Genome Initiatives of the 
WHO.  It is an international collaboration of laboratories that has received support from the 
WHO/UNDP/World Bank Special Program for Research and Training in Tropical Diseases 
(TDR) since 1994 (Johnston, Blaxter et al. 1999).  The financial support for this project 
provided by WHO is motivated by the desire to:    
“1) increase knowledge of parasite molecular biology, especially with respect to 
mechanisms of drug resistance, antigenic variation, and genetic diversity;  
2) identify genes with key cellular functions that could represent new drug targets 
and to identify antigens with diagnostic and/or vaccine potential;  
3) where practical, develop a physical map of the parasite’s genome and/or other 
library resources for distribution to the wider research community; and  
4) curate, analyze, and disseminate parasite genome data” (Johnston, Blaxter et al. 
1999). 
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The first S. mansoni genes were cloned in the early 1980s, but by the early 1990s there was 
still little progress made towards elucidating the S. mansoni genome: only a few more than 
one hundred cDNAs had been deposited in GenBank (Ohler and Niemann 2001). Initial 
efforts of the SGN focused on generating large numbers of expressed sequence tags 
(ESTs).  In 1994 partial sequencing of S. mansoni cDNA clones generated 607 ESTs, of 
which 16% had been previously identified, 22% showed homology to other organisms, and 
33% showed no significant homology to other organisms (Ohler and Niemann 2001).  This 
was one of the first large-scale studies to illuminate new S. mansoni genes.   
A large-scale effort across multiple labs in the State of São Paulo was initiated in 2001 to 
sequence S. mansoni EST clones generated by the ORESTES low-stringency RT-PCR 
amplification technique (Williams and Pierce 2005).  The central portion of messages 
containing the more conserved, function-defining coding regions are amplified in this 
technique through the use of arbitrary primers and low-stringency RT-PCR (Fietto, 
DeMarco et al. 2002).  163,000 ESTs from six developmental stages of S. mansoni were 
sequenced, resulting in 31,000 gene clusters, covering an estimated 92% of an estimated 
14,000 expressed genes (Verjovski-Almeida, DeMarco et al. 2003).   Approximately 
124,000 ESTs, 11,000 contigs, and 15,000 singletons resulting from this effort are available 
to the public through the S. mansoni Assembled ESTs database (April 2002, 
URL:http://cancer.lbi.ic.unicamp.br/schisto6/).  
 
Additional EST sequencing efforts have resulted in significant progress towards identifying 
both S. mansoni and S. japonicum genes.  S. mansoni EST sequences have been assembled, 
archived and made available to the public at The Institute for Genomic Research’s (TIGR) 
S. mansoni Gene Index (SMGI) database (The TIGR Gene Index Databases, The Institute 
for Genomic Research, Rockville, MD 20850, URL: http://www.tigr.org/tdb/tgi, 
(Quackenbush, Liang et al. 2000) .  It contains approximately 138,000 ESTs, 13,000 
tentative consensus sequences, and 21,000 singletons (version 5, January 22, 2005).   
 
In June 2003, the Sanger Institute initiated a 5x whole genome shotgun sequencing effort 
and clusters were created using a combined set of Sanger and TIGR sequences, giving a 
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total of 8x coverage of the genome (El-Sayed, Bartholomeu et al. 2004).  Sanger’s S. 
mansoni GeneDB (version 3.0, October 14, 2005) contains a total of 50, 376 contigs.  A 
project to complete sequencing of a 1.1 Mb S. mansoni BAC contig has also been initiated 
at The Sanger Institute. 
 
The SGN’s focus has been on S. mansoni mainly.  This is evident in the comparative 
numbers of ESTs contained in NCBI’s EST database, dbEST.  As of June 12, 2006, it 
database contains 158,841 S. mansoni, 97,526 S. japonicum, and 6 S. haematobium ESTs 
(URL: http://www.ncbi.nlm.nih.gov/dbEST/index.html).  There is, however, growing 
understanding that the different schistosome species vary in many ways including their 
range of definitive hosts, egg production, pathogenicity, and immunogenicity (Le, Blair et 
al. 2002).  This has motivated various projects that focus on other species including the 
sequencing of 43,000 ESTs from the egg and adult stages of S. japonicum as part of a 
cooperative project between the Chinese National Human Genome Center at Shanghai 
(CHGCS), Shanghai Institute of Parasitology, Chinese Academy of Medical Science, and 
Shanghai Second Medical University.  13,000 gene clusters resulted, of which 35% had no 
homology to known genes and 75% had not been previously reported (Hu, Yan et al. 
2003).  All ESTs, cDNAs, and EST assemblies are available through the Chinese Human 
Genome Center at Shanghai (URL: http://schistosoma.chgc.sh.cn/sj-old/index.htm) and 
have also been deposited in GenBank.  The availability of this data set is a great asset in the 
study of S. mansoni, as the two organisms are closely related. 
 
Very little work has been done to date on S. haematobium.  But recently a collaboration has 
begun at The Sanger Institute to generate 15,000 ESTs from both S. haematobium and 
Fasciola hepatica.  F. hepatica will be useful in comparative studies because it is also a 
platyhelminth digean that is phylogenetically close to Schistosoma and is an important 
human and veterinary pathogen.  This EST data will be available at Sanger’s Sm GeneDB 
(http://www.genedb.org/). 
The signal sequence trap method was first developed and described in the early 1990s as a 
method for selecting cDNAs encoding secreted and surface proteins with N-terminal signal 
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peptides.  cDNAs are fused with a signal sequence-deficient reporter gene with the 
expectation that those cDNAs containing a signal sequence will result in surface expression 
or secretion of the protein produced. It is an especially effective technique for studying 
genomes of organisms not yet sequenced.  The first application of this technique for 
identifying surface and secreted proteins from any pathogenic organism was performed in 
S. mansoni, where a protein kinase, tetraspanins similar to human cell surface antigens, and 
previously characterized S. mansoni surface proteins were identified from the adult stage 
blood fluke (Smyth, McManus et al. 2003).  Further work applying this method to cDNAs 
expressed during various S. mansoni life cycle stages revealed additional cDNAs 
containing a signal sequence as well as one encoding a seven transmembrane receptor 
(Pearson, McManus et al. 2005).  A bioinformatics analysis of 100 signal peptides each 
from 4 different species including Schistosoma, human, Escherichia coli, and 
Nippostrongylus brasiliensis (a parasitic nematode) was also performed.  It was found that 
the sequence composition of signal peptides varies across the four species, especially in 
residues flanking the cleavage site.  Another interesting result from this study was that 
cDNAs encoding S. mansoni elastases that were fused to a reporter gene did not result in 
surface expression, despite the fact that elastases are known to be secreted by the invasive 
larval stage of schistosomes (Pearson, McManus et al. 2005).  It was suggested that this 
was either due to the transfected COS7 cells used in this method being able to recognize 
some, but not all, signal sequences employed by S. mansoni, or other incompatibilities in 
protein trafficking in different species that cause incorrect reporter processing. The 
implication is that traditional signal peptides used for secretion of proteins by other 
eukaryotes may not be employed by the invasive larvae of schistosomes (for traditional 
signal peptides, see Current Understanding- Protein Secretion and Signal Peptides, page 
35). 
The accumulation of large amounts of genomic data for S. mansoni has enabled recent 
studies of its proteome, the complete set of proteins expressed by the organism.  A study of 
S. mansoni cercarial secretions, which employed 1D gel electrophoresis combined with 
LC-MS/MS, identified a total of 172 proteins from skin lipid-induced, mechanically 
induced, and  uninduced samples (Knudsen, Medzihradszky et al. 2005).  A study of the S. 
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mansoni adult tegumental sub-proteome, which also involved the use of 1D and 2D gel 
electrophoresis combined with LC-MS/MS and MALDI TOF-TOF, identified 740 
proteins, 43 of which were found to be unique to the tegument (van Balkom, van Gestel et 
al. 2005).  The first proteomic analysis of soluble proteins from four different life cycle 
stages of S. mansoni was performed using 2D gel electrophoresis and resulted in the 
identification of 32 proteins by MS/MS protein sequencing (Curwen, Ashton et al. 2004).   
cDNA microarrays have been used to identify S. mansoni gender-associated genes 
(Hoffmann, Johnston et al. 2002).  The first oligonucleotide microarray applied to studying 
S. mansoni was also used for studying gender-associated genes and was comprised of 
approximately 50% of the adult parasite’s transcriptome (Fitzpatrick, Johnston et al. 2005).  
197 transcripts were shown to have a “gender-biased pattern of gene expression” in adult 
schistosomes. 
Plasmodium falciparum 
P. falciparum is a protozoan (unicellular) parasite that causes malaria.  Plasmodia live 
within the host’s erythrocytes surrounded by a lipid membrane, termed the parasitophorous 
vacuolar membrane (Lingelbach and Joiner 1998).  An ER-type signal sequence (see 
Background- Protein Secretion and Signal Peptides) is responsible for parasitic proteins 
being exported across the parasitic plasma membrane and into the lumen of the 
parasitophorous vacuole (Wickham 2001).  It has been found that additional signaling 
sequences are necessary for proteins to be transported across the parasitophorous vacuole 
into the erythrocyte cytoplasm.   
Through the use of fluorescence microscopy, two different P. falciparum histidine-rich 
proteins (histidine-rich protein I, PfHRPI, and histidine-rich protein II, PfHRPII) were 
found to contain a domain, immediately after the signal sequence and before a histidine-
rich region, that is necessary for export of green fluorescent protein (GFP) from the lumen 
of the parasitophorous vacuole to the erythrocyte cytoplasm (Lopez-Estraño, Bhattacharjee 
et al. 2003).  For PfHRPI this domain was SNNCNNGNGSGDSFDFRNKRTLAQKQ and 
for PfHRPII this was FNNNLCSKNAKGLNLNKRLLYETQAHVDD.  In both cases the 
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domain was within 40 amino acids of the signal sequence and needed to be exposed at the 
N-terminus in order for export to the cytoplasm to occur. 
Through N-terminal sequence alignment a conserved pentameric sequence motif, RxLxE, 
referred to as the Pexel motif (Plasmodium export element), was also found at the N-
terminus of other exported proteins (Marti, Good et al. 2004).  The Pexel motif occurs in 
about 160 soluble and insoluble cytoplasmic-side proteins within 60 amino acids of an 
upstream signal sequence, and in about 225 virulence proteins, some of which lack the 
signal sequence.  The motif was verified by fusing fluorescent signaling proteins to proteins 
where this pentameric motif had been either removed or mutated and demonstrating that 
this did not result in fluorescence being exported to the cytoplasm.  An eleven amino acid 
motif, RxSRILAExxx (RILAE forms the core), referred to as a vacuolar transport sequence 
(VTS), that has features in common with the Pexel motif and also occurs 60 amino acids 
downstream of a signal sequence, was found in about 320 proteins through the reiterative 
use of MEME and MAST (Hiller, Bhattacharjee et al. 2004).  It was experimentally proven 
to be responsible for both soluble and insoluble proteins being exported from the 
parasitophorous vacuole to the erythrocyte cytoplasm.  It has recently been suggested that 
the region necessary for export in P. falciparum is actually larger (~30 aa) than the Pexel 
motif, but that Pexel is the core of the region and contains the most conserved amino acids 
(Bhattacharjee, Hiller et al. 2006).  Most interestingly, it has also been found that in 
hundreds of secretory proteins in a divergent eukaryote, Phytophthora, there is 
conservation of the RxLR motif (Bhattacharjee, Hiller et al. 2006).  Phytophthora is an 
oomycete that is the causative agent of potato late blight.  Three different species have been 
shown to contain the RxLR motif in a position that is conserved across Plasmodium and 
Phytophthora.  It was also found that there is conservation of E/D residues with 25 amino 
acids downstream of the RxLR motif in Phytophthora species.  It is important to note that 
predictive algorithms used to find the plasmodial motif did not recognize the RxLR motif 
in Phytophthora.  Rather this motif was experimentally proven to have equivalent function 
in the two species by expressing a chimera of GFP and a 50 amino acid sequence from the 
Phytophthora avirulence protein AVR3a containing the RxLR motif in P. falciparum.  The 
result was expression of GFP in the cytoplasm of P. falciparum. 
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A comparison of the VTS and Pexel motifs and the methodologies used to discover them 
found that the pentameric Pexel motif is contained within the 11 amino acid VTS motif, but 
that there is a 30% difference in their corresponding sets of secreted proteins (Haldar, Hiller 
et al. 2005).  It is postulated that the differences in the motifs are a result of the two 
different methodologies used:  the VTS motif was found using the MEME position-specific 
probability matrix, while the Pexel motif was found through sequence alignment and using 
a linear two exon-structured pattern to search databases of predicted proteins.  There is a P. 
falciparum protein known to be exported that does not contain the two exon structure.  Two 
different secretion models are proposed (Haldar, Hiller et al. 2005).  In the first model, 
proteins are secreted from the lumen of the parasitophorous vacuole to the lumen of 
specialized sorting and trafficking organelles, similar to the Golgi called Maurer’s clefts, 
via vesicles and then into the erythrocyte cytosol or plasma membrane. In the second 
model, proteins are delivered across the plasma membrane of the parasitophorous vacuole 
into the erythrocyte cytoplasm, where they associate with the cytoplasmic side of the 
Maurer’s clefts. 
Through N-terminal alignment of 60 PfEMP1 proteins it was found that the virulence 
protein encodes a motif, linearized to SAKHLLDRIGKDVHDQVK, that is different from 
the motif (Pexel) found in other virulence proteins, but that shares features with it (Marti, 
Good et al. 2004).  Hiller et al. discovered a different motif in PfEMP1 proteins, 
QFFRWFSEWSE, through reiterative use of MEME and MAST using an earlier 
discovered motif (VTS) (Hiller, Bhattacharjee et al. 2004).  
B. Current Understanding 
S. mansoni 
There are 5 species of Schistosoma that infect humans: 4 intestinal schistosomes including 
S. intercalatum, S. japonicum, S. mekongi, S. mansoni, and 1 urinary schistosome named S. 
haematobium.  Each species has a specific freshwater snail as its intermediate host.  85% of 
schistosomiasis cases occur in sub-Saharan Africa.  S. haematobium is the most prevalent 
and widespread species in Africa and the Middle East.  S. intercalatum occurs in 10 
countries in the rainforest belt of Africa.  S. japonicum is restricted to the Pacific region 
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including China and the Philippines.  S. mekongi is found in limited areas of Laos and 
Cambodia.  S. mansoni is found in Africa and is the only species seen in South America 
including Brazil, Venezuela, and Surinam.   
The life cycle of S. mansoni consists of 6 stages (Figure 2).  Parasitic eggs contained in 
human feces hatch into a larva, referred to as miracidia, upon contact with fresh water.  
The miracidia penetrate the tissue of their snail intermediate host, Biomphalaria glabrata, 
in which they develop into sporocysts.  Sporocysts multiply asexually, producing 
hundreds of thousands of cercariae.  The cercariae are free swimming and are induced by 
human skin lipid to lose their tails and penetrate human skin, at which time they are 
transformed into schistosomula.  Shistosomula use their host’s circulatory system to 
migrate to the blood vessels of the liver, intestine, or bladder.  They then sexually mature 
into adult schistosomes, form pairs, and live in copula for the rest of their lives, laying 
300 eggs per day.   
Schistosomiasis is caused by an immune response to eggs that are lodged in tissues, 
failing to be excreted (Capron and Capron 1994).  Granulomas form in response to the 
eggs and result in fibrosis that can cause enlargement of the liver, urinary obstruction in 
the bladder, and kidney damage.   Clinical signs do not appear until the worm burden 
increases through repeated infection causing an increase in the number of granulomas.  
Symptoms can include abdominal pain, cough, diarrhea, extremely high white blood cell 
count, fever, fatigue, and enlarged liver and spleen.  People repeatedly infected can have 
liver, intestine, lung, and bladder damage.   
The S. mansoni is a diploid organism with seven pairs of somatic chromosomes and one 
pair of sex chromosomes and a genome that is approximately 270 Mbp (Simpson, Sher et 
al. 1982), about one tenth the size of the human genome.  It is at least 30% repetitive (Le 
Paslier, Pierce et al. 2000), may be as much as 60% repetitive (Johnston, Blaxter et al. 
1999), and has a GC content of 34% (Hillyer 1974).  Recent findings suggest that much of 
this repetitive composition is comprised of mobile genetic elements, or retrotransposons, 
which have likely played a large role in their evolution (Brindley and Yoshino 2003).  The 
number of expressed genes is estimated to be 15-20,000.   
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Figure 2.  Life cycle of schistosomes 
Center for Disease Control’s  Public Health Image Library ID #3417  
Content Provider:  CDC/Alexander J. da Silva, PhD/Melanie Moser  
Copyright restrictions:  None (http://phil.cdc.gov/Phil/home.asp) 
 
 
The chromosomes of S. mansoni condense during cell division, making it possible to view 
them via light microscopy (Johnston, Blaxter et al. 1999).  They are large with varying 
sizes, shapes, centromere positions, and banding patterns.  Individual chromosomes cannot 
be isolated because even the smallest chromosome is too large to be separated using pulsed 
field gel electrophoresis (PFGE) (Johnston, Blaxter et al. 1999), but chromosome maps can 
be generated through such techniques as fluorescent in situ hybridization (FISH) and 
primed in situ hybridization (PRINS) techniques (Short, Liberatos et al. 1989).  
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Two of the three sample sets used in this study involve proteins released from the S. 
mansoni cercarial stage just before it penetrates the skin and infects its human host.  The 
ventral sucker (acetabulum) plays an active role in skin exploration and penetration. 
During skin exploration it deposits mucus and attaches to these deposits alternately with 
the oral sucker.  It serves to anchor the parasite to the skin while the oral sucker works its 
way through layers of skin (Stirewalt and Kruidenier 1961).    
 
Figure 3.  Scanning electron micrograph of a S. mansoni cercariae  
(a) oral sucker, (b) mouth, (c) acetabulum/ventral sucker,  
(d) body/tail junction, (e) tail and (f) tail bifurcation.   
Spines are easily visible covering both the body segment and tail.  
The entire length of the organism is approximately 500 μm,  
but can vary considerably due to its ability to contract and elongate.  
Reprinted with permission from Dr. Fred Lewis, Dr. Carolyn Cousin  
and the publishers of Micron. (Dorsey, Cousin et al. 2002). 
 
Schistosome cercaria are reported to have no fewer than four different types of glands 
including 1) the escape glands, 2) the head gland, and 3) two sets of acetabular glands- 
pre and post (Schmidt and Roberts 2000).  The escape glands have been shown to expel 
their contents when cercaria emerge from their snail host (Schmidt and Roberts 2000).  
The head gland has narrow duct openings into the tegument in cercariae that have 
recently emerged from their snail hosts.  In contrast, in new schistosomules the head 
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gland has greatly expanded ducts which are filled with secretory bodies (Dorsey, Cousin 
et al. 2002), which likely function in the adjustment of the schistosomulae post-
penetration.  The acetabular glands are named according to their position relative to the 
acetabulum (ventral sucker).  Two pairs of preacetabular glands are located anterior to the 
acetabulum and three pairs of postacetabular glands are located posterior to the 
acetabulum.  The preacetabular glands produce mucus and help cercariae adhere to 
surfaces, while the postacetabular gland vesicle secretions contain various enzymes, 
including proteases, as well as high levels of calcium, making them important in skin 
penetration.  It has been shown that an influx of calcium is necessary but not sufficient for 
release of proteinases from cercarial preacetabular glands (Fusco, Salafsky et al. 1991).  
Figures 4 and 5 provide two different perspectives of the head and acetabular glands.   
 
Figure 4.  Cross section of a S. mansoni cercaria 
Ventral area of the anterior organ near the esophagus. 
Head gland (H), two bundles each containing two preacetabular  
glands (PR), three postacetabular glands (P). Scale bar 1.5 μm. 
Reprinted with permission from Dr. Fred Lewis, Dr. Carolyn Cousin, 
and the publishers of Micron (Dorsey, Cousin et al. 2002). 
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Figure 5.  Anterior organ of a S. mansoni cercaria 
A low magnification section of part of the anterior organ of a cercaria.   
Shown are ducts of the pre- (PR) and postacetabular (P) glands, one  
of the two anterior organ support cells (SC),head gland ducts (arrowheads),  
and microtrichs (cytoplasmic processes) projecting from the limiting  
membrane of the acetabular gland ducts (arrows). Scale bar 1.5 μm.  
Reprinted with permission from Dr. Fred Lewis, Dr. Carolyn Cousin,  
and the publishers of Micron (Dorsey, Cousin et al. 2002). 
 
Schistosomes are eukaryotic organisms of the Kingdom Metazoa, Phylum Platyhelminthes, 
Class Trematoda, Subclass Diegenea, Order Strigeidida, Family Schistosomatidae, and 
Genus Schistosoma.  They are often referred to as blood flukes.  They are a unique family 
among the Digeneans, along with two other families, Spirorchiidae and Sanguinicolidae, in 
that they have two host life cycles, a snail intermediate host and a vertebrate (human) 
definitive host; most Digeneans have three host life cycles including a metacercariae stage 
(Loker and Mkoji 2005).  The tegument of all three of these families is also unique in that it 
is bound by a double lipid bilayer, whereas other flukes have only a single lipid bilayer 
(McLaren and Hockley 1977).  This additional lipid bilayer is most likely needed because 
the adult schistosome lives in the vascular system of its definitive human host. 
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Figure 6.  Components of the S. mansoni tegument 
Reprinted with permission from Dr. Malcolm Jones 
(Jones, Gobert et al. 2004). 
 
The morphology of the tegument and its involvement in host-parasite interactions has been 
extensively studied.  The tegument undergoes changes as the schistosome passes through 
the different stages of its life cycle.  Miracidia possess a tegument consisting of a layer of 
ciliated sheets, which is shed just before they infect their snail intermediate host.  Cercaria 
possess a tegument that has an osmotic-protective, but highly immunogenic glycocalyx 
layer.  This is shed within a few hours of penetrating the human host and is replaced by an 
immune-evasive adult tegument (Jones, Gobert et al. 2004).  Most characteristics of the 
tegument remain consistent throughout the different life cycles. 
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Proteins contained in postacetabular secretions (sample sets 1 and 2) are important to study 
because they are directly involved in initial human infection; they contain enzymes 
involved in breaking down skin components that allow the parasite to find its way into the 
bloodstream.  Proteins contained in the tegument (sample set 3) are also important to study 
because the tegument serves as the major interface between the schistosome and its 
environment.  Proteins isolated from postacetabular vesicles or the tegument are likely to 
contain antigenic proteins that could be good targets for drug or vaccine development. 
Protein Secretion, Signal Peptides, and Propeptides 
Proteins often start out as inactive pre-pro-peptide precursors.  The pre-domain consists of 
a signal peptide which directs the protein to the appropriate cellular compartment during 
synthesis and gets cleaved during this translocation process, while the pro-domain can have 
various functions once it is cleaved such as protein localization, regulation of activity, and 
involvement in protein folding.  In secreted proteins the pre-domain is the signal that 
causes transport into the endoplasmic reticulum (ER) and, subsequently, the trans Golgi 
network (TGN), and the pro-domain is the signal that causes the proteins to be directed into 
the regulated secretory pathway for eventual export out of the cell (Alberts, Bray et al. 
1994).   
 
Signal peptides that direct proteins to the lumen of the ER are referred to as ER-type signal 
peptides.  Signal peptides consist of a positively charged N-terminal region, a hydrophobic 
central segment, and a polar, but neutral, C-terminal region.  Their structure is said to 
follow the (-3, -1) rule which states that in order for cleavage to occur correctly, small and 
neutral amino acids must exist at positions -3 and -1 relative to the cleavage site (Von 
Heijne 1983).  ER-type signal peptides are cleaved by signal peptidase I.  N-terminal 
anchor sequences are also capable of delivering peptides to the ER, of which there are 
several types.  If only a signal peptide is present, the ribosome synthesizing the protein is 
signaled to deliver it to the lumen of the ER (High, Flint et al. 1991), while if either both a 
signal peptide and a signal anchor sequence is present or a signal anchor sequence alone is 
present, the protein is anchored into the ER membrane instead (Wahlberg and Spiess 1997).   
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All eukaryotic cells have an endoplasmic reticulum (ER), which plays a central role in lipid 
and protein biosynthesis.  The membrane of the ER is the site of synthesis of the 
transmembrane proteins for most of the cell’s organelles and all proteins that will be 
secreted outside the cell are initially delivered to the lumen of the ER.  The ER is made up 
of a convoluted, interconnected set of tubules and sacs that extend throughout the cytosol 
and make up a continuous space called the ER lumen.   
 
Once in the lumen of the ER, proteins are glycosylated, molecular chaperones aid protein 
folding, and misfolded proteins are identified and retrotranslocated to the cytosol, where 
they are degraded by a proteasome.  Properly-folded proteins enter the Golgi apparatus, 
where the glycosylation of the proteins is modified and further posttranslational 
modifications, including cleavage and functionalization, may occur.  They are then 
translocated to the cell surface via transport vesicles, in which further protein 
modification may occur.  This is referred to as the constitutive secretory pathway and it 
operates in all cells.  All eukaryotic cells require this type of secretion where proteins and 
small molecules leave the trans Golgi network in a steady stream in transport vesicles.  
These vesicles fuse with the plasma membrane causing their soluble contents to be 
released to the extracellular space, while the insoluble components provide new 
components for the cell’s plasma membrane as they become incorporated into it.   
 
Some of the proteins contained in the ER may contain a signal, or pro-domain, that 
causes them to either be retained in the ER or shuttled off into special secretory vesicles.  
Secretion via secretory vesicles is referred to as the regulated secretory pathway.  It 
operates only in specialized secretory cells and is used to secrete soluble proteins and 
other substances such as hormones and enzymes rapidly and on demand.   Similarly to 
transport vesicles, secretory vesicles fuse with the plasma membrane causing their 
soluble contents to be released to the extracellular space, but not until an extracellular 
signal is received (Alberts, Bray et al. 1994).  Proteins destined for secretory vesicles 
accumulate in the trans Golgi network (TGN).  The mechanism behind subsequent uptake 
into secretory vesicles is not fully understood, but is thought to resemble phagocytosis.  
When secretory vesicles bud from the TGN, their contents become greatly condensed.  
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As in the non-regulated secretory pathway, many of the proteins contained in secretory 
vesicles and destined to be exported are thought to undergo one or more rounds of 
cleavage, either while still in the TGN, in the secretory vesicles, or in the extracellular 
fluid after secretion has occurred.   
 
Pro-domains become exposed at their N-terminal once the signal peptide is cleaved.  Pro-
domains are often cleaved immediately C-terminally of motifs containing multiple basic 
residues (Duckert, Brunak et al. 2004).  A family of evolutionarily conserved dibasic-
specific and monobasic-specific Ca2+-dependent serine proteases called subtilisin/kexin-
like proprotein convertases (PCs) are responsible for this type of cleavage.   In mammals 
PCs are the major endoproteolytic processing enzymes in the secretory pathway and are 
involved in processing an extensive number of proteins including peptide hormones, 
receptors, extracellular matrix proteins, and glycoproteins from infectious viruses and 
bacterial toxins (Duckert, Brunak et al. 2004).  They usually cleave immediately after the 
consensus sequence [R/K]-Xn-[R/K] where R represents arginine, K represent lysine, X 
represents any amino acid, and n represents 0, 2, 4, or 6.  One of the aims of this thesis 
study is to reveal pro-domains recognized by PCs or other proteolytic enzymes in 
proteins secreted via acetabular secretory vesicles in schistosomes. 
 
Signal Peptide Prediction 
 
Original methods for predicting signal peptides and their cleavage sites used weight 
matrices (Heijne 1986).  More recent methods use neural networks.  SignalP, which uses 
neural networks, was used in this thesis study as it has shown accuracy, specificity, and 
sensitivity over other non-weight matrix type methods (Bendtsen, Nielsen et al. 2004) 
including PSORT-II (Nakai and Horton 1999) and SubLoc (Hua and Sun 2001).  It uses 
one neural network to predict signal peptides and another one to predict signal peptidase I 
cleavage sites.  (LipoP predicts signal peptidase II cleavage sites, which are found in lipo-
proteins (Juncker, Willenbrock et al. 2003).) 
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In the first version of SignalP (Nielsen, Engelbrecht et al. 1997) data for training the 
eukaryotic neural networks was obtained from SWISS-PROT version 29 (Bairoch and 
Boeckmann 1994) and included nonredundant secreted (first 30 amino acids), membrane, 
cytosolic and nuclear proteins (first 70 amino acids).  A total of 1011 proteins from 
eukaryotes and an additional 416 specifically from humans were used.  The network was 
a feed-forward network, trained using back-propagation.  Test performance was 
determined by using 5-fold cross-validation (data sets were divided in five approximately 
equal parts and each part was used as a test set while the other 4 parts were used to train 
the network) and taking an average over each of the five test sets.  Correlation 
coefficients were calculated based on the number of correctly and incorrectly predicted 
signal peptides.  It was found that for the eukaryotic sample set, the correlation 
coefficient for signal peptide discrimination was .97 and the percent of correctly 
predicted cleavage sites was 70.2%.  Eukaryotic signal peptides were shown to be 
dominated by Leu with some occurrence of Val, Ala, Phe, and Ile.  The subset of human 
proteins showed no significant difference from the eukaryotic data set in their signal 
peptides and training the networks on a single species did not improve predictive 
performance.  While the first version of SignalP was quite good at distinguishing between 
signal peptides and non-signal peptides, it had an error rate of about 5/% in distinguishing 
between signal peptides and signal anchor sequences, which are often quite similar to 
signal peptides after their hydrophobic region. 
 
SignalP version 3.0 was used in this thesis study.  Improved performance in this version 
over previous versions of the neural network algorithm was obtained by manually 
correcting annotation errors contained in training data (1192 eukaryotic sequences from 
SWISS-PROT), taking into account novel amino acid frequencies and positions for 
detecting annotation errors that were possibly not removed from training sequences, and 
implementing a new D-score for classification of signal peptides versus non-signal 
peptides (Bendtsen, Nielsen et al. 2004).  Prediction of signal peptides versus non-signal 
peptides improved from a correlation coefficient of 97 to 98, and prediction of signal 
peptide cleavage sites improved from 70.2% to 79%.  
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Propeptide/Conserved Motif Prediction 
 
Motif identification tools have traditionally taken one of two approaches- either alignment 
methods, which are sequence-driven, or enumerative/exhaustive methods which are 
pattern-driven (Ohler and Niemann 2001).  Tools that take the alignment approach include 
CONSENSUS, MEME, and BioProspector.  CONSENSUS (Hertz and Stormo 1999) 
performs a local multiple sequence alignment of all sequences, aligning them one at a time 
and constructing a weight matrix that optimizes the information content.  MEME (Bailey 
and Elkan 1994), which applies expectation maximization, and BioProspector (Liu, Brutlag 
et al. 2001), which uses a Gibbs sampling strategy, consider start positions of the motif to 
be unknown and determine which positions give the most conserved motif by performing a 
local optimization (Ohler and Niemann 2001).  Tools that take the enumerative/exhaustive 
approach update a nucleotide probability matrix as they evaluate the frequency of 
occurrence of all possible sequences of length n using an iterative process.  A new 
approach that claims advantages over existing algorithms employs evolutionary 
computation (Fogel, Weekes et al. 2004). 
 
 
MEME, a sequence-driven alignment method, was used in this thesis study.  It uses an 
unsupervised learning approach to searching for motifs in data sets about which very little 
is known.  The only inputs that MEME requires are the set of sequences and the width of 
motif to search for.  It can find several different motifs with differing numbers of 
occurrences in a single dataset.  An algorithm called MM, mixture model, is used to fit a 
two-component finite mixture model to the set of sequences (Bailey and Elkan 1994).  The 
two components consist of: 1) probability densities of the motif itself and 2) probability 
densities for all other positions in the sequences, the background.  The expectation 
maximization technique (Aitkin and Rubin 1985) is then applied to the two densities to 
estimate each of their parameters and the mixing parameter.   
A log likelihood ratio is calculated for each column in the motif: 
For I = 1…..n, where n = number of columns in the motif,  
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llr = ∑ log ( P(site-specific occurrence|motif)/P(occurrence|background model))  
 
The first probability in this equation is one of the outputs of MEME, a position-specific 
probability matrix, or PSPM, which shows probabilities of each amino acid vs. every 
position in a particular motif.  It is based on the set of input sequences.  The second 
probability in the equation is not position-specific.  It is based on either the input sequences 
or any other set of specified sequences.  
 
MEME computes a p-value for the log likelihood ratio (log L) of each column in the motif, 
instead of a p-value of the sum of the log likelihood ratios, and then arrives at an e-value 
for the motif by computing the product of the p-values.  This makes the e-value reported by 
MEME an approximation, which is much more efficient to compute, rather than an actual 
e-value.  The e-value corresponds to the number of motifs that would have an equal or 
higher log likelihood ratio if the training set of sequences had been generated randomly 
according to the background model.  The e-value is also based on the width of the motif, 
the number of occurrences, the size of the training set, and the type of distribution.  MEME 
outputs the motif with the smallest e-value, represented as a position-specific scoring 
matrix, PSSM.  
 
Given the missing data Z , the observed data X, and the current parameter values, θ  = θ(0) 
and λ = λ(0), the e-value for the first component of the mixture model (the motif itself), is 
computed as:   
 
 
The e-value for the second component of the mixture model (all other positions in the 
sequences) is computed as: 
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High log likelihood ratios correspond to low the e-values.  Generally the e-value for the 
motif should be lower then .01 to be considered real.   
 
The total information contained in each motif can be determined by summing up the 
information contained in each position of the motif.  Positions that are highly conserved 
have high information content (IC, measured in bits), while positions that are not highly 
conserved have low information content.  MEME documentation states that for a motif to 
be useful for database searches, it must contain at least log2(N) bits of information, where 
N is the number of sequences in the database being searched.  For example, when searching 
a database of 20,000 sequences for a MEME motif, the IC of the motif should be at least 
14.4. 
 
MAST (Bailey and Gribskov 1998) uses the position-specific scoring matrix and threshold 
produced by MEME together as a Bayes-optimal classifier to search for occurrences of the 
motif in databases.  A match score is computed for each sequence in the specified database.  
The score for the match of a position in a sequence to a motif is computed by summing the 
appropriate entry from each column of the position-dependent scoring matrix that 
represents the motif.  The QFAST algorithm (Bailey and Gribskov 1998) is then used to 
compute the combined p-value of a sequence, which measures the strength of the match of 
the sequence to all the motifs.  It is calculated by 1) finding the score of the single best 
match of each motif to the sequence, 2) calculating the sequence p-value of each score 
(defined as the probability of a random sequence of the same length containing some match 
with a score as good or better), 3) forming the product of the p-values, and 4) taking the p-
value of the product.  The E-value of a sequence is the expected number of sequences in a 
random database of the same size that would match the motifs as well as the sequence 
does.  It is equal to the combined p-value of the sequence times the number of sequences 
in the database.  A motif occurrence is defined as a position in the sequence whose match 
to the motif has position p-value less than 0.0001.  The position p-value of a match is the 
probability of a single random subsequence of the length of the motif scoring at least as 
well as the observed match.   
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Protein Domain and Gene Ontology Analysis 
Assignment of a particular functional domain and Gene Ontology (GO) terms to a protein 
can help determine potential relationships to other proteins as well as physiochemical 
properties.  There are multiple and various tools for searching protein fingerprint databases.  
InterProScan (Mulder, Apweiler et al. 2005) is a tool that unites all protein signature 
recognition methods and databases of all of its consortium members, making it the most 
comprehensive tool available.  These member databases and methods include 
ProDom/BlastProDom (Blastall), PRINTS/FingerPrintScan, TIGRFAMs/Hmmpfam, 
Pfam/Hmmpfam, PROSITE/ScanRegExp + ProfileScan, PIRSF/Hmmpfam, 
CATH/Hmmpfam, PANTHER/Hmmsearch, SignalPHMM/SignalPHMM, 
Transmembrane/TMHMM2.0, SMART/Hmmpfam, and SUPERFAMILY/Hmmpfam.  
The last four listed are not public and so will not be used.  InterProScan launches all of 
these various applications, taking advantage of pre-computed results whenever possible, 
and then merges all the data together.  GO annotation data can also be included in the 
output of InterProScan and included in the merged result file. 
C. Research Question 
Are there any significant common motifs among secreted and/or tegumental proteins and, if 
so, what role do they play in S. mansoni secretion? 
D. Intended Research Project 
The intent of this project is to follow the same workflow that Hiller et al. (2004) used to 
find an export signal in P. falciparum sequences. MEME will be used to perform motif 
analysis on cercarial secretion and adult tegument proteins from S. mansoni to determine if 
a conserved signal is present.  If such a signal is found, MAST will be used to search for 
the motif in public S. mansoni databases.  Recursive iterations of MEME and MAST will 
be used to continually optimize the motif and search for it in public databases until the 
motif cannot be refined further and it is not revealed in any new sequences.  Bioinformatic 
analysis of the motif and the proteins found to contain it will be used to propose a secretion 
model.   
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III.  METHODS 
 
A. Materials: Software and Hardware 
 
NCBI’s BLAST 2.2.1 (Altschul, Madden et al. 1997) was executed on a UNIX server (6-
337 MHz processors, 4 Gb RAM, 600 Gb disk space) for performing local sequence 
alignments to determine sequence similarity.  ClustalW (Thompson, Higgins et al. 1994) 
was executed from the European Bioinformatics Institute’s web server 
(http://www.ebi.ac.uk/clustalw/) for performing multiple sequence alignments and 
generating phylogenetic trees, and SignalP 3.0 (Bendtsen, Nielsen et al. 2004) was 
executed from the SignalP web server (http://www.cbs.dtu.dk/services/SignalP/) for 
predicting signal peptides.  The following software was installed and executed from a 
UNIX server (2 Xeon 3.5 MHz processors, 4 Gb memory, 1.8 Tb disk space):  MEME, 
Multiple Expectation Maximization for Motif Elicitation, (Bailey and Elkan 1994) version 
3. 0 for predicting conserved sequence motifs, MAST, Motif Alignment Search Tool, 
(Bailey and Gribskov 1998) version 3.0 for searching databases for motifs predicted by 
MEME, and  InterProScan version 12.0 (Mulder, Apweiler et al. 2005) for protein domain 
and Gene Ontology (GO) annotation.  The same machine was used to run Matlab 7.0.1 
(The Mathworks) for developing a script to compute the entropy of sequence protein 
domain and GO features.  Perl 5.8.4, including the BioPerl module, was used to develop 
scripts that automate the parsing and reformatting various result files. 
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B. Samples and Subjects 
 
1. Animal or Human Subject Clearance 
 
This project did not involve any wet lab work; there was no direct contact with the parasite 
of interest. 
 
2. Sample Size 
 
A total of 177 proteins were analyzed.  This included two different sample sets from S. 
mansoni cercarial secretions (Knudsen, Medzihradszky et al. 2005) and one from S. 
mansoni adult tegument (van Balkom, van Gestel et al. 2005) as follows:  1) 81 S. mansoni 
cercarial secretion proteins induced by skin lipid (average length = 423 aa), 2) 53 S. 
mansoni cercarial secretion proteins induced by tail shearing (average length = 347), 3) 43 
adult tegument proteins (average length = 224) and 4) 155 full-length S. mansoni proteins 
downloaded from NCBI for use as a control set (average length = 434).  To distinguish 
between the two different sets of cercarial proteins, the 81 proteins from tail shearing 
induction will be referred to as “vesicles” and the 53 proteins from lipid induction will be 
referred to as “secretions” hereafter.  The vesicles sample set provided the most 
information as it contains the most sequences, has an average length of sequence that is 
significantly longer than the other two sample sets, and is the result of a method that 
minimized contamination, as explained below. 
 
Sequence databases were downloaded for use with the MAST program as follows: 
1. 455 full-length S. mansoni proteins NCBI’s nonredundant protein database (accessed 
July 17, 2006) 
2. 3894 full-length S. mansoni and S. japonicum proteins from NCBI’s nonredundant 
protein database (accessed April 23, 2005) 
3. A set of 26,228 assembled EST contigs and singletons from the Schistosoma Genome 
Network’s SmAE database (Verjovski-Almeida, DeMarco et al. 2003) (accessed 
September 12, 2005, url:  http://cancer.lbi.ic.unicamp.br/schisto6/), 
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4. A set of 33,704 assembled EST contigs and singletons from TIGR’s SmGI release 5 
(accessed January 22, 2005), S. mansoni Gene Index database (Quackenbush, Liang et 
al. 2000) (url: http://www.tigr.org/tigr-scripts/tgi/T_reports.cgi?species=s_mansoni). 
 
3. Samples 
 
Three different sets of samples were used in this study as listed in Appendix A.  
Experiments for stimulating, isolating, and identifying the samples were completed 
previously by Knudsen et al. (2005) and van Balkom et al. (2005).  Those experimental 
procedures are briefly described here for the purposes of understanding the source of the 
samples and methods used to induce secretion. 
 
Two sets of samples from S. mansoni cercariae were isolated and identified by Knudsen et 
al. (2005).  In summary, the first set of samples was collected from cercariae after vesicle 
secretion was stimulated by mechanical tail shearing, artificially transforming the cercariae 
into schistosomula.  After cercariae were pushed through a small syringe, which forced 
their tails to be sheared, they were allowed to secrete for 1.5-2.0 hours on a Petri dish 
containing culture medium, medium was removed from the plate, and vesicles that were 
left behind on the Petri dish were collected.  This method resulted in a set of samples that 
had minimal contamination with snail, lettuce, and human proteins from the lab 
environment.  The second set consists of samples isolated after cercariae were exposed to 
human skin lipid, the parasite’s natural biological stimulus, on a Petri dish for 1.5-2.0 hours 
in warm water.  Their secretions were separated from the cercarial bodies and tails through 
centrifugation.  The proteins in both the first and second sample sets were isolated and 
sequenced using 1D SDS PAGE, in-gel digestion, and LC-MS/MS.  Data was analyzed 
using Analyst QS software (Applied Biosciences) with Mascot (Matrix Science, London, 
UK) and then identified using Mascot server version 2.0.01 to search both the 
nonredundant protein database at NCBI (September 8, 2004) and a six-frame translation of 
TIGR’s SMGI database, version 5.  These sample sets will be referred to hereafter as 
“vesicles” and “secretions”, respectively.   
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The third set of samples was isolated from the adult schistosome tegument as described by 
van Balkom et al. (van Balkom, van Gestel et al. 2005).  Briefly, the tegument surface 
membranes of adult worms was “stripped” through a series of steps that included washing, 
freezing, applying vortex pulses, passing the tegument membrane-containing supernatant 
over a fine stainless steel mesh, and centrifuging the filtrate to collect the tegument 
membrane.  Proteins contained in the tegument membranes were then isolated and 
sequenced using both 1D and 2D SDS PAGE, in-gel digestion, immunoblotting, LC-
MS/MS, and MALDI TOF-TOF (applied to proteins excised from 2D gels only).  They 
were then analyzed using ProteinLynx Browser version 2.1 software (Micromass), and 
identified by searching a six-frame translation of TIGR’s S. mansoni Gene Index database 
version 5 with Mascot software (Matrix Science, London, UK).  Proteins that could not be 
identified using TIGR’s database were identified using the S. mansoni GeneDB where 
possible (El-Sayed, Bartholomeu et al. 2004).  This sample set will be referred to hereafter 
as “tegument”. 
 
A set of control proteins were derived by searching NCBI’s nonredundant database for full-
length S. mansoni cDNA sequences, downloading the resulting 686 sequences, translating 
them to protein, and using them as both the query and subject sequences in a BLAST 
search.  BLAST results determined that 531 sequences were either identical or highly 
homologous to other sequences.  These were removed from the data set, resulting in 155 
nonredundant proteins that were used as a control set. 
 
C. Procedures and Interventions 
 
As outlined in Figure 7, Workflow #1, sequences were analyzed for the presence of ER-
type signal peptides using SignalP and propeptides using MEME and MAST.  Initial 
sequences were obtained by searching either NCBI’s nonredundant protein database or 
TIGR’s SmGI database for accession number provided in the two papers “Proteomic 
Analysis of Schistosoma mansoni Cercarial Secretions” (Knudsen, Medzihradszky et al. 
2005) and “Mass Spectrometric Analysis of the Schistosoma mansoni Tegumental Sub-
proteome” (van Balkom, van Gestel et al. 2005).  TIGR’s database provided nucleotide 
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sequences and several different corresponding translations including an ESTScan 
translation (Iseli, Jongeneel et al. 1999), FrameFinder translation (Slater 1996-1999) and a 
six-frame translation.  The best translation (i.e. best alignment between query sequence and 
subject sequence) was determined using a manual BLAST (Altschul, Madden et al. 1997) 
search against NCBI’s nonredundant protein database.  In some instances protein 
translations were not provided by TIGR, in which case a Perl script was used to translate 
the DNA sequence into six frames and the longest frame was selected and verified using 
BLAST. 
 
Sequences were analyzed using SignalP version 3.0 (Bendtsen, Nielsen et al. 2004) to 
determine if they contain an N-terminal signal sequence.  Presumably these are the 
sequences targeted for export via a traditional extracellular secretion model.  SignalP will 
be set to run both its neural network trained on eukaryotic sequences and input sequences 
will be trimmed to 100 amino acids.  
 
Proteins from each sample set were submitted to MEME (Bailey and Elkan 1994) to search 
for conserved motifs.  Sequences containing a predicted signal peptide were submitted 
separately from those without one.  Proteins with a predicted signal sequence were trimmed 
to 100 bases from the cleavage site predicted by SignalP before submission to MEME.  If 
MEME found a statistically significant motif, the resulting motif file (PSSM) was used by 
the MAST program (Bailey and Gribskov 1998) to search three databases for the motif:  1) 
full-length S. mansoni and S. japonicum protein sequences from NCBI’s nonredundant 
protein database, 2) SmGI (Quackenbush, Liang et al. 2000), and 3) SmAE (Verjovski-
Almeida, DeMarco et al. 2003) for the same motif.  If the motif was found in additional 
sequences, those sequences were combined with the ones that MEME originally found to 
contain the motif, and all sequences were run through MEME again to refine the initial 
motif.  Recursive iterations of submitting sequences to MEME and motifs to MAST were 
performed until the motif could not be refined any further and was not found in any 
additional sequences.  To validate these methods, identical materials and processes were 
followed as those employed by Hiller et al. to elucidate a conserved motif in P. falciparum 
and the end results were compared. 
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A complimentary workflow was also executed, as outlined in Figure 8, Workflow #2.  To 
determine the amount of overlap of proteins between data sets as well as within a single 
data set (to determine diversity), sequence alignment methods were applied.  BLAST 
(Altschul, Madden et al. 1997) was used to perform local alignments and CLUSTALW 
(Thompson, Higgins et al. 1994) was used to perform multiple sequence alignments.  The 
alignment file resulting from the CLUSTALW alignment of each sample set was used to 
generate a phylogenetic tree, which was visualized using JalView (Clamp, Cuff et al. 
2004).    InterProScan (Mulder, Apweiler et al. 2005) was used to predict protein domains 
and GO terms for the S. mansoni cercarial secretome and adult tegument proteins.  Scripts 
were written to process the InterProScan raw data to generate counts and percentages of 
protein domains and GO terms represented in each sample set, as well matrices of 
sequences versus protein domains and sequences versus GO terms.  A Matlab script was 
written to calculate entropy and information gain for each feature within a dataset to 
determine the most significant protein domains and GO terms.  These methods provided 
means for comparing and contrasting proteins enriched in the different sample sets for 
improved understanding of the set of functions used by the invading parasite. 
 
D. Statistical Analysis 
 
Expectation and probability scores resulting from MEME and MAST were used to 
determine the validity of motifs found.  A Matlab script was used to calculate the entropy 
of protein domain and GO annotation data, from which the most significant features in each 
data set were determined. 
 
E. Expected Results 
 
The expectation is that iterative use of MEME and MAST will elucidate a common motif 
across multiple S. mansoni cercarial secretion and/or adult tegumental proteins downstream 
of an ER-type signal sequence.  This motif will be used to infer a proposed model for the 
mechanism of secretion in schistosomes. 
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F. Alternate Plans 
 
If reiterative use of MEME and MAST does not reveal a conserved motif, alternative 
methods for finding conserved motifs will be applied, such as multiple sequence alignment, 
ProP (Duckert, Brunak et al. 2004), and alignment using sequence logos.  Functional 
annotation methods will also be further improved and automated. 
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Figure 7.  Workflow #1 
Signal peptide and propeptide analysis 
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Figure 8.  Workflow #2 
Annotation (BLAST, Protein Domain, GO) and statistical analysis of annotation 
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IV. RESULTS 
 
A. Introduction 
 
Detailed and summary results are provided in the following Specific Findings result 
section.  Results are presented in the following order:  1) signal pepide analysis, 2) results 
of method validation, 3) a detailed explanation of steps followed in the motif analysis and 
summary results, 4) homology analysis, 5) protein domain and GO annotation data, 6) 
statistical analysis of annotation data including the most significant domains and GO terms.  
   
B. Important Highlights 
 
Reiterative use of MEME and MAST yielded a proposed conserved sequence motif of 
x[K/R]xGE across 11 sample proteins and 2 proteins from S. japonicum.  The vesicles were 
enriched for the motif.  An effort to reproduce the workflow followed by Hiller et al, which 
resulted in discovery of a conserved motif across P. falciparum proteins, was only 
successful after manual manipulation of the N-terminal starting positions of the initial five 
protein sequences used in that analysis.  The use of a stringent background model was 
found to be important to the success of MEME searches.  Interestingly, the sample proteins 
had a significantly lower percentage of predicted signal peptides.  Methods were developed 
for quickly creating matrices of protein domains or GO terms versus protein names.  These 
matrices provided a way for comparing proteins to determine similarities and differences.  
They were useful in determining functional differences in the lipid-induced proteins versus 
the tail shearing-induced proteins, and in evaluating proteins proposed to contain a 
conserved motif.  Statistical methods for determining the most statistically significant 
domains and GO terms were also automated and applied.  It was determined that ATP 
binding was the most represented biological function in the vesicles, at a level 2-1/2 times 
higher than in the secretions, and glycolysis was the most represented biological process in 
the secretions. 
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C. Specific Findings 
 
Signal Peptide Prediction 
 
Table 1 below provides SignalP neural network predictions of signal peptides and cleavage 
sites for each of the sample sets.  Figure 9 gives a summary comparison of the three 
different sample sets by showing the total number of proteins in each sample set and the 
total number of proteins that contain a signal peptide in each sample set.  All sample sets 
had relatively low numbers of sequences that were predicted to contain a signal peptide.  
11%, 9%, and 7% of vesicles, secretions, and tegument proteins respectively were 
predicted to have signal peptides.  By contrast, 36 of 155 control proteins, or 23% were 
predicted to contain a signal peptide.  It was expected that a higher number of the secreted 
proteins contained in the vesicles, secretions, and tegument proteins would have a signal 
peptide than the control proteins.  Possible reasons for this discrepancy will be discussed 
later.  
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Figure 9.  Comparison of 3 Sample Sets 
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Table 1.  Signal peptide predictions 
 
Tables below show SignalP neural network prediction results.  Note:  Only positive results are shown for the control samples.  Two 
neural networks are used by SignalP: one to predict the actual signal peptide and one to predict the cleavage site.  S-score: calculated 
for every amino acid in the submitted sequence; a high S-score for an amino acid is an indicator that it is part of a signal peptide.  S-
mean is the average of the S-score and is calculated for the length of the signal peptide.  C-max: measure of the likelihood of an amino 
acid being part of the cleavage site; calculated for every amino acid in the submitted sequence; the amino acids with the highest C-
max scores are predicted to be part of the cleavage site.  Y-max: derived from a combination of the C-max score and S-mean score.  
D-score: a new scoring method in version 3.0, the average of the S-mean and Y-max scores.  It outperforms S-score for discriminating 
between signal peptides and non-signal peptides (Bendtsen, Nielsen et al. 2004). 
 
Vesicles 
description Name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
Similar to B-cell receptor-associated protein 32 TC10689 0.103 25 N 0.213 25 N 0.976 12 Y 0.687 Y 0.45 Y 
Surface protein, fluke    T30271 0.594 20 Y 0.695 20 Y 0.978 2 Y 0.898 Y 0.796 Y 
Protein-disulfide isomerase homolog CAA80520 0.284 16 N 0.442 18 Y 0.987 2 Y 0.94 Y 0.691 Y 
Elastase 2a    AAM43941 0.62 25 Y 0.646 25 Y 0.971 13 Y 0.82 Y 0.733 Y 
Endoplasmin AAF66929 0.861 21 Y 0.691 21 Y 0.981 16 Y 0.932 Y 0.811 Y 
SPO-1 protein (anti-inflammatory protein 6)  AAD26122 0.357 17 Y 0.378 17 Y 0.994 14 Y 0.942 Y 0.66 Y 
Elastase (elastase 1b)    AAC46967 0.797 25 Y 0.719 25 Y 0.98 6 Y 0.825 Y 0.772 Y 
Calreticulin AAA19024 0.86 17 Y 0.831 17 Y 0.958 2 Y 0.879 Y 0.855 Y 
Pancreatic elastase precursor (elastase 1a)  A28942 0.603 26 Y 0.616 26 Y 0.972 7 Y 0.82 Y 0.718 Y 
Phosphoglycerate mutase TC7546 0.072 39 N 0.043 15 N 0.314 2 N 0.085 N 0.064 N 
Similar to HEL protein TC7459 0.109 22 N 0.041 17 N 0.192 1 N 0.051 N 0.046 N 
Similar to pyruvate kinase TC7454 0.31 24 N 0.353 24 Y 0.748 13 N 0.491 Y 0.422 N 
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Vesicles 
description Name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
Weakly similar to troponin T  TC7449 0.174 25 N 0.013 25 N 0.028 2 N 0.013 N 0.013 N 
Homolog to tubulin beta-2 chain  TC7336 0.076 19 N 0.047 19 N 0.104 1 N 0.055 N 0.051 N 
Similar to T-complex protein-1, epsilon subunit TC6878 0.075 21 N 0.086 11 N 0.491 1 N 0.136 N 0.111 N 
Similar to hypothetical Schistosoma japonicum 
protein TC17017 0.095 24 N 0.128 24 N 0.597 3 N 0.274 N 0.201 N 
Similar to chaperonin containing T-complex 
protein-1, zeta subunit TC16896 0.185 17 N 0.124 30 N 0.238 13 N 0.107 N 0.116 N 
Similar to ADP/ATP translocase   TC16858 0.254 25 N 0.3 32 N 0.831 22 N 0.229 N 0.265 N 
Similar to malate dehydrogenase precursor  TC16844 0.07 25 N 0.111 22 N 0.696 9 N 0.365 N 0.238 N 
Homolog to calmodulin    TC16812 0.1 27 N 0.025 42 N 0.044 7 N 0.016 N 0.02 N 
Similar to lactate dehydrogenase   TC16735 0.275 39 N 0.341 39 Y 0.917 35 Y 0.222 N 0.282 N 
Similar to transketolase    TC16539 0.123 29 N 0.047 29 N 0.087 1 N 0.038 N 0.042 N 
Similar to histone H4   TC14578 0.019 25 N 0.021 4 N 0.096 1 N 0.08 N 0.051 N 
Similar to succinate dehydrogenase Fp subunit TC13974 0.149 23 N 0.042 15 N 0.235 1 N 0.065 N 0.053 N 
Similar to chaperonin containing T-complex 
protein-1, gamma subunit  TC13671 0.277 41 N 0.262 41 N 0.831 30 N 0.122 N 0.192 N 
Similar to histone H3   TC13658 0.023 24 N 0.017 11 N 0.073 1 N 0.05 N 0.034 N 
Similar to chaperonin containing T-complex 
protein-1, beta subunit TC13620 0.066 22 N 0.059 13 N 0.531 1 N 0.149 N 0.104 N 
Homolog to H2B histone  TC13606 0.028 48 N 0.017 9 N 0.051 1 N 0.033 N 0.025 N 
Similar to ATP synthase [1]-chain mito TC13604 0.091 27 N 0.095 21 N 0.427 11 N 0.225 N 0.16 N 
Similar to glycogen phosphorylase, muscle  TC13591 0.055 32 N 0.029 32 N 0.107 11 N 0.025 N 0.027 N 
Similar to nucleoside-diphosphate kinase  TC11413 0.19 20 N 0.023 41 N 0.111 5 N 0.045 N 0.034 N 
Thioredoxin peroxidase 3  TC10839 0.057 22 N 0.074 22 N 0.394 12 N 0.173 N 0.124 N 
Similar to ribosomal protein L12 TC10765 0.161 20 N 0.085 25 N 0.387 5 N 0.165 N 0.125 N 
Similar to citrate synthase TC10655 0.034 39 N 0.024 39 N 0.08 3 N 0.024 N 0.024 N 
Weakly similar to phosphoglucomutase TC10613 0.259 16 N 0.071 16 N 0.082 1 N 0.041 N 0.056 N 
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Vesicles 
description Name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
Similar to transitional ER ATPase  TC10596 0.044 16 N 0.02 16 N 0.062 11 N 0.027 N 0.024 N 
Similar to ATP synthase alpha-chain mito TC10585 0.044 21 N 0.065 4 N 0.74 1 N 0.612 Y 0.339 N 
Weakly similar to heterogeneous nuclear 
ribonucleoprotein A2 homolog 1 TC10489 0.389 32 Y 0.224 32 N 0.487 29 N 0.078 N 0.151 N 
T-complex protein-1, alpha subunit   Q94757 0.087 22 N 0.092 35 N 0.378 31 N 0.118 N 0.105 N 
Probable dynein light chain (SM10)  Q94748 0.084 28 N 0.023 28 N 0.061 1 N 0.019 N 0.021 N 
Enolase (2-phosphoglycerate dehydratase)    Q27877 0.254 17 N 0.114 17 N 0.232 2 N 0.091 N 0.102 N 
Peptidyl-prolyl cis-trans isomerase (PPIase)   Q26565 0.039 32 N 0.043 18 N 0.291 12 N 0.108 N 0.075 N 
14-3-3 protein homolog 1   Q26540 0.1 27 N 0.045 27 N 0.113 1 N 0.05 N 0.047 N 
Fructose-bisphosphate aldolase     P53442 0.091 23 N 0.055 33 N 0.114 29 N 0.035 N 0.045 N 
Triose-phosphate isomerase (TPI)    P48501 0.03 21 N 0.034 5 N 0.196 2 N 0.151 N 0.093 N 
Tropomyosin 2 (TMII)    P42638 0.044 23 N 0.022 2 N 0.079 1 N 0.079 N 0.051 N 
Tropomyosin 1 (TMI) (polypeptide 49)  P42637 0.036 19 N 0.016 2 N 0.049 1 N 0.049 N 0.032 N 
Phosphoglycerate kinase     P41759 0.081 32 N 0.039 32 N 0.124 13 N 0.049 N 0.044 N 
GAPDH (major larval surface antigen) (P-37) P20287 0.078 25 N 0.168 25 N 0.769 11 N 0.508 Y 0.338 N 
ATP:guanidino kinase SMC74    P16641 0.039 38 N 0.022 38 N 0.06 1 N 0.017 N 0.02 N 
Major egg antigen P40 P12812 0.035 44 N 0.039 5 N 0.225 1 N 0.146 N 0.093 N 
Glutathione S-transferase (Sm, 211 aa)   P09792 0.657 18 Y 0.082 18 N 0.17 26 N 0.066 N 0.074 N 
Paramyosin      P06198 0.064 23 N 0.027 28 N 0.072 5 N 0.039 N 0.033 N 
Similar to myosin regulatory light chain CD180182 0.309 27 N 0.045 37 N 0.082 36 N 0.032 N 0.038 N 
Elongation factor 1-alpha    CAA69721 0.106 20 N 0.026 4 N 0.119 3 N 0.103 N 0.065 N 
70000 molecular weight antigen/hsp70 homolog  CAA28976 0.072 33 N 0.029 33 N 0.06 11 N 0.024 N 0.026 N 
Actin-binding/filamin-like protein AAR26703 0.218 44 N 0.065 44 N 0.089 1 N 0.026 N 0.046 N 
Arginase  AAP94031 0.295 35 N 0.074 35 N 0.121 1 N 0.029 N 0.051 N 
Heat shock protein HSP60   AAM69406 0.242 33 N 0.19 33 N 0.437 29 N 0.097 N 0.144 N 
Thioredoxin      AAL79841 0.116 40 N 0.109 40 N 0.33 34 N 0.054 N 0.081 N 
Putative histamine-releasing factor  AAL11633 0.366 25 Y 0.035 33 N 0.127 25 N 0.034 N 0.034 N 
SNaK1 (Na+/K+-ATPase alpha)    AAL09322 0.027 33 N 0.017 33 N 0.016 3 N 0.011 N 0.014 N 
   42
Vesicles 
description Name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
14-3-3 epsilon isoform AAF21436 0.066 27 N 0.032 3 N 0.167 1 N 0.13 N 0.081 N 
Myosin light chain    AAD41591 0.297 28 N 0.048 28 N 0.09 9 N 0.035 N 0.042 N 
Phosphoenolpyruvate carboxykinase     AAD24794 0.041 30 N 0.024 30 N 0.107 4 N 0.037 N 0.03 N 
Thioredoxin peroxidase 2    AAD17299 0.04 55 N 0.025 11 N 0.134 5 N 0.091 N 0.058 N 
Tegumental protein Sm20.8    AAC79131 0.212 19 N 0.068 19 N 0.175 1 N 0.056 N 0.062 N 
Calcium ATPase 2    AAC72756 0.179 26 N 0.021 26 N 0.072 1 N 0.018 N 0.02 N 
Gynecophoral canal protein  AAC47216 0.026 17 N 0.017 37 N 0.065 4 N 0.022 N 0.02 N 
Actin 2 AAC46966 0.128 24 N 0.037 38 N 0.057 19 N 0.028 N 0.032 N 
Unknown (serpin)  AAB86571 0.127 27 N 0.03 37 N 0.081 4 N 0.024 N 0.027 N 
Calponin homolog  AAB47536 0.088 21 N 0.032 3 N 0.177 1 N 0.128 N 0.08 N 
Putative cytosol aminopeptidase    AAB41442 0.119 21 N 0.113 21 N 0.648 1 N 0.186 N 0.15 N 
glutathione S-transferase, GST [Sm] AAB21173 0.104 22 N 0.193 22 N 0.879 12 Y 0.372 N 0.282 N 
Calcium-binding protein     AAA29921 0.069 19 N 0.017 19 N 0.064 12 N 0.019 N 0.018 N 
Fimbrin AAA29882 0.059 25 N 0.024 36 N 0.057 2 N 0.022 N 0.023 N 
Myosin heavy chain    A59287 0.047 24 N 0.02 34 N 0.046 21 N 0.023 N 0.021 N 
Tubulin alpha     A48433 0.117 20 N 0.1 20 N 0.345 12 N 0.132 N 0.116 N 
Vaccine-dominant antigen Sm21.7    A45630 0.202 26 N 0.045 26 N 0.344 3 N 0.066 N 0.056 N 
Heat shock protein 86, fluke (fragment) A45529 0.032 46 N 0.016 46 N 0.049 3 N 0.015 N 0.016 N 
Calcium-binding protein, fluke  A30792 0.078 21 N 0.051 8 N 0.206 1 N 0.065 N 0.058 N 
 
Secretions 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
Elastase 1b AAC46967 0.797 25 Y 0.719 25 Y 0.98 6 Y 0.825 Y 0.772 Y 
Peptidyl-prolyl cis-trans isomerase B precursor (Sm)  Q26551 0.502 24 Y 0.612 24 Y 0.978 5 Y 0.9 Y 0.756 Y 
Elastase 2a (Sm)  AAM43941 0.62 25 Y 0.646 25 Y 0.971 13 Y 0.82 Y 0.733 Y 
Pancreatic elastase precursor (elastase 1a) (Sm)  A28942 0.603 26 Y 0.616 26 Y 0.972 7 Y 0.82 Y 0.718 Y 
SPO-1 protein (anti-inflammatory protein 6) (Sm)  AAD26122 0.357 17 Y 0.378 17 Y 0.994 14 Y 0.942 Y 0.66 Y 
Similar to pyruvate kinase (Sm)  TC7454 0.31 24 N 0.353 24 Y 0.748 13 N 0.491 Y 0.422 N 
GAPDH (major larval surface antigen) (P-37) (Sm)  P20287 0.078 25 N 0.168 25 N 0.769 11 N 0.508 Y 0.338 N 
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Secretions 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
GST (Sm, 218 aa)  AAB21173 0.104 22 N 0.193 22 N 0.879 12 Y 0.372 N 0.282 N 
Weakly similar to lactate dehydrogenase (Sm)  TC16735 0.275 39 N 0.341 39 Y 0.917 35 Y 0.222 N 0.282 N 
Similar to malate dehydrogenase, mito (Sm)  TC16844 0.07 25 N 0.111 22 N 0.696 9 N 0.365 N 0.238 N 
ATP-diphosphohydrolase 1 (Sm)  AAP94734 0.1 24 N 0.139 57 N 0.899 52 Y 0.318 N 0.228 N 
Similar to malate dehydrogenase, cytosolic (Sm)  TC17066 0.11 22 N 0.168 22 N 0.685 12 N 0.275 N 0.221 N 
Cu,Zn-superoxide dismutase (Sm)  AAC14467 0.074 16 N 0.129 16 N 0.506 4 N 0.263 N 0.196 N 
6-Phosphofructokinase (Sm)  Q27778 0.242 30 N 0.08 14 N 0.442 12 N 0.284 N 0.182 N 
Similar to ATP synthase _-chain mito (Sm)  TC13604 0.091 27 N 0.095 21 N 0.427 11 N 0.225 N 0.16 N 
Heat shock protein HSP60 (Sm)  AAM69406 0.242 33 N 0.19 33 N 0.437 29 N 0.097 N 0.144 N 
Putative cytosol aminopeptidase (Sm)  AAB41442 0.127 20 N 0.108 20 N 0.273 10 N 0.14 N 0.124 N 
Enolase (2-phosphoglycerate dehydratase) (Sm)  Q27877 0.254 17 N 0.114 17 N 0.232 2 N 0.091 N 0.102 N 
Cysteine protease inhibitor (Sm)  AAQ16180 0.051 17 N 0.031 4 N 0.188 3 N 0.16 N 0.096 N 
Triose-phosphate isomerase (TIM) (Sm)  P48501 0.03 21 N 0.034 5 N 0.196 2 N 0.151 N 0.093 N 
Fatty acid-binding protein Sm14 (Sm)  AAL15461 0.227 22 N 0.066 36 N 0.255 12 N 0.099 N 0.082 N 
Thioredoxin (Sm)  AAL79841 0.116 40 N 0.109 40 N 0.33 34 N 0.054 N 0.081 N 
Calponin homolog (Sm)  AAB47536 0.088 21 N 0.032 3 N 0.177 1 N 0.128 N 0.08 N 
Peptidyl-prolyl cis-trans isomerase (PPIase) (Sm) 1 Q26565 0.039 32 N 0.043 18 N 0.291 12 N 0.108 N 0.075 N 
Glutathione S-transferase, 28 kDa (GST 28) (Sm)  P09792 0.657 18 Y 0.082 18 N 0.17 26 N 0.066 N 0.074 N 
Similar to carbonyl reductase (Sm)  AAC46898 0.16 30 N 0.062 17 N 0.222 12 N 0.078 N 0.07 N 
Elongation factor 1 (Sm)  CAA69721 0.106 20 N 0.026 4 N 0.119 3 N 0.103 N 0.065 N 
Homolog to phosphoglycerate mutase (Sm)  TC7546 0.072 39 N 0.043 15 N 0.314 2 N 0.085 N 0.064 N 
Tegumental protein Sm20.8 (Sm)  AAC79131 0.212 19 N 0.068 19 N 0.175 1 N 0.056 N 0.062 N 
Thioredoxin peroxidase 2 (Sm)  AAD17299 0.04 55 N 0.025 11 N 0.134 5 N 0.091 N 0.058 N 
Vaccine-dominant antigen Sm21.7 (Sm)  A45630 0.202 26 N 0.045 26 N 0.344 3 N 0.066 N 0.056 N 
Ferritin-2 heavy chain (Sm)  P25319 0.156 35 N 0.074 35 N 0.097 33 N 0.033 N 0.053 N 
Similar to histone H4 (Sm)  TC14578 0.019 25 N 0.021 4 N 0.096 1 N 0.08 N 0.051 N 
Homolog to tubulin _-2 chain (Sm)  TC7336 0.076 19 N 0.047 19 N 0.104 1 N 0.055 N 0.051 N 
14-3-3 protein homolog 1 (Sm)  Q26540 0.1 27 N 0.045 27 N 0.113 1 N 0.05 N 0.047 N 
Actin-binding/filamin-like protein (Sm)  AAR26703 0.218 44 N 0.065 44 N 0.089 1 N 0.026 N 0.046 N 
Fructose-bisphosphate aldolase (Sm)  P53442 0.091 23 N 0.055 33 N 0.114 29 N 0.035 N 0.045 N 
Phosphoglycerate kinase (Sm)  P41759 0.081 32 N 0.039 32 N 0.124 13 N 0.049 N 0.044 N 
Similar to nucleoside-diphosphate kinase (Sm)  TC11413 0.19 20 N 0.023 41 N 0.111 5 N 0.045 N 0.034 N 
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Secretions 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
Similar to histone H3 (Sm)  TC13658 0.023 24 N 0.017 11 N 0.073 1 N 0.05 N 0.034 N 
Actin (Sm)  AAC46966 0.128 24 N 0.037 38 N 0.057 19 N 0.028 N 0.032 N 
Phosphoenolpyruvate carboxykinase (Sm)  AAD24794 0.041 30 N 0.024 30 N 0.107 4 N 0.037 N 0.03 N 
Unknown (serpin) (Sm)  AAB86571 0.127 27 N 0.03 37 N 0.081 4 N 0.024 N 0.027 N 
Similar to muscle glycogen phosphorylase (Sm)  TC13591 0.055 32 N 0.029 32 N 0.107 11 N 0.025 N 0.027 N 
70,000 molecular weight antigen/hsp70 homolog (Sm) CAA28976 0.072 33 N 0.029 33 N 0.06 11 N 0.024 N 0.026 N 
Calpain (EC 3.4.22.17) large chain (Sm)  A39343 0.111 17 N 0.025 17 N 0.068 1 N 0.025 N 0.025 N 
Homolog to H2B histone (Sm)  TC13606 0.028 48 N 0.017 9 N 0.051 1 N 0.033 N 0.025 N 
Fimbrin (Sm)  AAA2988 0.059 25 N 0.024 36 N 0.057 2 N 0.022 N 0.023 N 
Probable dynein light chain (SM10) (T-cell-
stimulating antigen SM10) Q94748 0.084 28 N 0.023 28 N 0.061 1 N 0.019 N 0.021 N 
ATP:guanidino kinase SMC74 (Sm)  P16641 0.039 38 N 0.022 38 N 0.06 1 N 0.017 N 0.02 N 
Homolog to calmodulin (Sm)  TC16812 0.1 27 N 0.025 42 N 0.044 7 N 0.016 N 0.02 N 
Calcium-binding protein (Sm)  AAA29921 0.069 19 N 0.017 19 N 0.064 12 N 0.019 N 0.018 N 
Heat shock protein 86 (Sm)  A45529 0.032 46 N 0.016 46 N 0.049 3 N 0.015 N 0.016 N 
 
Tegument 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
CD63-like protein Sm-TSP-2a TC13732 0.205 22 N 0.282 36 N 0.951 32 Y 0.815 Y 0.549 Y 
Nebulette TC13379 0.328 22 Y 0.413 22 Y 0.88 2 Y 0.674 Y 0.543 Y 
no significant homology found TC8556 0.36 22 Y 0.217 43 N 0.997 38 Y 0.747 Y 0.482 Y 
putative related to F3G5b TC11571 0.609 20 Y 0.428 20 Y 0.898 12 Y 0.404 N 0.416 N 
22K surface membrane antigen TC10917 0.122 36 N 0.295 36 N 0.95 31 Y 0.527 Y 0.411 N 
rat coatamer beta subunit TC7811 0.195 63 N 0.184 22 N 0.892 11 Y 0.516 Y 0.35 N 
no significant homology found TC19226 0.17 22 N 0.246 22 N 0.615 10 N 0.406 N 0.326 N 
syntenin TC14697 0.799 21 Y 0.371 21 Y 0.512 10 N 0.279 N 0.325 N 
actin-binding and severin family group-protein TC8208 0.237 26 N 0.21 26 N 0.774 25 N 0.336 N 0.273 N 
Exocyst complex component Sec10 (hSec10) TC11347 0.144 29 N 0.206 29 N 0.681 20 N 0.275 N 0.24 N 
fatty acid coenzyme A ligase 5 TC17495 0.347 21 Y 0.123 37 N 0.833 32 N 0.344 N 0.234 N 
ATP-diphosphohydrolase 1a TC11432 0.1 24 N 0.139 57 N 0.899 52 Y 0.318 N 0.228 N 
SCP-like extracellular proteinb TC10635 0.689 23 Y 0.228 23 N 0.767 2 N 0.227 N 0.227 N 
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Tegument 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
SGTP4 TC17442 0.216 24 N 0.209 37 N 0.769 32 N 0.234 N 0.222 N 
aquaporin-3 TC10637 0.224 33 N 0.218 50 N 0.684 41 N 0.212 N 0.215 N 
no significant homology found TC9780 0.191 16 N 0.166 16 N 0.623 3 N 0.241 N 0.203 N 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 CD194580 0.067 25 N 0.108 21 N 0.569 7 N 0.291 N 0.2 N 
no significant homology found AI882660 0.214 24 N 0.145 61 N 0.796 50 N 0.244 N 0.195 N 
hypothetical proteinb TC7948 0.634 21 Y 0.186 21 N 0.431 2 N 0.113 N 0.15 N 
annexin 11a isoform 2 CD098410 0.429 25 Y 0.164 25 N 0.38 4 N 0.128 N 0.146 N 
no significant homology found TC14238 0.288 32 N 0.153 32 N 0.342 31 N 0.064 N 0.109 N 
SCP-like extracellular proteinb TC10634 0.056 43 N 0.047 5 N 0.331 1 N 0.165 N 0.106 N 
ubiquitin/ribosomal fusion proteinb TC11590 0.257 29 N 0.059 16 N 0.34 2 N 0.153 N 0.106 N 
adenylyl cyclase-associated proteinb TC8265 0.224 26 N 0.122 26 N 0.355 16 N 0.08 N 0.101 N 
no significant homology found TC9174 0.101 39 N 0.105 39 N 0.317 32 N 0.083 N 0.094 N 
filamin isoform A TC17006 0.181 24 N 0.082 24 N 0.204 23 N 0.095 N 0.089 N 
similar to Pcmt1-prov protein TC11206 0.174 25 N 0.066 26 N 0.372 1 N 0.102 N 0.084 N 
Alpha-actinin, sarcomeric (F-actin cross linking 
protein) TC14047 0.17 25 N 0.073 25 N 0.274 5 N 0.093 N 0.083 N 
no significant homology found TC13203 0.563 22 Y 0.077 22 N 0.229 1 N 0.085 N 0.081 N 
amidase CD157335 0.086 33 N 0.083 33 N 0.282 25 N 0.073 N 0.078 N 
dysferlin CD157335 0.045 57 N 0.041 17 N 0.184 12 N 0.103 N 0.072 N 
LIM and SH3 protein 1b CD182193 0.077 16 N 0.056 16 N 0.196 3 N 0.068 N 0.062 N 
ectonucleotide pyrophosphatase/phosphodiesterase 5 TC14339 0.351 23 Y 0.064 23 N 0.173 2 N 0.049 N 0.057 N 
no significant homology found CD192195 0.075 28 N 0.051 36 N 0.113 12 N 0.049 N 0.05 N 
thioredoxin peroxidase 1a TC14049 0.032 55 N 0.025 17 N 0.133 5 N 0.067 N 0.046 N 
HLA-B associated transcript 1b TC7459 0.109 22 N 0.041 17 N 0.192 1 N 0.051 N 0.046 N 
no significant homology found TC18339 0.092 26 N 0.042 26 N 0.188 1 N 0.039 N 0.04 N 
Myosin D TC13851 0.064 44 N 0.042 44 N 0.1 1 N 0.03 N 0.036 N 
phosphatidylinositol transfer protein TC12230 0.124 33 N 0.038 33 N 0.103 2 N 0.028 N 0.033 N 
breast adenocarcinoma marker like (26.0 kD) (2N58) TC13662 0.041 24 N 0.028 24 N 0.088 11 N 0.035 N 0.031 N 
major egg antigen TC7485 0.022 25 N 0.012 6 N 0.059 3 N 0.038 N 0.025 N 
fimbrin TC7585 0.059 25 N 0.024 36 N 0.057 2 N 0.022 N 0.023 N 
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Tegument 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
no significant homology found BF936329 0.05 26 N 0 1 N 0.967 29 Y 0 N 0 N 
 
Controls 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
Female specific 800 protein (FS800)     P16463 0.935 23 Y 0.888 23 Y 0.993 13 Y 0.931 Y 0.909 Y 
13 kDa tegumental antigen Sm13 [Sm]   AAC25419.1 0.979 18 Y 0.88 18 Y 0.983 2 Y 0.886 Y 0.883 Y 
peptidylglycine alpha hydroxylating mono-oxygenase 
[Sm]    AAO18222.1 0.963 18 Y 0.88 18 Y 0.978 4 Y 0.877 Y 0.879 Y 
insulin receptor protein kinase RTK-2 [Sm]   AAN39120.1 0.977 22 Y 0.865 22 Y 0.989 12 Y 0.89 Y 0.878 Y 
nicotinic acetylcholine receptor alpha subunit 
precursor [Sm]  AAR84361.1 0.962 20 Y 0.852 20 Y 0.964 8 Y 0.888 Y 0.87 Y 
p48 eggshell protein       AAA29908.1 0.871 20 Y 0.844 20 Y 0.985 1 Y 0.893 Y 0.869 Y 
calreticulin         AAA19024.1 0.86 17 Y 0.831 17 Y 0.959 2 Y 0.881 Y 0.856 Y 
albumin precursor [Sm]      AAL08579.1 0.752 19 Y 0.791 19 Y 0.974 1 Y 0.919 Y 0.855 Y 
carbohydrate-binding calcium-dependent lectin 
precursor [Sm]    AAX63737.1 0.929 24 Y 0.841 24 Y 0.979 6 Y 0.869 Y 0.855 Y 
LGG         AAB81008.1 0.713 19 Y 0.766 19 Y 0.973 4 Y 0.907 Y 0.836 Y 
unknown [Sm]       AAN17275.1 0.65 19 Y 0.716 19 Y 0.989 4 Y 0.923 Y 0.819 Y 
endoplasmin [Sm]       AAF66929.1 0.861 21 Y 0.687 21 Y 0.98 16 Y 0.923 Y 0.805 Y 
glutathione peroxidase-2 [Sm]      AAU34080.1 0.692 19 Y 0.691 19 Y 0.949 3 Y 0.907 Y 0.799 Y 
acetylcholinesterase [Sm]       AAQ14321.1 0.697 26 Y 0.704 26 Y 0.959 11 Y 0.822 Y 0.763 Y 
developmentally regulated antigen 10.3 precursor [Sm]  AAP13803.1 0.641 25 Y 0.677 25 Y 0.962 13 Y 0.81 Y 0.744 Y 
elastase 2a [Sm]      AAM43941.1 0.62 25 Y 0.641 25 Y 0.969 13 Y 0.81 Y 0.726 Y 
receptor tyrosine kinase [Sm]     AAL67949.1 0.423 24 Y 0.55 24 Y 0.984 7 Y 0.901 Y 0.725 Y 
tyrosinase 1 precursor [Sm]     AAP93838.1 0.575 24 Y 0.623 24 Y 0.972 2 Y 0.824 Y 0.723 Y 
unknown [Sm]       AAN17279.1 0.497 27 Y 0.599 27 Y 0.984 8 Y 0.845 Y 0.722 Y 
CD9-like protein Sm-TSP-1 [Sm]     AAN17278.2 0.323 31 Y 0.502 31 Y 0.994 20 Y 0.939 Y 0.721 Y 
unknown [Sm]       AAB86568.1 0.237 17 N 0.431 17 Y 0.969 1 Y 0.921 Y 0.676 Y 
nicotinic acetylcholine receptor non-alpha subunit 
precursor [Sm]  AAR84362.1 0.625 24 Y 0.633 24 Y 0.901 22 Y 0.719 Y 0.676 Y 
elastase 2b [Sm]      AAM43942.1 0.274 22 N 0.433 22 Y 0.995 13 Y 0.878 Y 0.655 Y 
ORF-RF2; putative        AAA74696.1 0.635 22 Y 0.283 32 N 0.985 25 Y 0.944 Y 0.613 Y 
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Controls 
description name Cmax pos ? Ymax pos ? Smax pos ? Smean ? D ? 
cathepsin B endopeptidase [Sm]     CAC85211.2 0.275 28 N 0.414 23 Y 0.93 9 Y 0.79 Y 0.602 Y 
ORF 2        AAA29910.1 0.267 29 N 0.321 21 N 0.945 5 Y 0.812 Y 0.566 Y 
CD63-like protein Sm-TSP-2 [Sm]     AAN17276.1 0.205 22 N 0.282 36 N 0.951 32 Y 0.816 Y 0.549 Y 
NADH dehydrogenase subunit 4L [Sm]    AAG13165.2 0.226 33 N 0.271 33 N 0.989 6 Y 0.817 Y 0.544 Y 
NADH dehydrogenase subunit 4L [Sm]    NP_66213.2 0.226 33 N 0.271 33 N 0.989 6 Y 0.817 Y 0.544 Y 
cathepsin B1 isotype 2 [Sm]    CAD44625.1 0.474 18 Y 0.485 18 Y 0.867 4 N 0.582 Y 0.534 Y 
unknown         AAC46888.1 0.404 30 Y 0.41 30 Y 0.964 12 Y 0.639 Y 0.524 Y 
Sm29 [Sm]       AAC98911.1 0.665 27 Y 0.478 27 Y 0.856 6 N 0.539 Y 0.509 Y 
neuropeptide F precursor [Sm]     AAT77204.1 0.279 39 N 0.489 39 Y 0.993 28 Y 0.501 Y 0.495 Y 
potassium channel protein       AAC37227.1 0.785 20 Y 0.51 20 Y 0.714 1 N 0.415 N 0.463 Y 
alpha 38720 fucosyltransferase [Sm]     AAF71198.1 0.209 35 N 0.394 35 Y 0.984 30 Y 0.53 Y 0.462 Y 
putative seven transmembrane receptor [Sm]    AAR84066.2 0.089 24 N 0.208 31 N 0.932 25 Y 0.688 Y 0.448 Y 
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Method Validation 
 
To validate the methodology used by Hiller et al. (Hiller, Bhattacharjee et al. 2004) to find 
and refine a conserved sequence motif, an attempt was made to reproduce the authors’ 
workflow using the same exact samples and methods.  A pattern had initially been 
identified by using MEME to analyze the first 100 residues of five P. falciparum 
sequences, known to be vacuolar transport sequences, starting immediately after the 
predicted SS cleavage site.  To validate this, the five sequences were downloaded from the 
nonredundant protein database and submitted to SignalP for signal peptide prediction.  
Interestingly, only three of the five sequences were found to contain a signal sequence 
using the neural networks method (and only two of five using the hidden Markov model 
method).  When just these three sequences were trimmed to 100 residues after the predicted 
cleavage site and submitted to MEME, the same motif found by Hiller et al. was not found.  
The other two sequences were added into the analysis and submitted to MEME in an 
attempt to discover the same motif.  But only after manipulation of the starting point of the 
sequences was the same motif found.  The rest of the workflow was not difficult to 
validate. This leads to two points: 1) finding conserved motifs with MEME when the initial 
number of input sequences is small, is not trivial, and 2) finding a motif using MEME is 
likely to be more successful when it is complimented by lab experiments.  Hiller et al. had 
the benefit of prior experimental knowledge of exactly which amino acids were required 
for a protein to be exported.    
 
Conserved Motif Analysis 
 
By default, MEME uses the input sequences to build a 0-order Markov model of amino 
acid frequencies for use as a background model in determining the likelihood of particular 
motifs.  It follows that when the number of input sequences is small, the background model 
is not as sensitive as when the number of input sequences is large.  To improve the 
sensitivity of the search and provide a consistent background for each analysis, a 
background model was built based on amino acid frequencies of the control set.  The 
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control set consisted of 155 full-length S. mansoni cDNA sequences downloaded from 
NCBI, from which redundancy and highly homologous sequences had been removed.  This 
model was specified as the background in all MEME searches in place of the input 
sequences.  In the control set, shown on the left in Figure 10, amino acids Cys (C), Phe (F), 
His (H), Ile (I), Asn (N), Ser (S), Thr (T), Trp (W), and Tyr (Y) are enriched, with Asn 
(1.7% difference) and Ser (2.1% difference) being the most significantly different.  In the 
vesicle data set, shown on the right in Figure 10 below, amino acids Ala (A), Asp (D), Glu 
(E), Gly (G), Lys (K), and Val (V), with Ala (2.1% difference) and Glu (2.0% difference) 
being the most significantly different. 
 
 
Figure 10.  S. mansoni amino acid frequencies 
Left:  Amino acid frequencies of control data set,  
used as background in MEME analysis; 
Right:  Amino acid frequencies of vesicles data set 
 
Without either elimination or careful weighting of overrepresented proteins, the motif 
analysis led to false positives that were due to high sequence homology, not necessarily to 
common secretion function.  Sequences that had high homology to other input sequences 
were weighted equally by specifying weights in the first line of the fasta input file as 
follows.  For example, if two highly homologous sequences existed in the file, the first line 
of the input file contained the line:  “>WEIGHTS 0.5 0.5” followed by the two highly 
homologous then all other sequences.   
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In order to increase the sensitivity of the search when the number of input sequences to 
MEME was small (twenty or fewer), parameters were set to assume that each sequence in 
the data set contained exactly one occurrence of each motif and to search for a motif that is 
five amino acids wide, corresponding to the following example command line: meme –
inputfile.fasta –bfile Sm_nr_155.txt –mod oops –w 5 >output.html.  The increased speed 
and sensitivity of this search sacrifices accuracy and may result in fuzzy motifs.  When the 
number of input sequences was not small (greater than twenty),  MEME parameters were 
set to assume that each sequence contains at most one occurrence of each motif (since it is 
likely that some may not contain the motif) and to allow MEME to automatically choose 
the best motif width (the default).  These settings correspond to the example command line:  
<meme –inputfile.fasta –bfile Sm_nr_155.txt –mod zoops >output.html>.  While this 
option is slower and slightly less sensitive to weak motifs, it results in more accurate 
motifs.   
 
MEME output includes (as labeled in Figure 11): A) an information content (IC) diagram, 
B) a simplified PSPM, C) a multilevel consensus sequence, D) a block diagram of the 
occurrence of the motif in each training/input sequence, and E) the occurrences of the 
motif.  In the IC diagram, the positions with the highest IC are the most conserved.  The 
most hydrophobic amino acids are colored blue, while polar, non-charged, non-aliphatic 
residues are colored green, acidic residues are magenta, and positively charged are red.  
Other residues are various other colors.  The simplified PSPM gives the probability of each 
possible letter appearing at each possible position in an occurrence of the motif.  For 
readability the letter probabilities are multiplied by 10 and rounded to the nearest integer, 
where 10 is replaced by “a” and zeros are replaced by ":".  The multilevel consensus 
sequence is calculated from the PSPM.  The most likely motif is on the first line and any 
letter substitutions that have a probability greater than .2 are shown in lines below it.  The 
block diagram shows all occurrences of the motif in each sequence, sorted by the lowest p-
value.  It can be used to compare relative motif positions across sequences.  The p-value of 
an occurrence is the probability of a single random subsequence the length of the motif, 
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generated according to the 0-order background model, having a score at least as high as the 
score of the occurrence.  The diagram of the occurrences of the motif within each sequence 
shows the exact motif found in each sequence.  It can be used to get a view of how 
conserved the motif is across sequences. 
When the nine vesicle proteins that were predicted to contain an ER-type signal sequence 
were submitted to MEME, a conserved motif of [E/L]K[H/R]GE resulted, with the K, G, 
and E residues being the most conserved, as shown in Figure 11, MEME #1.  The input 
sequences (Table 2) included 1) three highly homologous elastases, 2) an endoplasmin and 
a surface protein that showed 20% homology in a BLAST comparison, 3) four other 
proteins that had no homology to any other sequences within this subset or the entire 
vesicle sample set:  calreticulin, PDI, a SPO-1 protein, and an unidentified protein.  They 
were trimmed to start at their predicted signal peptide cleavage site and extend 100 amino 
acids.  The three elastases which shared 80% to 92% sequence identity were each weighted 
equally at 33.3% to eliminate bias caused by overrepresentation of these proteins.   
The motif elucidated in MEME #1 contains 13.6 bits of information, an e-value of 770 and 
a log likelihood value of 85.  The motif starts with a positively charged residue, lysine (K), 
and ends with an acidic residue, glutamic acid (E).  Inspection of the occurrences of the 
motifs shows that it exists across calreticulin, endoplasmin, PDI, and the elastases.  
Arginine substitutes for lysine in the elastases.  The motif does not exist in the SPO-1 
protein (AAD26122), the surface protein (T30271), or the protein annotated as similar to 
B-cell receptor associated protein (T10689). 
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Table 2.  MEME #1 input sequences 
accession Description weight source 
Signal 
Sequence? 
Trimmed to 
start at SS and 
extend 100 aa? 
In 
Sample 
Sets? 
AAC46967 Elastase 0.33 vesicles with signal sequence no yes yes 
AAM43941 elastase 2a [Sm] 0.33 vesicles with signal sequence yes yes yes 
A28942  pancreatic elastase precursor - fluke  (Sm) 0.33 vesicles with signal sequence yes yes yes 
AAA19024 calreticulin 1 vesicles with signal sequence yes yes yes 
AAF66929 endoplasmin [Sm] 1 vesicles with signal sequence yes yes yes 
T30271 surface protein - fluke (Sm) 1 vesicles with signal sequence yes yes yes 
CAA80520 PDI homologue [Sm] 1 vesicles with signal sequence yes yes yes 
AAD26122 SPO-1 protein [Sm] 1 vesicles with signal sequence yes yes yes 
TC10689 
Similar to B-cell receptor-associated 
protein 32 1 vesicles with signal sequence yes yes yes 
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Figure 11.  MEME #1 
xKxGE motif:  information content = 13.6; e-value = 770; log likelihood ratio = 85 
 
 
A
B
E
C
D
(13.6 
bits) 
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The first MAST search using this motif was against a database of 455 full-length S. 
mansoni proteins downloaded from NCBI’s nonredundant protein database.  A database 
containing 455 sequences requires that the motif has at least log2(455) bits of information 
(as discussed on page 42).  This corresponds to 8.8 bits, hence the motif is significant 
enough for the search.  Results of MAST search #1 are shown in Figure 12.   
 
MAST motif diagrams show all motif occurrences.  A motif occurrence is defined as a 
position in the sequence whose match to the motif has position p-value less than .0001.  
The position p-value is equal to the probability that a single random subsequence of the 
length of the motif scoring at least as well as the observed match.  The score is computed by 
summing the appropriate entry from each column of the PSSM.  The sequence p-value of a 
score is defined as the probability of a random sequence of the same length containing 
some match with as good or better score.  The combined p-value of a sequence (p-value of 
the product of the sequence p-values) measures the strength of the match of the sequence to 
all motifs.  The e-value of a sequence (combined p-value of the sequence times the number 
of sequences in the database) is the expected number of sequences in a random database of 
the same size that would match the motifs as well as the sequence does and is equal to the.  
 
Figure 12 shows that there were 24 sequences with e-values less than 10 resulting from the 
first MAST search (MAST #1).  This included eleven different proteins.  Outlined in blue 
are five proteins that existed in the original data set used in MEME #1 and outlined in red 
are six new proteins that did not.  The new ones include:  thioredoxin peroxidase, 
thioredoxin, myosin light chain, calcium binding protein, immunophilin, and AUT1.  
Thioredoxin peroxidase is found across all sample sets, thioredoxin is unique to the 
secretions, myosin light chain is unique to vesicles, calcium binding protein exists in both 
vesicles and secretions, and immunophilin and AUT1 are not contained in any of the 
sample sets.  Figure 13 depicts relative positions of motifs in order of increasing e-value.  
The motif occurs in a different position for each protein.   
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Figure 12.  MAST #1 high scoring sequences 
Input:  motif from MEME #1 & 455 full-length S. mansoni proteins NCBI’s nonredundant protein database 
Proteins not contained in original input sequences (used in MEME #1) are outlined in red, proteins contained in the 
original input sequences are outlined in blue.  Redundant proteins are not outlined. 
 
same as calreticulin 
same as 
 immunophilin 
same  
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Figure 13.  MAST #1 motif diagram 
Input:  motif from MEME #1 & 455 full-length S. mansoni proteins NCBI’s nonredundant protein database 
Motifs with significant position p-values (<.0001) are indicated by “1”. 
 
 
To refine the proposed motif using an additional iteration of MEME,  the six new proteins 
(outlined in red in Figure 12) were added to the set analyzed in MEME #1 (vesicle proteins 
containing signal peptides).  Two of the three redundant elastases were removed from the 
input sequences so that the input contained only unique sequences.  If sequences contained 
a signal peptide, they were trimmed to start at the signal peptide and extend 100 amino 
acids.  If they did not contain a signal peptide, the entire sequence was used.  Sequences 
used as input to MEME #2 are shown in Table 3 below.   
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Table 3.  MEME #2 input sequences 
accession description weight source 
Signal 
Sequence? 
Trimmed 
to start at 
SS and 
extend 
100 aa? 
In 
Sample 
Sets? 
AAM43941 elastase 2a [Sm] 1 vesicles with signal sequence yes yes yes 
AAA19024 calreticulin 1 vesicles with signal sequence yes yes yes 
AAF66929 endoplasmin [Sm] 1 vesicles with signal sequence yes yes yes 
T30271 surface protein - fluke (Sm) 1 vesicles with signal sequence yes yes yes 
CAA80520 PDI homologue [Sm] 1 vesicles with signal sequence yes yes yes 
AAD26122 SPO-1 protein [Sm] 1 vesicles with signal sequence yes yes yes 
TC10689 
Similar to B-cell receptor-associated protein 
32 1 vesicles with signal sequence yes yes yes 
AAD17299 thioredoxin peroxidase 1 MAST #1- 455 nr Sm sequences no no yes 
AAA69867 immunophilin 1 MAST #1- 455 nr Sm sequences no no no 
AAD41591 myosin light chain 1 MAST #1- 455 nr Sm sequences no no yes 
AAA29921 calcium binding protein 1 MAST #1- 455 nr Sm sequences no no yes 
AAL79841 thioredoxin 1 MAST #1- 455 nr Sm sequences no no yes 
gi_9081807 AUT1 [Sm] 1 MAST #1- 455 nr Sm sequences no no no 
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Figure 14.  MEME #2 
xKxGE motif:  information content = 13.3 bits; e-value = .0059; log likelihood ratio = 120 
    
 
 
Results of MEME #2 are shown in Figure 14.  The consensus sequence changed slightly 
but the most conserved residues remained unchanged:  xKxGE.  This motif contains 13.3 
bits of information and had an e-value of .0059 (improved from 770 in MEME #1) and a 
(13.3 
bits) 
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log likelihood ratio of 120 (improved from 85 in MEME #1).  Given that for a motif to be 
considered real it needs to have an e-value below .01, this motif can be considered valid.  
13.3 bits of information is sufficient to search databases containing approximately 10,000 
or fewer sequences (log2(10000)=13.3 bits), so this motif could not be used to search the 
entire SMGI or same, or nr databases, but it could be used to search smaller sets of 
proteins. 
Two additional MAST searches were performed.  MAST #2 (Figures 15 and 16) was 
executed using the motif from MEME #2 to search a subset of NCBI’s nonredundant 
protein database containing ~4000 full-length S. mansoni and S. japonicum sequences 
including the 455 S. mansoni sequences contained in the database used in the first MAST 
search.  The motif was found in many of the same proteins as in MAST #1:  thioredoxin, 
thioredoxin peroxidase, myosin light chain, calreticulin, calcium binding protein, and 
immunophilin.  It was also found in 10 S. japonicum sequences.  AAW26398 has 97% 
identity to myosin light chain which is found in vesicles (AAD41591), AAW25436 has 
88% identity to S. mansoni thioredoxin peroxidase 3 (AAG15509), AAW25625 is S. 
japonicum thioredoxin peroxidase 2 (BAD90102), and AAW27121 has 78% identity to S. 
mansoni immunophilin (AAB05213).  The other S. japonicum sequences the motif was 
found in either lack homology to any other sequence or are homologous only to unknown 
proteins.  The motif occurs between amino acids 40 and 105 in immunophilin, myosin light 
chain, thioredoxin, calreticulin, and calcium binding protein.  It occurs outside this range, 
starting between amino acid 60 and 90, only in thioredoxin peroxidases (AAD17299, 
AAG15507, AAG15507, AAD40685, AAW25625 and AAW25436) and unknown S. 
japonicum proteins (AAW25402 and AAW24755).   
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Figure 15.  MAST #2 high scoring sequences 
Input:  motif from MEME #2 and ~4000 full-length S. mansoni and S. japonicum sequences 
New proteins are outlined in red. 
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Figure 16.  MAST #2 motif diagram 
Input:  motif from MEME #2 and ~4000 full-length S. mansoni and S. japonicum sequences 
Motifs with significant position p-values (<.0001) are indicated by “1”. 
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Another MAST search, MAST #3, Figures 17 and 18, was executed using MEME motif #2 
to search all original vesicle, secretion, and tegument proteins.  Exact duplicate sequences 
were eliminated from this database resulting in a total of 130 proteins.  Proteins with 
position p-values less than .0001 appear in the motif diagram in Figure 18.  These include:  
thioredoxin, thioredoxin peroxidase 1a, thioredoxin peroxidase 2, myosin light chain, 
calreticulin, calcium binding protein, SPO-1 protein, PDI, endoplasmin, elastase 1b, 
phosphoglycerate mutase, and malate dehydrogenase.  Elastase 1b, phosphoglycerate 
mutase, and malate dehydrogenase were new proteins, not discovered in previous MAST 
searches. 
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Figure 17.  MAST #3 high scoring sequences 
Input:  motif from MEME #2 and all sample set proteins with redundancy removed (vesicles, secretions, tegument) 
Motifs with significant position p-values (<.0001) are outlined in red. 
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Figure 18.  MAST #3 motif diagram 
Input:  motif from MEME #2 and all sample set proteins with redundancy removed (vesicles, secretions, tegument) 
Motifs with significant position p-values (<.0001) indicated by “1”. 
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Table 4.  Sample proteins containing xKxGE motif 
Based on MAST #3.  Note that the motif is not conserved in SPO-1 protein shown in red and it was not carried forward into the rest of the analyses. 
An asterisk (*) in the ‘SS?’ column indicates that SignalP did not predict a signal peptide but SIGCLEAVE did predict a signal peptide. 
Protein V S T 
protein 
length 
(aa) SS? 
SS 
cleavage 
site motif 
motif 
start 
motif 
combined 
p-value 
motif 
e-
value 
motif 
position 
p-value 
thioredoxin AAL79841 AAL79841   106 yes* 37 IKNGE 80 1.01E-03 0.17 1.00E-05 
thioredoxin peroxidase 1a     TC14049 185 no n/a EKHGE 162 2.11E-04 0.036 1.00E-06 
thioredoxin peroxidase 2 AAD17299 AAD17299  185 no n/a EKHGE 162 2.11E-04 0.036 1.00E-06 
myosin light chain AAD41591     106 no n/a IKQGE 56 7.23E-04 0.12 5.00E-06 
calreticulin AAA19024     373 yes 17 EKQGE 40 1.05E-03 0.18 3.00E-06 
calcium binding protein AAA29921 AAA29921   154 no n/a NKRGE 100 1.49E-03 0.25 1.00E-05 
SPO-1 protein AAD26122 AAD26122   117 yes 17 EKRME 97 7.21E-03 1.2 6.00E-05 
PDI CAA80520     482 yes 18 LKHGE 90 1.04E-02 1.8 2.00E-05 
elastase 1b AAC46967 AAC46967   274 yes* 19 LKKGE 186 1.33E-02 2.3 5.00E-05 
endoplasmin AAF66929     796 yes 21 TKEGE 49 3.10E-02 5.2 4.00E-05 
phosphoglycerate mutase TC7546 TC7546   250 no n/a 
IRHGE, 
AKHGE 
8,  
91 7.33E-03 1.2 
9.00E-05, 
3.00E-05 
malate dehydrogenase   TC17066   329 no n/a TKEGE 260 1.29E-02 2.2 4.00E-05 
 
   66
For each sample protein predicted by MAST to contain the proposed conserved motif, 
Table 4 (above) provides details about the motif prediction as well as signal peptide 
prediction, where applicable.  Only three of the eleven proteins (27%) were predicted to 
contain a signal peptide by SignalP.  These eleven proteins were further analyzed for signal 
peptides with SIGCLEAVE (Peter Rice, European Bioinformatics Institute, 1989).  
SIGCLEAVE uses the von Heijne method to distinguish signal peptides from non-signal 
peptides (95% accuracy) and to predict the cleavage site (75-80% accuracy).  This analysis 
predicted that five of the eleven proteins had signal peptides:  the same three predicted by 
SignalP and also thioredoxin and elastase 1b.    
The SPO-1 protein does not actually contain the xKxGE motif.  Starting in position 97 the 
amino acid sequence xKxME exists (shown in red in Table 4 ).  It is not likely that 
methionine can substitute for glycine.  Other SPO-1 sequences were evaluated to ensure the 
difference was not due to sequencing error and they were found to also xKxME instead of 
xKxGE.  Hence, SPO-1 was not considered to contain the motif and not included in further 
analyses. CLUSTALW analysis of the remaining eleven proteins and two additional public 
domain proteins found to contain the xKxGE motif was performed.  The resulting multiple 
sequence alignment, which has gaps removed, is shown in Figure 19.  Predicted signal 
peptides are underlined in red.  Cleavage sites are at the C-terminal of the signal peptide.  
The downstream conserved motif predicted by MEME and MAST is underlined in blue for 
each protein.  MEME/MAST does not provide cleavage site predictions. 
The alignment shows that the motif is predicted to occur at positions 261-265 in malate 
dehydrogenase, a protein that is 329 amino acids long.  Given the predicted position and 
the fact that the e-value of the motif in malate dehydrogenase was higher (2.2) than for any 
of the other eleven proteins, it is unlikely that the motif is not real in that protein.  
Phosphoglycerate mutase also has the motif in an unlikely position- amino acid 9-13.  This 
does not leave room for a signal peptide to target the protein to the ER. (It was verified 
using BLAST that the N-terminal of the protein was included.)  These two proteins were 
not considered in further analyses to have the motif of interest.
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Figure 19.  Multiple sequence alignment of sample proteins with the predicted xKxGE motif  
(CLUSTALW alignment with gaps removed) 
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Elastase, of which there are many isoforms, is well-known to be secreted by Schistosoma 
during human invasion.  The xKxGE motif was only found in one of the three isoforms 
identified in vesicles and/or secretions (elastase 1b) and it was found in an unlikely 
position- 186.  Results from MEME #1 (page 65), however, show that in all three elastases 
contained in the sample proteins (AAC46967, A28941, and AAM43941), a motif of 
xRxGE exists starting two amino acids downstream of a signal sequence.  Theorizing that 
the motif is a proprotein convertase recognition site and considering the fact that, at least in 
mammals, proprotein convertases (PCs) are known to cleave immediately after a consensus 
sequence that starts with either K or R (discussed on page 36), we can extrapolate that 
arginine (R) substitutes for lysine (K) in the second position of our proposed conserved 
motif in elastases.  Figure 19 shows the motif IRSGE in elastase 1b (AAC46967) 
underlined in a dotted blue line starting in position 27, and the motif predicted by 
MEME/MAST underlined in a solid blue line starting in position 186.   
Based on all MEME and MAST analyses, two additional S. mansoni proteins not contained 
in any of the sample groups contain the motif:  immunophilin and AUT1.  Immunophilin 
has 88% identity to an S. japonicum protein identified only as SJCHGC01391.  It is not 
predicted to contain a signal peptide but has the conserved motif EKHGE starting at amino 
acid 66.  Two S. mansoni AUT1 proteins exist in NCBI’s nonredundant protein database, 
but only have homology to unidentified proteins.  AUT1 was also predicted not to have a 
signal peptide.  It has the conserved motif SKRGE starting at position 40. 
If, based on the above findings, SPO-1, malate dehydrogenase, and phosphoglycerate 
mutase are eliminated from those proteins we consider to have the conserved motif, and all 
three elastases are considered to have the motif, a total of 11 sample proteins and 2 non-
sample proteins are included, as summarized in Figure 20.  10 of 81 (12.3%) vesicle 
proteins, 6 of 53 (11.3%) secretion proteins, and only 1 of 43 (2.3%) tegument proteins 
contain the motif. As the diagram shows, all 6 proteins contained in secretions that have the 
motif are also contained in vesicles- none are unique to secretions.  However, 4 of the 10 
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proteins in vesicles found to have the motif are unique to vesicles.  Hence, the motif is  
enriched in the vesicles. 
 
Figure 20.  Distribution of proteins found to contain xKxGE 
motif. 
Based on MAST #3 
 
The sequences with the motif but without a predicted signal sequence were analyzed 
further to determine if the reason no signal sequence was predicted was because the N-
terminus of the sequence was missing.  A BLAST search against NCBI’s nonredundant 
protein database was performed using each of these sequences and the starting positions of 
the query sequence and homologous sequences were compared.  Myosin light chain, for 
example, was predicted not to contain a signal peptide.  The top five BLAST hits for 
myosin light chain are shown in Figure 21.  In four of the five hits the homology between 
the query sequence and subject sequence starts at position 1 or position 2.  But in the 
second hit to myosin light chain in Eisenia fetida the homology starts at position 1 of the  
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Figure 21.  Top five BLAST hits for myosin light chain AAD41591 
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subject sequence that had a different N-terminal portion than the query sequence, the 
subject sequence was submitted to SignalP for signal peptide prediction.  But in each case, 
SignalP results still indicated the lack of a signal peptide. 
 
The logo for the proposed conserved motif, below in Figure 22, shows the relative 
conservation of each amino acid in the motif.  The second, fourth, and fifth residues are 
most conserved corresponding to lysine (basic), glycine (nonpolar), and glutamic acid 
(acidic).  This corresponds to an enrichment of Lysine, Glutamic Acid, and Glycine 
residues in the vesicles over the control data set.  Interestingly, the motif does have features 
in common with a conserved motif found in P. falciparum, shown in Figure 23.  The first 
most conserved residue in both motifs is a basic amino acid:  lysine in Schistosoma and 
arginine in Plasmodium.  The last most conserved residue in both motifs is glutamic acid.  
The central most conserved amino acids differ across the two, although there are amino 
acids with nonpolar side chains in both: in Schistosoma glycine is conserved, and in 
Plasmodium lysine and alanine are conserved.  One difference is that serine, which has an 
uncharged polar side chain, is somewhat conserved in Plasmodium. 
 
 
Figure 22.  WebLogo of motif found in S. mansoni sample 
proteins 
(Crooks, Hon et al. 2004) 
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Figure 23.  WebLogo of motif in P. falciparum.   
(Crooks, Hon et al. 2004)  Found across ~320 soluble and insoluble proteins that are  
exported across the PVM into the red blood cell (Hiller, Bhattacharjee et al. 2004). 
 
Further analyses were performed in an effort to determine the possible functions of this 
motif.  Based on the positions of the motifs and signal peptide prediction by SignalP, the 
motif is not a signal peptide.  It was also determined to not be a glycosylation site, a 
protease site, a phosphorylation site, or an elastase recognition motif.  BLAST searches 
determined that the set of proteins containing the motif do not have any significant 
homology to each other (Appendices C and D), hence MEME is not simply finding regions 
of homology across the proteins.  Some propeptide convertases are known to cleave on the 
C-terminal side of sites composed of single or paired basic amino acids; it is possible that 
the motif is a propeptide that is cleaved on the C-terminal side of the second position of the 
motif, lysine or arginine (K/R).   
 
Proteins containing the motif were submitted to ProP, a propeptide predictor based on 
neural networks (Duckert, Brunak et al. 2004).  The general propeptide convertase-specific 
network was used, which was trained on 235 cleavage sites and 1072 negative sites from 
the SWISS-PROT protein database.  It is important to note that the training sequences did 
not contain any Schistosoma sequences.  The sensitivity of the network is 61.7, the 
specificity is 59.7, and the correlation coefficient is .60.  Appendix E contains the positive 
results from this prediction method.  9 of the 14 proteins (64%) containing the motif 
predicted by MEME/MAST were predicted to have one or more propeptides by ProP:  the 
three elastases, the two thioredoxin peroxidases, calcium binding protein, calreticulin, 
phosphoglycerate mutase, and AUT1.  ProP only predicted the same motif/position for 
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calcium binding protein that MEME/MAST predicted:  NKRGE starting at position 100.  
Given the relatively low sensitivity and specificity of the ProP predictor, the 
MEME/MAST results were considered authoritative over the ProP results. 
 
In order to determine how the proposed conserved motif fits into a secretion model, it is 
necessary to better understand the functions of the proteins that contain it.  All sample 
proteins were functionally annotated with protein domains and GO terms using 
InterProScan.  Methods were developed for transforming the data into matrices of protein 
domain and GO annotations versus sequence identifiers/descriptions, as explained under 
Protein Domain/Gene Ontology Annotation and Statistical Analysis.  Smaller matrices 
containing the subset of sample proteins containing the proposed conserved motif were 
extracted from the larger matrices and are shown in Tables 5 and 6.  These matrices 
provide a quick visualization of protein domains and GO annotations that the proteins do 
and do not have in common.  They also give a starting point for more detailed analysis. 
The domain matrix in Table 5 shows that several of the proteins have domains in common:  
1) both the calcium binding protein and myosin light chain have an EF-Hand motif, 2) both 
thioredoxin and PDI have a thioredoxin-related domain, and 4) thioredoxin peroxidase 1a, 
thioredoxin peroxidase 2, thioredoxin, and PDI have a thioredoxin-like fold.  The GO 
annotation matrix in Table 6 shows the following:  both endoplasmin and calreticulin are 
involved in protein folding; calcium binding protein, myosin, and calreticulin are all 
involved in calcium ion binding; thioredoxin and PDI are involved in electron transport 
activity; and the elastases are involved in peptidase activity.   
 
AUT1 (AAF82607, not included in Tables 5 or 6) contains a Hyaluronan/mRNA binding 
protein domain (IPR006861), which includes a family of proteins that have been shown to 
bind hyaluronan, a glucosaminoglycan.  Immunophilin (AAA67867, not included in tables 
5 or 6) contains a peptidylprolyl isomerase domain (IPR001179) as well as three 
tetratricopeptide-related domains (IPR001440, IPR11990, IPR13026).  The peptidylprolyl 
isomerase domain is involved in accelerating protein folding by catalyzing the cis-trans 
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isomerization of proline imidic peptide bonds in oligopeptides.  The tetratricopeptide-
related domains mediate protein-protein interactions and the assembly of multiprotein 
complexes.  They are involved in a variety of biological processes including peroxisomal 
protein transport and protein folding. 
 
Interestingly, endoplasmin, calreticulin, and PDI have historically all been known to reside 
in the ER lumen.  Such ER-residing proteins are usually distinguished by the presence of 
the sequence KDEL at the C-terminal.  This sequence does indeed exist at the C-terminal 
of PDI.  In endoplasmin the C-terminal sequence is KNEL and in calreticulin the C-
terminal sequence is HDEL.  It has been shown, however, that PDI and endoplasmin can be 
secreted via the normal secretory pathway even when they contain an ER-retention signal 
(Takemoto, Yoshimori et al. 1992) and PDI has also found to be more highly concentrated 
in secretory cells (Edman, Ellis et al. 1985).  It has been found that the active site of PDI 
closely resembles that of the redox protein thioredoxin and, therefore, may catalyze 
disulphide bond formation  (Freedman R. B., Hirst T. R. et al. 1994).  
 
To determine the relatedness of proteins within a sample group, a phylogenetic tree was 
also constructed for each sample group using CLUSTALW as explained under Homology 
Analysis.  The complete phylogenetic trees are shown on pages 104-106.  Proteins were 
assigned to phylogenetic groups as labeled on the trees according to the natural groups they 
would fall into if the tree was cut just below the main branch.  The tables on pages 107-115 
provide details about the functions related to the proteins contained in each phylogenetic 
group for each sample set.   
 
Phylogenetic groupings, domains and GO terms are summarized in Table 7 for the vesicle 
and secretion proteins containing the proposed conserved motif.  It shows that all of the 
proteins except the elastases belong to the same major phylogenetic group, 1.  Five of the 
proteins belong to 1a, one belongs to 1d, one belongs to 1g, and the elastases belong to 
group 2.  Phylogenetic group 1a is related to unfolded protein binding, calcium ion 
binding, motor activity, and electron transporter activity.  Group 1d is related to electron 
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transporter activity, glycolysis, and gluconeogenesis.  Group 1g is related to a diverse set 
of functions including glycolysis, carbohydrate metabolism, protein polymerization, and 
protein folding.  Group 2 corresponds to peptidase activity. 
 
Considering all detailed annotation data together it is possible to theorize about the 
functions of the proteins containing the xKxGE motif.  It was found in proteins related to 
calcium binding and regulation, protein folding, and protease activity. Calreticulin is 
implicated in a large and diverse number of functions.  One of its key functions in 
Schistosoma cercaria may be to bind to the clathrin coat of the vesicles while still in the 
Golgi apparatus.  Perhaps it also plays a role in the uptake of other proteins into the 
vesicles.  Once inside the vesicles calreticulin likely plays a role in protein folding along 
with several other proteins.  Myosin light chain and calcium binding protein are likely 
involved in motor activity that propels the vesicles out of the acetabular glands and guides 
them to their target epidermal cells.  The proteins with calcium binding domains, which 
include calcium binding protein, myosin, and calreticulin, are likely to be important in the 
initial binding to target epidermal cells.  PDI, endoplasmin, calreticulin, and the two 
proteins not in the samples but found in S. japonicum, immunophilin and AUT1, all have 
chaperone activity, which promotes proper protein folding to prevent protein aggregation 
and degradation by proteases.  Though AUT1 was not found in the sample proteins, 
domain analysis indicates it has functions in common with calreticulin, and the proposed 
motif occurs in the same position in these two proteins.   Thioredoxin and PDI, as 
discussed, are likely to function as catalysts for disulfide bond formation.  The thioredoxin 
peroxidases are involved in oxidation of thioredoxin and have antioxidant activity which 
likely helps protect the secreted proteins from damage during human host invasion.  
Finally, the elastases have peptidase activity which is directly related to breaking down 
various layers of human host epidermal tissues. 
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Table 5.  Proteins containing predicted conserved motif vs. protein domains 
0 indicates the protein does not contain the corresponding domain, 1 indicates the protein does contain the corresponding domain. 
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Table 6.  Sample sequences containing predicted conserved motif vs. GO terms 
0 indicates the protein does not contain the corresponding GO term, 1 indicates the protein does contain the corresponding GO term.   
Note that thioredoxin peroxidase 1a and 2 do not have any corresponding GO terms. 
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Table 7.  Summary of motif-containing vesicle and secretion proteins. 
 
Description 
Accession 
number 
Phylogenetic 
Group 
Sample Group 
(V= Vesicles, 
S= Secretions) Protein domains GO terms 
Calcium-binding 
protein     AAA29921 1a V, S 
EF-Hand; calcium-binding; flagellar 
calcium-binding protein 
calcium ion binding, 
ciliary or flagellar 
motility 
Thioredoxin 
peroxidase 2    AAD17299 1a V, S 
Thioredoxin-like fold; alkyl 
hydroperoxide reductase; Thiol 
specific antioxidant protein folding 
Myosin light chain    AAD41591 1a V EF-Hand calcium ion binding 
Endoplasmin AAF66929 1a V 
Four-helical cytokine; Heat shock 
protein Hsp90 
unfolded protein 
binding; protein folding 
Protein-disulfide 
isomerase homolog CAA80520 1a V Thioredoxin fold; thioredoxin related electron transport 
Thioredoxin      AAL79841 1d V, S Thioredoxin fold; thioredoxin related electron transport 
Calreticulin AAA19024 1g V 
calreticulin/calnexin; Concanavalin 
A-like lectin/glucanase, subgroup; 
Concanavalin A-like lectin/glucanase 
unfolded protein 
binding; protein folding; 
calcium ion binding 
Elastase (elastase 1b)    AAC46967 2 V, S 
Peptidase S1A, chymotrypsin; 
Peptidase S1 and S6, 
chymotrypsin/Hap; Peptidase, 
trypsin-like serine and cysteine 
serine-type 
endopeptidase activity; 
proteolysis 
Pancreatic elastase 
precursor (elastase 1a)  A28942 2 V, S 
Peptidase S1A, chymotrypsin; 
Peptidase S1 and S6, 
chymotrypsin/Hap; Peptidase, 
trypsin-like serine and cysteine 
serine-type 
endopeptidase activity; 
proteolysis 
Elastase 2a    AAM43941 2 V, S 
Peptidase S1A, chymotrypsin; 
Peptidase S1 and S6, 
chymotrypsin/Hap; Peptidase, 
trypsin-like serine and cysteine; 
Peptidase S1B, glutamyl 
endopeptidase I 
serine-type 
endopeptidase activity; 
proteolysis;  serine-type 
peptidase activity 
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Homology Analysis 
 
To determine the level of identity within and across sample sets, BLAST searches were 
performed using each sample set as the query against either itself or a different sample set.  
The blastp program was used with the default settings.  A Perl script was used to parse all 
hits where the total length of the high scoring pair (HSP) was greater than 100, the hit 
significance was better than 1 x 10-05, and the percent identity was greater than 50%.  
Results are shown in Appendices D (homology within sample sets) and E (homology 
across sample sets). 
 
None of the sample sets has a high level of identity within it.  Within the vesicle proteins 
there are three elastases with 80% or greater homology to each other and three other 
proteins with 55% - 66% homology to each other, including tropomyosin, thioredoxin 
peroxidase, and a 14-3-3 protein homolog.  Within the secretion proteins, the same three 
elastases exist and also two peptidyl-prolyl cis-trans isomerase proteins with 57% 
homology to each other.  Within the tegument proteins there are two unidentified proteins 
with 74% homology to each other. 
 
Two of fifty three secretion proteins showed ~99% homology to tegument proteins; these 
were thioredoxin peroxidase and ATP dephosphohydrolase I.  Similarly, two of eighty one 
vesicle proteins had high homology to tegument proteins- thioredoxin peroxidase and 
fimbrin.  Two other vesicle proteins, a major egg antigen and an unidentified protein, 
showed about 50% homology to two unidentified tegument proteins.  These intersections 
are illustrated in Figure 24. 
 
Considerably higher homology was found between vesicle and secretion proteins, as 
expected.  Of the 53 secretion proteins, 41, or 77% were identical to vesicle proteins.  
Homology between the other proteins was not high.  There are several proteins unique to 
either secretions or vesicles.  The protein domains and GO terms that correspond to each 
set of proteins that are unique to a specific sample set are shown in Figures 25-29.  
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Figure 24.  Venn diagram of similarity across sample proteins 
Numbers in parentheses represent the percent similarity between the proteins across sample types. 
 
 
 
Proteins unique to vesicles included: calcium-binding protein (fluke), tubulin, myosin 
heavy chain, myosin light chain, paramyosin, tropomyosin, calreticulin, calcium ATPase, 
translationally-controlled tumor protein (TCTP)/histamine-releasing factor, and arginase.  
Calcium-binding protein, tubulin, myosin heavy chain, myosin light chain, paramyosin, 
and tropomyosin are all related to motor activity and microtubule-based movement and are 
likely used in early stages of human host invasion to guide the vesicles to their target.  The 
role of TCTP/histamine-releasing factor is unknown, but it has been shown to bind to 
tubulin and has a high affinity for calcium.  It is also the binding target for the anti-malarial 
compound artemisinin.  The reason that so many of these proteins are uniquely found in the 
mechanically-induced sample compared to the lipid-induced sample may be related to the 
method used to collect the lipid-induced secretions.  Cercarial bodies and heads were 
separated from lipid-induced secretions by centrifugation (Knudsen, Medzihradszky et al. 
2005).  This process may have also separated out the aggregated vesicular membranes, 
where proteins related to vesicular movement were attached.  Mechanical induction 
secretions were separated by scraping vesicles from the surface of the plate, which retained 
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the vesicular membrane in the sample.  Calreticulin is implicated in protein folding and 
may be degraded in the lipid-induced secretions.  Both calcium ATPase and arginase are 
metabolic enzymes that are responsible for extrusion of calcium and nitrogen respectively 
and, as such, would not be expected to be contained in the vesicles.  Calcium ATPase 
contains a transmembrane domain.   
 
Secretion proteins that did not show homology to either of the other two sample sets 
include: Cu,Zn-superoxide dismutase, ferritin-2 heavy chain, 6-phosphofructokinase,  fatty 
acid-binding protein, calpain,  cysteine protease inhibitor, and dynein light chain.  Cu,Zn-
superoxide dismutase, ferritin-2 heavy chain, 6-phosphofructokinase and fatty acid-binding 
protein are all soluble proteins.  Calpain is an intracellular cysteine protease that is 
regulated by calcium.  Its inhibitor is also unique to the secretions sample.  As raised by 
Knudsen et al., one possible reason for the presence of soluble proteins in the vesicle 
secretions is that the secretions do not just contain vesicle proteins, but also proteins 
contained in the cytosol of the acetabular glands (Knudsen, Medzihradszky et al. 2005).  
With the exception of dynein light chain, this could explain the presence of all of the 
proteins unique to the lipid-induced sample.  
 
The proteins found in the tegument were quite different than those found in the vesicles and 
secretions, including such proteins as amidase, dysferlin, aquaporin, and many unidentified 
proteins.  These proteins, not surprisingly, are all related to transport.  
 
To determine the evolutionary relationships between the proteins contained in each sample 
set, a phylogenetic tree was created for each, as shown in Figures 30-32. The trees were 
generated using the alignment files resulting from the CLUSTALW alignment of each 
sample set.  Proteins were then assigned to phylogenetic groups as labeled on the trees 
according to the natural groups they would fall into if the tree was cut just below the main 
branch.  Table 8 provides full details about the protein domains and GO functions related to 
the proteins contained in each phylogenetic group for each sample set.   
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The vesicle, secretion, and tegument proteins seem to have four, six, and three major 
phylogenetic groupings respectively.  In the vesicles there are four major phylogenetic 
groups.  Group 1 is very large and represents 55 proteins with a diverse set of functions 
including calcium-binding protein and microtubule and motor-based movement proteins.  
Group two has 17 members representing mainly chaperones and the elastases.  Groups 
three and four are very small with glycolysis and metabolism represented.  In the secretions 
there are three major groups.  The chaperones, calcium-binding proteins, and elastases 
group together in the same major phylogenetic group, group one.  Group two contains 
glycolytic and metabolic enzymes as well as two antigenic proteins.  Group three relates to 
proton, electron, and iron transport as well as microtubule-based processes.  In the 
tegument there are also 3 major groups.  Group one is the largest group representing a 
diverse set of processes including transport, protein modification, biosynthesis and 
targeting, and metabolism.  Group two contains only proteins related to transport and group 
three contains proteins related to exocytosis/vesicle docking and nucleotide metabolism. 
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Figure 25.  Protein domains corresponding to vesicle-specific proteins 
 
       84
 
Figure 26.  GO terms corresponding to vesicle-specific proteins. 
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Figure 27.  Protein domains corresponding to secretion-specific proteins 
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Figure 28.  GO terms corresponding to secretion-specific proteins
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Figure 29.  Protein domains and GO terms corresponding to tegument-specific proteins
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Figure 30.  Phylogenetic tree of vesicle proteins 
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Figure 31.  Phylogenetic tree of secretion proteins 
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Figure 32.  Phylogenetic tree of tegument proteins 
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Table 8.  GO terms and protein domains associated with phylogenetic groups 
Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Vesicles 1a 
Molecular Functions: ATP binding, unfolded 
protein binding, calcium ion binding, motor activity, 
electron transporter activity, glutamate-ammonia 
ligase activity;  
Biological Process: protein folding, electron 
transport, ciliary or flagellar motility, nitrogen 
compound metabolism;  
Cellular Component: myosin, flagellum 
Troponin; Calcium-binding EF-hand; Flagellar calcium-binding 
protein calflagin; Recoverin; EF-Hand type; Thioredoxin-like fold; 
Thioredoxin fold; Thioredoxin-related; Alkyl hydroperoxide 
reductase/ Thiol specific antioxidant/ Mal allergen; Tropomyosin; 
Myosin tail; Myosin, N-terminal, SH3-like; Myosin head, motor 
region;  Endoplasmic reticulum targeting sequence; Four-helical 
cytokine; Heat shock protein Hsp90; Protein of unknown function 
DUF465; Glutamine synthetase class-I, adenylation site 
Vesicles 1b 
Molecular Function: catalytic activity, ATPase 
activity;  
Biological Process: metabolism, cation transport;  
Calcium-binding EF-hand; EF-Hand type; Filamin/ABP280 repeat; 
Carbohydrate kinase, PfkB; Haloacid dehalogenase-like hydrolase; 
Cation transporting ATPase, N-terminal; Cation transporting 
ATPase, C-terminal; ATPase, E1-E2 type; E1-E2 ATPase-associated 
region; Cation transporting ATPase;  
Vesicles 1c 
Molecular Function: serine-type endopeptidase 
inhibitor activity;  
Biological Process: cell adhesion;  
Beta-Ig-H3/fasciclin; Proteinase inhibitor I4, serpin;  
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Vesicles 1d 
Molecular Function: intramolecular transferase 
activity, ATP binding, GTP binding, hydrogen-
transporting ATP synthase activity, hydrogen-
transporting ATPase activity, hydrolase activity, 
electron transporter activity, molecular function 
unknown, phosphoenolpyruvate carboxykinase 
activity;  
Biological Process: glycolysis, electron transport, 
ATP synthesis coupled proton transport, ATP 
biosynthesis, gluconeogenesis;   
Cellular Component: cytoplasm, proton-
transporting two-sector ATPase complex;  
Phosphoglycerate mutase; Phosphoglycerate mutase 1 
H+-transporting two-sector ATPase, alpha/beta subunit, central 
region; H+-transporting two-sector ATPase, alpha/beta subunit, N-
terminal; H+-transporting two-sector ATPase, alpha/beta subunit, C-
terminal; Thioredoxin fold; ATP synthase F1, alpha subunit; 
Thioredoxin-related; Translationally controlled tumor protein; Mss4-
like; Phosphoenolpyruvate carboxykinase GTP;  
Vesicles 1e 
Molecular Function: binding, transporter activity, 
DNA binding, phosphorylase activity, pyridoxal 
phosphate binding, triose-phosphate isomerase 
activity;  
Biological Process: transport, nucleosome assembly, 
chromosome organization and biogenesis [sensu 
Eukaryota], carbohydrate metabolism, metabolism 
Cellular Component: membrane, mitochondrial 
inner membrane, nucleosome, nucleus;   
Mitochondrial substrate carrier; Adenine nucleotide translocator 1; 
Mitochondrial carrier protein; Histone core; Histone-fold; Histone 
H2B; Glycosyl transferase, family 35; Glycogen/starch/alpha-glucan 
phosphorylase; Triosephosphate isomerase;  
Vesicles 1f 
Molecular Function: ATP binding, pyruvate kinase 
activity, protein binding, microtubule motor activity, 
phosphoglycerate kinase activity, motor activity, 
protein kinase activity, arginase activity, catalytic 
activity, structural constituent of cytoskeleton, actin 
binding;  
Biological Process: glycolysis, microtubule-based 
process, protein amino acid phosphorylation, 
arginine catabolism;  
Cellular Component: microtubule associated 
complex, actin filament; 
Pyruvate kinase; Thioredoxin fold; Dynein light chain, type 1; 
Phosphoglycerate kinase; Glutathione S-transferase, C-terminal-like; 
Glutathione S-transferase, C-terminal; Glutathione S-transferase, N-
terminal; Protein kinase; Protein kinase-like; Arginase; 
Arginase/agmatinase/formiminoglutamase; Actin; Actin/actin-like; 
Calponin-like actin-binding; Actin-binding, actinin-type;  
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Vesicles 1g 
Molecular Function: nucleic acid binding, ATP 
binding, GTP binding, GTPase activity, structural 
molecule activity, unfolded protein binding, enzyme 
inhibitor activity, calcium ion binding, hydrogen-
transporting ATP synthase activity, hydrogen-
transporting ATPase activity, nucleotide binding, 
nucleoside-triphosphatase activity, hydrogen-
exporting ATPase activity, nucleoside diphosphate 
kinase activity, magnesium ion binding, transferase 
activity, citrate [Si]-synthase activity, hydrolase 
activity, phosphopyruvate hydratase activity, 
Biological Process: glycolysis, protein 
polymerization, microtubule-based movement, 
protein folding, negative regulation of nucleoside 
metabolism, ATP synthesis coupled proton transport, 
ATP biosynthesis, GTP biosynthesis, UTP 
biosynthesis, CTP biosynthesis, pyrimidine 
ribonucleoside triphosphate biosynthesis, main 
pathways of carbohydrate metabolism, tricarboxylic 
acid cycle;   
Cellular Component: cytoplasm, protein complex, 
microtubule, mitochondrion, proton-transporting 
two-sector ATPase complex, integral to membrane, 
hydrogen-translocating F-type ATPase complex, 
phosphopyruvate hydratase complex, endoplasmic 
reticulum 
Tubulin/FtsZ, C-terminal; Tubulin; Tubulin/FtsZ, GTPase; Beta 
tubulin; Mitochondrial ATPase inhibitor, IATP; H+-transporting 
two-sector ATPase, alpha/beta subunit, central region; AAA 
ATPase; H+-transporting two-sector ATPase, alpha/beta subunit, N-
terminal; H+-transporting two-sector ATPase, alpha/beta subunit, C-
terminal; ATP synthase F1, beta subunit; Nucleoside diphosphate 
kinase; Nucleoside-diphosphate kinase; Band 7 protein; Prohibitin; 
Citrate synthase; Citrate synthase, eukaryotic; AAA-protein 
subdomain; AAA ATPase VAT, N-terminal; Aspartate 
decarboxylase-like fold; AAA ATPase, central region; AAA 
ATPase, CDC48; RNA-binding region RNP-1 RNA recognition 
motif; Nucleotide-binding, alpha-beta plait; Enolase; Peptidyl-prolyl 
cis-trans isomerase, cyclophilin type;HSP20-like chaperone; Alpha 
crystallin; Heat shock protein Hsp20; Heat shock protein 70; Heat 
shock protein Hsp70; Calreticulin/calnexin; Concanavalin A-like 
lectin/glucanase, subgroup; Concanavalin A-like lectin/glucanase; 
Calreticulin; Alpha tubulin 
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Vesicles 2 
Molecular Function: intramolecular transferase 
activity; nucleic acid binding; helicase activity; ATP 
binding; protein binding; structural constituent of 
ribosome; fructose-bisphosphate aldolase activity; 
kinase activity; transferase activity; serine-type 
peptidase activity; serine-type endopeptidase activity; 
actin binding; unfolded protein binding; transketolase 
activity; DNA binding; 
Biological Process: glycolysis; protein folding; 
anaerobic glycolysis; cellular protein metabolism; 
nucleosome assembly; chromosome organization and 
biogenesis [sensu Eukaryota]; carbohydrate 
metabolism; protein biosynthesis; proteolysis; 
actomyosin structure organization and biogenesis 
Cellular Component: nucleosome; nucleus; 
intracellular; ribosome;  
Helicase, C-terminal; DEAD/DEAH box helicase, N-terminal; 
Chaperonin TCP-1; Chaperonin Cpn60; Chaperonin Cpn60/TCP-1; 
GroEL-like chaperone, ATPase; T-complex protein 1, epsilon 
subunit; T-complex protein 1, zeta subunit; L-lactate dehydrogenase; 
Transketolase, central region; Transketolase, C-terminal-like; 
Transketolase, C-terminal; Transketolase, N-terminal; Bacterial 
transketolase; Histone core; Histone-fold; Histone H4; T-complex 
protein 1, gamma subunit; T-complex protein 1, beta subunit; 
Ribosomal protein L11; 
Phosphoglucomutase/phosphomannomutase; 
Phosphoglucomutase/phosphomannomutase C terminal; 
Phosphoglucomutase/phosphomannomutase alpha/beta/alpha 
domain II; Phosphoglucomutase/phosphomannomutase 
alpha/beta/alpha domain III; 
Phosphoglucomutase/phosphomannomutase alpha/beta/alpha 
domain I; Fructose-bisphosphate aldolase, class-I; ATP:guanido 
phosphotransferase; Peptidase S1B, glutamyl endopeptidase I; 
Peptidase S1A, chymotrypsin; Peptidase S1 and S6, 
chymotrypsin/Hap; Peptidase, trypsin-like serine and cysteine; 
Calponin repeat; Calponin; Calponin-like actin-binding; 
SM22/calponin 
Vesicles 3 
Molecular Function: malate dehydrogenase activity, 
L-lactate dehydrogenase activity, oxidoreductase 
activity, L-malate dehydrogenase activity, protein 
domain specific binding 
Biological Process: glycolysis, malate metabolism, 
tricarboxylic acid cycle intermediate metabolism, 
anaerobic glycolysis, electron transport;  
Cellular Component: cytoplasm;  
Malate dehydrogenase, active site; L-lactate/malate dehydrogenase; 
Lactate/malate dehydrogenase; Malate dehydrogenase, NAD-
dependent, eukaryotes and gamma proteobacteria; L-lactate 
dehydrogenase; Fumarate reductase/succinate dehydrogenase 
flavoprotein, N-terminal; Fumarate reductase/succinate 
dehydrogenase flavoprotein, C-terminal; 14-3-3 protein;  
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Vesicles 4 
Molecular Function: GTP binding, DNA binding, 
glyceraldehyde-3-phosphate dehydrogenase 
[phosphorylating] activity, NAD binding, 
aminopeptidase activity, leucyl aminopeptidase 
activity, manganese ion binding 
Biological Process: glycolysis, nucleosome 
assembly, chromosome organization and biogenesis 
[sensu Eukaryota], protein biosynthesis, proteolysis, 
protein metabolism;  
Cellular Component: cytoplasm, nucleosome, 
nucleus, intracellular;  
Histone core; Histone-fold; Histone H3; Glyceraldehyde 3-
phosphate dehydrogenase; Elongation factor Tu, domain 2; 
Translation factor; Protein synthesis factor, GTP-binding; EF-
Tu/eEF-1alpha/eIF2-gamma, C-terminal; Elongation factor Tu, C-
terminal; Peptidase M17, leucyl aminopeptidase, C-terminal; 
Peptidase M17, leucyl aminopeptidase 
Secretions 1a 
Molecular Function: serine-type endopeptidase 
activity, calcium ion binding, aminopeptidase 
activity, GTP binding, binding, lipid binding, serine-
type peptidase activity, ATP binding, hydrolase 
activity, phosphorylase activit, pyridoxal phosphate 
binding, DNA binding, structural molecule activity, 
pyruvate kinase activity  
Biological Process: proteolysis, ciliary or flagellar 
motility, transport, protein biosynthesis, glycolysis, 
carbohydrate metabolism, nucleosome assembly, 
chromosome organization and biogenesis, 
microtubule-based movement, GTPase activity, 
protein polymerization 
Cellular Component: intracellular, flagellum, 
cytoplasm, nucleosome, nucleus, microtubule, 
protein complex 
Peptidase S1 and S6, chymotrypsin/Hap, Peptidase, trypsin-like 
serine and cysteine, Peptidase S1A, chymotrypsin, Peptidase C2, 
calpain, EF-Hand type, Peptidase, cysteine peptidase active site, 
Calcium-binding EF-hand, Flagellar calcium-binding protein 
calflagin, Peptidase M17, leucyl aminopeptidase, C-terminal, 
Cytosolic fatty-acid binding, Calycin, Lipocalin-related protein and 
Bos/Can/Equ allergen, Calycin-like, Peptidase S1B, glutamyl 
endopeptidase I, Nucleoside phosphatase GDA1/CD39, Heat shock 
protein Hsp70, Heat shock protein 70, Protein synthesis factor, GTP-
binding, Elongation factor Tu, C-terminal, EF-Tu/eEF-1alpha/eIF2-
gamma, C-terminal, Translation factor, Elongation factor Tu, domain 
2, Glycosyl transferase, family 35, Glycogen/starch/alpha-glucan 
phosphorylase, Histone-fold, Histone core, Histone H3, Histone H4, 
Recoverin, Tubulin, Beta tubulin, Tubulin/FtsZ, GTPase, 
Tubulin/FtsZ, C-terminal, Cell division protein FtsZ, Pyruvate 
kinase 
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Secretions 1b 
Molecular Function: unfolded protein binding, 
copper, zinc superoxide dismutase activity, metal ion 
binding, protein binding, ATP binding, 
glyceraldehyde-3-phosphate dehydrogenase, 
phosphorylating activity, NAD binding, 
phosphoglycerate kinase activity, phosphopyruvate 
hydratase activity, DNA binding 
Biological Process: protein folding, superoxide 
metabolism, cellular protein metabolism, glycolysis, 
nucleosome assembly, chromosome organization and 
biogenesis  
Cellular Component: phosphopyruvate hydratase 
complex, nucleosome, nucleus 
Heat shock protein Hsp90, Four-helical cytokine, Superoxide 
dismutase, copper/zinc binding, Chaperonin Cpn60, Chaperonin 
Cpn60/TCP-1, GroEL-like chaperone, ATPase, Glyceraldehyde 3-
phosphate dehydrogenase, Phosphoglycerate kinase, Peptidyl-prolyl 
cis-trans isomerase, cyclophilin type, Enolase, Histone H2B, 
Histone-fold, Histone core,  
Secretions 1c 
Molecular Function: calcium ion binding, 
oxidoreductase activity, ATP binding, cysteine 
protease inhibitor activity, endopeptidase inhibitor 
activity, kinase activity, transferase activity, 
nucleoside diphosphate kinase activity, magnesium 
ion binding, L-lactate dehydrogenase activity 
Biological Process: actomyosin structure 
organization and biogenesis, metabolism, glycolysis, 
GTP biosynthesis, UTP biosynthesis, CTP 
biosynthesis, pyrimidine ribonucleoside triphosphate 
biosynthesis, anaerobic glycolysis, tricarboxylic acid 
cycle intermediate metabolism 
Cellular Component: intracellular, cytoplasm  
Calponin-like actin-binding, Thioredoxin fold, Calponin repeat, 
SM22/calponin, Calponin, Glucose/ribitol dehydrogenase, Alkyl 
hydroperoxide reductase/ Thiol specific antioxidant/ Mal allergen, 
Proteinase inhibitor I25, cystatin, Proteinase inhibitor I25A, stefin 
A,ATP:guanido phosphotransferase, Nucleoside diphosphate kinase, 
Nucleoside-diphosphate kinase, L-lactate dehydrogenase, 
Lactate/malate dehydrogenase, L-lactate/malate dehydrogenase  
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Secretions 2 
Molecular Function: calcium ion binding, calcium 
ion binding, oxidoreductase activity, 
phosphoenolpyruvate carboxykinase activity, GTP 
binding 
Biological Process: metabolism, gluconeogenesis, 
glycolysis, triose-phosphate isomerase activity, 
fructose-bisphosphate aldolase activity, protein 
domain specific binding, 6-phosphofructokinase 
activity 
Cellular Component: 6-phosphofructokinase 
complex, cytoplasm, L-lactate dehydrogenase 
activity, tricarboxylic acid cycle intermediate 
metabolism, malate metabolism, L-malate 
dehydrogenase activity, malate dehydrogenase 
activity, intramolecular transferase activity 
EF-Hand type, Calcium-binding EF-hand, Actin-binding, actinin-
type, Calponin-like actin-binding, Phosphoenolpyruvate 
carboxykinase GTP, Triosephosphate isomerase, Fructose-
bisphosphate aldolase, class-I, 14-3-3 protein, Phosphofructokinase, 
6-phosphofructokinase, eukaryotic type, Lactate/malate 
dehydrogenase, L-lactate/malate dehydrogenase, Malate 
dehydrogenase, NAD-dependent, eukaryotes and gamma 
proteobacteria, Malate dehydrogenase, active site, Malate 
dehydrogenase, NAD-dependent, cytosolic, Malate dehydrogenase, 
NAD or NADP, Malate dehydrogenase, Phosphoglycerate mutase 1, 
Phosphoglycerate mutase 
Secretions 3 
Molecular Function: serine-type endopeptidase 
inhibitor activity, protein binding, motor activity, 
structural constituent of cytoskeleton, binding, 
electron transporter activity, ATP binding, ferric iron 
binding, microtubule motor activity, hydrogen-
exporting ATPase activity, hydrogen-transporting 
ATP synthase activity, hydrogen-transporting 
ATPase activity, nucleotide binding, nucleoside-
triphosphatase activity 
Biological Process: ATP synthesis coupled proton 
transport, electron transport, iron ion transport, iron 
ion homeostasis, microtubule-based process, ATP 
biosynthesis 
Cellular Component: actin filament, microtubule 
associated complex, integral to membrane, hydrogen-
translocating F-type ATPase complex, proton-
transporting two-sector ATPase complex  
Glutathione S-transferase, C-terminal, Glutathione S-transferase, C-
terminal-like, Glutathione S-transferase, N-terminal, Thioredoxin 
fold, Proteinase inhibitor I4, serpin, Actin/actin-like, Actin, 
Thioredoxin-related, Carbohydrate kinase, PfkB, Filamin/ABP280 
repeat, Ferritin, Ferritin-related, Ferritin and Dps, 
Ferritin/ribonucleotide reductase-like, Dynein light chain, type 1, 
ATP synthase F1, beta subunit, H+-transporting two-sector ATPase, 
alpha/beta subunit, central region, H+-transporting two-sector 
ATPase, alpha/beta subunit, C-terminal, H+-transporting two-sector 
ATPase, alpha/beta subunit, N-terminal, AAA ATPase 
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Tegument 1a 
Molecular Function: transporter activity, protein 
binding  
Biological Process: transport 
Cellular Component: integral to membrane, 
membrane, extracellular region 
C2 calcium/lipid-binding region, CaLB, Allergen V5/Tpx-1 related, 
Aquaporin, Major intrinsic protein, CD9/CD37/CD63 antigen, 
Tetraspanin, PDZ/DHR/GLGF, Calponin-like actin-binding, HSP20-
like chaperone, Heat shock protein Hsp20, Alpha crystallin,  
Tegument 1b 
Molecular Function: calcium ion binding, calcium-
dependent phospholipid binding, protein-L-
isoaspartate [D-aspartate] O-methyltransferase 
activity, structural constituent of ribosome 
Biological Process: protein modification, protein 
biosynthesis, protein targeting  
Cellular Component: intracellular, ribosome, Golgi 
stack 
Annexin, FerI, C2 calcium/lipid-binding region, CaLB, Protein-L-
isoaspartateD-aspartate O-methyltransferase, Thioredoxin-like fold, 
Ubiquitin, Ribosomal protein L40e, Protein of unknown function 
DUF1606, AP2 clathrin adaptor, alpha and beta chain, appendage 
Tegument 1c 
Molecular Function: amidase activity, catalytic 
activity, nucleic acid binding, helicase activity, ATP 
binding  
Biological Process: metabolism  
Cellular Component: integral to membrane 
Amidase, Thioredoxin-like fold, CD9/CD37/CD63 antigen, 
Tetraspanin, Alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen, Thioredoxin fold, AMP-dependent 
synthetase and ligase, DEAD/DEAH box helicase, N-terminal, 
Helicase, C-terminal 
Tegument 2 
Molecular Function: transporter activity, hydrolase 
activity, sugar porter activity 
Biological Process: transport, carbohydrate transport  
Cellular Component: integral to membrane, 
membrane, intracellular 
Nucleoside phosphatase GDA1/CD39, Phosphatidylinositol transfer 
protein, General substrate transporter, Sugar transporter, Sugar 
transporter superfamily, CAP protein 
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Sample 
Type 
Phylo-
genetic 
Group Associated GO terms Associated Protein Domains 
Tegument 3 
Molecular Function: calcium ion binding, hydrolase 
activity, molecular function unknown 
Biological Process: exocytosis, vesicle docking, 
nucleotide metabolism  
Cellular Component: cytoplasm 
Exocyst complex component Sec10, Snf7, Spectrin repeat, Calcium-
binding EF-hand, EF-Hand type, Type I 
phosphodiesterase/nucleotide pyrophosphatase, Filamin/ABP280 
repeat, Calponin-like actin-binding 
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Protein Domain/Gene Ontology Annotation and Statistical Analysis 
All proteins in each of the sample sets were annotated with GO terms and protein domains 
using InterProScan.  Domains and GO terms with an e-value less than 1x10-5 were 
considered significant.  A partial example of the raw results generated by InterProScan is 
provided in Figure 33.  A Perl script (Appendix J) was written to parse the raw results into 
1) counts of GO terms (Appendix F), 2) counts of protein domains (Appendix G), 3) 
matrices of sequence identifier vs. GO terms, and 4) matrices of sequence identifier vs. 
protein domains.  The matrices were used as input files for a Matlab script (Appendix J) 
that computed the entropy of each GO term (Appendix H) and protein domain (Appendix 
I).   
Entropy was calculated for each attribute (protein domain or GO id) and used to determine 
the most statistically significant GO terms and protein domains.  The overall information 
(I) contained in a data set is equal to the amount of information needed to decide if an 
arbitrary sample in S belongs to P or N, for example.  Entropy (E(A)) represents the 
expected information needed to classify objects in all subtrees, while information gain 
(G(A)) represents the encoding information that would be gained by branching on A.  The 
formulas used in these calculations are as follows: 
   
Low entropy values correspond to high information gain values.  In the entropy calculation 
tables in Appendix H, the columns “yy”, “ny”, “nn”, and “yn” indicate how many times a 
GO term or protein domain occurred in both samples, one but not the other, and neither 
sample.  The table headings correspond to these entries; the sample type that is listed first 
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Figure 33.  InterProScan raw data file example 
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corresponds to the first value in each of those four columns (y, n, n, y).  For example, if the 
table heading indicates the calculations are for “vesicles vs. secretions”, then the “ny” 
column corresponds to a GO term not occurring in the vesicles but occurring in the 
secretions. 
Gene Ontology Analysis 
Detailed GO annotation data are provided in Appendix F and visual representations of 
categories Biological Process, Molecular Function (I and II), and Cellular Component are 
provided in Figures 34-37 respectively. 
The most represented GO terms in the vesicle proteins in the category Biological Process 
include protein folding (12.35%), glycolysis (9.88%), cellular protein metabolism (7.41%) 
and proteolysis (4.94%).   The most represented term in the Cellular Component category 
is cytoplasm (6.17%).  The most represented Molecular Function is by far ATP binding at 
19.75%, followed by unfolded protein binding (11.11%), calcium ion binding (8.64%) and 
protein binding (8.64%).   
The secretions proteins have glycolysis as the most represented term under Biological 
Process (18.87%) followed by proteolysis (9.43%) and protein folding (7.55%).   Under the 
Cellular Component category intracellular, cytoplasm, nucleosome, and nucleus are all 
evenly represented at 5.66%.  Under the Molecular Function category calcium ion binding 
is most represented (9.43%) followed by oxidoreductase activity and ATP binding (both 
7.55%).  Secretions have a slightly higher representation of catalytic and enzymatic activity 
than vesicles (5.6% vs. 3.7%). 
Not surprisingly, the tegument proteins have transport as the most represented Biological 
Process (6.98%) followed by protein modification (4.65%).  Under Cellular Component 
integral to membrane (9.3%) and membrane (6.98%) are most represented.  Under  
Molecular Function calcium ion binding, transporter activity, and hydrolase activity are 
equally represented (4.65%).  
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Figure 34.  % of sequences corresponding to GO annotations from category biological process 
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Figure 35.  % of sequences corresponding to GO annotations from category cellular component 
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Figure 36.  % of sequences corresponding to GO annotations from category molecular function (I) 
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Figure 37.  % of sequences corresponding to GO annotations from category molecular function (II) 
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The control samples have regulation of transcription (7.10%), protein amino acid 
phosphorylation (5.81%), metabolism (5.16%), cation transport (4.52%), and transport 
(4.52%) as the most represented terms under the Biological Process category.  Under the 
category Molecular Function, the most represented terms include:  ATP binding at 11.61%, 
DNA binding at 7.74%, catalytic activity and protein kinase activity both at 5.81%, and 
calcium ion binding at 5.16%.  Membrane (11.61%), integral to membrane (10.32%), and 
nucleus (7.74%) were the most represented terms under the Cellular Component category. 
Appendix H shows the entropy calculations that were performed to determine the most 
significant GO terms.   These calculations determine the extent to which each GO term 
contributes to the predicted class label.  The class label in this case is vesicles, secretions, 
tegument, or control.  In comparing vesicles vs. secretions and vesicles vs. tegument ATP 
binding was found to be the most significant feature/GO term in determining that the 
protein belonged to the vesicles.  Also, between vesicles and tegument, in the Cellular 
Component category integral to membrane was the most significant feature that determined 
membership in the class of tegument proteins.  Between secretions and tegument, 
glycolysis was significant in membership in the class of secretion proteins and the cellular 
component membrane was significant in determining membership in the class of tegument 
proteins.  In comparing the control samples to the vesicles and secretions samples, 
glycolysis was the most significant term determining membership in either vesicles or 
secretions, and the cellular component membrane was most significant in determining 
membership in the class of control proteins.  In comparing control proteins to tegument 
proteins, transporter activity and protein modification were significant in determining 
membership in the class of tegument proteins and DNA binding and nucleus were 
significant in determining membership in the class of control proteins. 
These results are summarized in Table 9 below.  The values in the table indicate GO terms 
which are significant in determining whether a sample belongs to one sample set versus 
another.  The values ‘V’, ‘S’, and ‘T’ in parentheses indicate which sample class the term 
favors.   
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Table 9.  GO terms with highest entropy 
  V S T C 
V   
Molecular Function: 
ATP binding (V) 
Molecular Function: ATP 
binding (V); 
Cellular Location:  
integral to membrane (T) 
Biological Process: 
glycolysis (V) 
S 
Molecular 
Function: ATP 
binding (V)   
Biological Process: 
glycolysis (S); 
Cellular Location:  
membrane (T) 
Biological Process: 
glycolysis (S); 
Cellular Location: 
membrane (T) 
T 
Molecular 
Function: ATP 
binding (V); 
Cellular Location: 
integral to 
membrane (T) 
Biological Process: 
glycolysis (S); 
Cellular Location: 
membrane (T)   
Molecular Function: 
transporter activity (T);
Biological Process: 
protein modification 
(T); 
Molecular Function: 
DNA binding (C); 
Cellular Location: 
nucleus (C) 
C 
Biological Process: 
glycolysis (V) 
Biological Process: 
glycolysis (S); 
Cellular Location: 
membrane (T) 
Molecular Function: 
transporter activity (T); 
Biological Process: 
protein modification (T); 
Molecular Function: 
DNA binding (C); 
Cellular Location: 
nucleus (C)   
 
Protein Domain Analysis 
Detailed protein domain annotation data are provided in Appendix G and a visual 
representation of the data is provided in Figure 38. 
In the vesicle samples, three different chaperonin domains are all highly represented (4.94-
7.41%) as well as an ATPase domain, two EF-hand domains, and a thioredoxin fold 
domain, while peptidase domains are represented at about 3.7%.  In the secretions, the EF-
hand domain is represented in 9.43% of proteins and the thioredoxin fold is represented in 
7.55% of proteins, followed by peptidases, dehyrogenase, and histone fold and core all 
represented in 5.66% of proteins.  This corresponds to the GO term percentages that 
showed that secretions had higher representation of enzymatic and catalytic activity.  The 
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Figure 38.  % of sequences corresponding to InterPro protein domains 
Only showing those protein domains represented in > 3% of sequences 
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tegument samples showed calcium/lipid-binding, thioredoxin-like fold, antigen, 
tetraspanin, and calponin-like actin-binding being equally represented.  The control 
samples indicated protein kinase and protein kinase-like domains being represented very 
highly (18.60-20.93%), as well as thioredoxin fold, EF-hand type, and hydrolase. 
Chaperonin domains are significant in classifying a protein as belonging to vesicles over 
controls, secretions, and tegument:  each of four different chaperonin domains contributes 
to classifying a protein as being in the vesicles over the controls, chaperonin TCP-1 is also 
significant in classifying a protein as belonging to vesicles over secretions, and chaperonin 
Cpn60/TCP-1 in classifying a protein as belonging to vesicles over tegument.  The domains 
histone core, lactate/malate dehydrogenase, and L-lactate/malate dehydrogenase all 
contribute equally to classifying a protein as belonging to secretions over controls.  
Calcium/lipid-binding region is somewhat significant in classifying a protein as belonging 
to the tegument set over the control set.  Calcium/lipid-binding region, CD9/CD37/CD63 
antigen, and tetraspanin all contribute to classifying a protein as tegument over vesicles.  
Similarly, calcium/lipid-binding region, CD9/CD37/CD63 antigen, tetraspanin, and 
thioredoxin-like fold contribute to classifying a protein as belonging to tegument over 
secretions. 
These results are summarized in Table 10 below.  The values in the table indicate protein 
domains which are significant in determining whether a sample belongs to one sample set 
vs. another.  The values ‘V’, ‘S’, and ‘T’ in parentheses indicate which class/sample set the 
domain favors.   
       111
Table 10.  Protein domains with highest entropy values 
 
  V S T C 
V   chaperonin TCP-1 (V) 
Calcium/lipid-binding region 
(T) 
CD9/CD37/CD63 antigen (T) 
tetraspanin (T) 
Chaperonin Cpn60/TCP-1 (V) 
GroEL-like chaperone, ATPase 
(V) 
Chaperonin Cpn60 (V) 
Chaperonin TCP-1 (V) 
S chaperonin TCP-1 (V)   
calcium/lipid-binding region 
(T) 
CD9/CD37/CD63 antigen (T) 
tetraspanin (T) 
thioredoxin-like fold (T) 
histone core (S) 
lactate/malate dehydrogenase (S) 
L-lactate/malate dehydrogenase 
(S) 
T 
Calcium/lipid-binding region (T)
CD9/CD37/CD63 antigen (T) 
tetraspanin (T) 
calcium/lipid-binding region (T) 
CD9/CD37/CD63 antigen (T) 
tetraspanin (T) 
thioredoxin-like fold (T)   Calcium/lipid-binding region (T) 
C 
Chaperonin Cpn60/TCP-1 (V) 
GroEL-like chaperone, ATPase 
(V) 
Chaperonin Cpn60 (V) 
Chaperonin TCP-1 (V) 
histone core (S) 
lactate/malate dehydrogenase (S) 
L-lactate/malate dehydrogenase 
(S) 
Calcium/lipid-binding region 
(T)   
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D. Summary 
A total of 177 proteins found in S. mansoni cercarial secretions and adult outer tegumental 
membrane were analyzed for the presence of conserved motifs using MEME and MAST.  
A 5-amino acid motif was enriched in the vesicles and found across a total of 11 sample 
proteins and 2 proteins from an orthologous species, S. japonicum.  A secretion model was 
proposed based on functional analysis of the motif and the 13 proteins found to contain it.  
Sample sets were analyzed for homology using BLAST and CLUSTALW and were 
annotated with protein domains and GO terms using InterProScan.  Methods were 
developed using Perl, BioPerl, and Matlab for processing InterProScan raw data and 
determining the most represented, as well as the most statistically significant motifs and 
GO terms.  This data was used to theorize about the effects of the lipid induction versus tail 
shearing induction experimental methods as well as to analyze the proteins containing the 
proposed conserved motif.  
V. CONCLUSION 
A. Overview of Significant Findings 
A five amino acid motif, x[K/R]xGE, was found across 12 sample proteins including 
calreticulin, myosin light chain, calcium binding protein, endoplasmin, protein  disulfide 
isomerase, thioredoxin, thioredoxin peroxidase 1a, thioredoxin 2,  and elastases 1a, 1b, and 
2a.  The mechanically-induced sample was enriched for the motif.  It was also found in 
immunophilin and AUT1 in the orthologous species, S. japonicum.  These proteins 
represent three major functions:  calcium binding, chaperone (protein folding) activity, and 
protease activity.  The first position of the motif is nonconserved, in the second position is 
the basic residue lysine or arginine (arginine being specific to the elastases), the third 
position is nonconserved, in the fourth position is the nonpolar residue glycine, and in the 
fifth position is the acidic residue glutamic acid.  The motif was found at the N-terminal 
between amino acid 27 and 110, except in the thioredoxin peroxidases, where it was found 
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close to the C-terminal.  It was found downstream from a signal peptide in 7 of the 12 
sample proteins.   
A surprising finding was that the overall percentage of proteins within each sample set that 
were predicted to contain a signal peptide was significantly lower than the percentage of 
the control set found to contain a signal peptide.  11% of the vesicles, 9% of the secretions, 
and 7% of the tegument proteins were predicted to contain a signal peptide in comparison 
to 23% of control proteins.   
The automated workflow developed during this thesis study provides a reliable method for 
determining which protein domains are most significant.  The functional annotation 
generated in this thesis study correlates well with conclusions reached in the proteomic 
study of cercarial secretions conducted by Knudsen et al., including: 1) proteins related to 
calcium-binding and regulation were enriched in the mechanically-induced, as well as in 
the lipid-induced secretion samples, and 2) EF-hand motifs were present in many of the 
vesicle proteins (Knudsen, Medzihradszky et al. 2005).  The Molecular Function 
Comparison I chart in Figure 36 shows that calcium-binding is one of the most represented 
GO terms in both the vesicles and secretion samples, and the Protein Domain Comparison 
chart in Figure 38 shows that the EF-hand motif is one of the most represented in the 
vesicle and secretion samples.  This thesis analysis also revealed some unexpected 
differences between the secretion and vesicle proteins:  1) the biological process protein 
folding is almost 5% higher in the vesicles than secretions, 2) the molecular function ATP 
binding is about 12.5% higher in the vesicles than in the secretions, and 3) the biological 
process glycolysis is almost 10% higher in the secretions than in the vesicles.  Entropy 
analysis revealed that the molecular function ATP binding and several chaperone domains 
were significant in classifying proteins as belonging to the vesicles over the secretions and 
the controls.  Analysis of the proteins found to be unique to either the vesicle or secretion 
samples resulted in motor activity and microtubule-based movement being unique to the 
vesicles and some soluble proteins being unique to the secretions.  Possible explanations 
for this are discussed in the next section. 
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B. Consideration of Findings in Context of Current Knowledge 
The motif was found to not be any of the following:  a phosphorylation site, glycosylation 
site, protease recognition motif, elastase recognition motif, or ER-type signal peptide.  It is 
proposed to be a pro-domain that signals proteins to be shuttled off into special secretory 
vesicles from the Golgi apparatus.  It may be a PC recognition site, as PCs are known to 
cleave on the C-terminal side of sites composed of single or paired basic amino acids e.g. 
lysine or arginine (K/R).  It bears similarity to the motif found in the malarian parasite, 
which was experimentally proven to be essential for the export of 320 soluble and insoluble 
proteins.  Similarly to the Schistosoma proteins containing the x[K/R]xGE motif, not all of 
the Plasmodium (pfEMP1) proteins found to contain a conserved motif had a predicted 
signal peptide.   
  
A possible explanation for the low percentage of signal peptides in the adult tegument 
sample is that the quality of the tegument sequences is lower than the vesicle and secretion 
samples, resulting in very short sequences in many cases where the signal peptide, if it 
existed, is missing.  Signal peptides may be less frequent in the vesicle and secretion 
samples because they come from Schistosoma cercaria and, as discussed on page 25, 
cercaria may have evolved sophisticated invasion mechanisms that do not always employ 
the traditional eukaryotic signal peptides with which SignalP has been trained.  The control 
sample contains proteins from all stages of S. mansoni and has a higher percentage of 
signal peptides.  This may be because the life cycle stages other than cercaria use more 
traditional signal peptides.  Also, GO analysis of the control sample shows that 11.61% and 
10.32% of proteins belong to the Cellular Location categories membrane and integral to 
membrane respectively.  This is in contrast to the vesicle and secretion samples, neither of 
which have membrane or integral to membrane as one of the most represented cellular 
locations; only 3.7% of vesicle proteins have a cellular location of membrane and only 
1.89% of secretion proteins had a cellular location of integral to membrane.  Perhaps S. 
mansoni employs more traditional signal peptides for membrane proteins and less 
traditional signal peptides for proteins that are secreted extracellularly. As Bendtsen et al. 
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points out, it is important to note that a negative SignalP prediction does not necessarily 
mean that the protein is not secreted as some are exported via “non-classical and leaderless 
pathways” (Bendtsen, Nielsen et al. 2004). 
 
The protein domains and GO terms found to be significant or unique to the vesicle or 
secretion proteins are likely to be the result of the different experimental sample collection 
methods.  The lipid-induced sample was collected by centrifuging to separate out cercarial 
bodies and tails from the secretions, while the mechanically-induced sample was collected 
by scraping vesicles from the surface of the plate.  The first method may have caused some 
of the vesicular membranes, in which some of the chaperone-related proteins may be 
inserted, to be separated out from the sample along with the cercarial tails and bodies.  It 
may have also resulted in the collection of non-vesicle-specific proteins, such as the 
cytosolic contents of the acetabular glands.  The latter method likely retained most of the 
vesicular membrane and not as many non-vesicle-specific proteins, resulting in a cleaner 
sample.   
     
C. Theoretical Implications of the Findings 
If the proposed motif can be experimentally validated as necessary for certain proteins to be 
exported, it could be used to predict secreted proteins.  As the motif is present on proteins 
that are directly exposed to the host and likely to contribute to virulence, it could 
potentially be used as a target against which a preventative topical drug treatment could be 
designed.  Antigenic variation within proteins makes it difficult to target specific proteins, 
but if a common motif exists across multiple proteins, a drug could be designed to 
target/interact with that motif and have activity against multiple virulence factors (the 
proteins that contain the motif) at once.  The drug could be specifically designed to 
interfere with one or more of the three main functions identified within the proteins found 
to contain the motif: calcium ion binding, protein folding, or serine protease activity.   
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The differences between the proteins isolated in the vesicle and secretion samples provide 
insight into the effects of the different experimental sample preparation methods.  The 
mechanical induction method produced a sample that contained proteins that were more 
specific to cercarial secretions than the lipid-induced method. 
VI.   DISCUSSION 
A. Limitations of the Study 
This study was limited in that it was not complimented by laboratory investigation which 
could verify that the motif is indeed essential for protein export via secretion vesicles.  
Also, this study was based on qualitative rather than quantitative proteomic data, which 
could provide information about which proteins are up and down regulated in secretions.  
The relatively small sample sizes made it difficult to achieve good MEME e-values.  This 
in turn meant only smaller MAST databases could be searched using the motif revealed by 
MEME, resulting in larger MAST e-values.  A larger sample size would improve e-values 
of both the MEME and MAST searches.  A larger sample size would also allow clustering 
of the samples based on all sequence features (GO terms and protein domains).  Other 
limitations include the fact that SignalP was not trained on any S. mansoni sequences and 
the fact that GO annotations are not available for every protein domain. 
B. Recommendations for Further Research 
The proposed conserved motif elucidated in this thesis study needs to be experimentally 
validated.  The ability to transfect Schistosoma has been established (Yuan, Shen et al. 
2005), as well as the ability to express Schistosoma proteins in a heterologous system 
(Price, Doenhoff et al. 1997).  A mutation could be introduced into the proposed motif in 
the 11 proteins found to contain it and then a reporter gene could be used to track whether 
the proteins are secreted or not.  If the mutation is shown to prevent secretion, then a 
recombinant expression system could be used to produce large amounts of the proteins as 
potential antigens for immunological studies.   
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Additional MEME and MAST iterations should be performed to increase the understanding 
of the proposed motif or elucidate other conserved motifs.  New MAST databases for motif 
searching could be developed using the larger number of public sequences that are 
becoming available.  All publicly available Schistosoma sequences that are annotated with 
cellular location and life cycle stage could be downloaded, subdivided according to life 
cycle stage and/or cellular location, and analyzed to search for corresponding conserved 
motifs and significant domains.  The sensitivity of the neural network behind SignalP could 
be specifically trained on Schistosoma proteins to improve its sensitivity and specificity.   
The methods presented here for automated analysis of InterProScan raw data could be 
enhanced in a variety of ways.  The Perl and Matlab scripts could be built into an 
automated workflow and presented as a web application that allows the end-user to submit 
raw data from InterProScan to retrieve corresponding domain matrices, GO matrices, and 
entropy calculations.  An option could be built into the application that would allow the 
end-user to automatically extract a smaller matrix from a larger one, based on sequence 
identifiers, for purposes of being able to focus on specific sets of sequences and their 
corresponding domains and GO terms within a data set.  This was done manually in this 
thesis study for proteins that were either unique to a sample set and that contained the 
proposed motif.  Analysis of entropy data could be automated such that the most significant 
domains and GO terms are automatically presented to the user, perhaps in the table format 
shown in Tables 9 and 10.   
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APPENDICES 
 
 
Appendix A:  Summary of Sample Data Sets 
 
Following are tables listing all samples used in this study including cercarial vesicles (induction by tail shearing), secretions (induction 
by skin lipid) and adult tegument.  The three sample sets were obtained as detailed in the Methods- Samples and Subjects section.  
Column heading of sample sets:  “Phylo” = phylogenetic group corresponding to phylograms in Results section on pages 50-52.  “S?” 
indicates whether or not a signal peptide was predicted by SignalP.  The last column, “KxGEx Motif?”, indicates whether or not the 
sequence contains the motif found in MEME #3. 
 
SAMPLE SET 1:  VESICLES           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
Pancreatic elastase precursor (elastase 1a)  A28942 2 264 Y Y 
Calcium-binding protein, fluke  A30792 1a 69 N N 
Heat shock protein 86, fluke (fragment) A45529 1a 442 N N 
Vaccine-dominant antigen Sm21.7    A45630 1b 184 N N 
Tubulin alpha     A48433 1g 451 N N 
Myosin heavy chain    A59287 1a 1940 N N 
Calreticulin AAA19024 1g 373 Y Y 
Fimbrin AAA29882 1f 651 N N 
Calcium-binding protein     AAA29921 1a 154 N Y 
glutathione S-transferase, GST [Schistosoma mansoni, Peptide, 218 aa] AAB21173 1f 218 N N 
Putative cytosol aminopeptidase    AAB41442 4 521 N N 
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SAMPLE SET 1:  VESICLES           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
Calponin homolog  AAB47536 2 361 N N 
Unknown (serpin)  AAB86571 1c 256 N N 
Actin 2     AAC46966 1f 376 N N 
Elastase (elastase 1b)    AAC46967 2 274 Y Y 
Gynecophoral canal protein  AAC47216 1c 688 N N 
Calcium ATPase 2    AAC72756 1b 1011 N N 
Tegumental protein Sm20.8    AAC79131 1b 181 N N 
Thioredoxin peroxidase 2    AAD17299 1a 185 N Y 
Phosphoenolpyruvate carboxykinase     AAD24794 1d 626 N N 
SPO-1 protein (anti-inflammatory protein 6)  AAD26122 1a 117 Y N 
Myosin light chain    AAD41591 1a 160 N Y 
14-3-3 epsilon isoform AAF21436 3 249 N N 
Endoplasmin AAF66929 1a 796 Y Y 
SNaK1 (Na+/K+-ATPase alpha)    AAL09322 1b 1007 N N 
Putative histamine-releasing factor  AAL11633 1d 166 N N 
Thioredoxin      AAL79841 1d 106 N Y 
Elastase 2a    AAM43941 2 263 Y Y 
Heat shock protein HSP60   AAM69406 2 549 N N 
Arginase  AAP94031 1f 364 N N 
Actin-binding/filamin-like protein AAR26703 1b 984 N N 
70000 molecular weight antigen/hsp70 homolog  CAA28976 1g 619 N N 
Elongation factor 1-alpha    CAA69721 4 465 N N 
Protein-disulfide isomerase homolog CAA80520 1a 482 Y Y 
Similar to myosin regulatory light chain CD180182 1f 866 N N 
Paramyosin      P06198 1a 211 N N 
Glutathione S-transferase (Sm, 211 aa)   P09792 1f 354 N N 
Major egg antigen P40 P12812 1g 675 N N 
ATP:guanidino kinase SMC74    P16641 2 338 N N 
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SAMPLE SET 1:  VESICLES           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
GAPDH (major larval surface antigen) (P-37) P20287 4 416 N N 
Phosphoglycerate kinase     P41759 1f 284 N N 
Tropomyosin 1 (TMI) (polypeptide 49)  P42637 1a 284 N N 
Tropomyosin 2 (TMII)    P42638 1a 253 N N 
Triose-phosphate isomerase (TPI)    P48501 1e 363 N N 
Fructose-bisphosphate aldolase     P53442 2 252 N N 
14-3-3 protein homolog 1   Q26540 3 161 N N 
Peptidyl-prolyl cis-trans isomerase (PPIase)   Q26565 1g 434 N N 
Enolase (2-phosphoglycerate dehydratase)    Q27877 1g 89 N N 
Probable dynein light chain (SM10)  Q94748 1f 545 N N 
T-complex protein-1, alpha subunit   Q94757 2 1679 N N 
Surface protein, fluke    T30271 1d 100 Y N 
Weakly similar to heterogeneous nuclear ribonucleoprotein A2 homolog 1 TC10489 1g 314 N N 
Similar to ATP synthase alpha-chain mito TC10585 1d 547 N N 
Similar to transitional ER ATPase  TC10596 1g 803 N N 
Weakly similar to phosphoglucomutase TC10613 2 601 N N 
Similar to citrate synthase TC10655 1g 433 N N 
Similar to B-cell receptor-associated protein 32 TC10689 1g 274 Y N 
Similar to ribosomal protein L12 TC10765 2 165 N N 
Thioredoxin peroxidase 3  TC10839 1a 219 N N 
Similar to nucleoside-diphosphate kinase  TC11413 1g 149 N N 
Similar to glycogen phosphorylase, muscle  TC13591 1e 847 N N 
Similar to ATP synthase [1]-chain mito TC13604 1g 517 N N 
Homolog to H2B histone  TC13606 1e 122 N N 
Similar to chaperonin containing T-complex protein-1, beta subunit TC13620 2 530 N N 
Similar to histone H3   TC13658 4 136 N N 
Similar to chaperonin containing T-complex protein-1, gamma subunit  TC13671 2 466 N N 
Similar to succinate dehydrogenase Fp subunit TC13974 3 258 N N 
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SAMPLE SET 1:  VESICLES           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
Similar to histone H4   TC14578 2 103 N N 
Similar to transketolase    TC16539 2 631 N N 
Similar to lactate dehydrogenase   TC16735 3 332 N N 
Homolog to calmodulin    TC16812 1a 149 N N 
Similar to malate dehydrogenase precursor  TC16844 3 341 N N 
Similar to ADP/ATP translocase   TC16858 1e 221 N N 
Similar to chaperonin containing T-complex protein-1, zeta subunit TC16896 2 547 N N 
Similar to hypothetical Schistosoma japonicum protein TC17017 1g 119 N N 
Similar to T-complex protein-1, epsilon subunit TC6878 2 545 N N 
Homolog to tubulin beta-2 chain  TC7336 1g 443 N N 
Weakly similar to troponin T  TC7449 1a 325 N N 
Similar to pyruvate kinase TC7454 1f 572 N N 
Similar to HEL protein TC7459 2 440 N N 
Phosphoglycerate mutase TC7546 1d 250 N N 
 
SAMPLE SET 2:  SECRETIONS           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
Pancreatic elastase precursor (elastase 1a) (Sm)  A28942 1a 264 Y Y 
Calpain (EC 3.4.22.17) large chain (Sm)  A39343 1a 758 N N 
Heat shock protein 86 (Sm)  A45529 1b 442 N N 
Vaccine-dominant antigen Sm21.7 (Sm)  A45630 2 184 N N 
Fimbrin (Sm)  AAA2988 2 651 N N 
Calcium-binding protein (Sm)  AAA29921 1a 154 N Y 
GST (Sm, 218 aa)  AAB21173 3 218 N N 
Putative cytosol aminopeptidase (Sm)  AAB41442 1a 520 N N 
Calponin homolog (Sm)  AAB47536 1c 361 N N 
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SAMPLE SET 2:  SECRETIONS           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
Unknown (serpin) (Sm)  AAB86571 3 256 N N 
Cu,Zn-superoxide dismutase (Sm)  AAC14467 1b 153 N N 
Similar to carbonyl reductase (Sm)  AAC46898 1c 276 N N 
Actin 2 (Sm)  AAC46966 3 376 N N 
Elastase (elastase 1b) (Sm)  AAC46967 1a 274 Y Y 
Tegumental protein Sm20.8 (Sm)  AAC79131 2 181 N N 
Thioredoxin peroxidase 2 (Sm)  AAD17299 1c 185 N Y 
Phosphoenolpyruvate carboxykinase (Sm)  AAD24794 2 626 N N 
SPO-1 protein (anti-inflammatory protein 6) (Sm)  AAD26122 3 117 Y N 
Fatty acid-binding protein Sm14 (Sm)  AAL15461 1a 133 N N 
Thioredoxin (Sm)  AAL79841 3 106 N Y 
Elastase 2a (Sm)  AAM43941 1a 263 Y Y 
Heat shock protein HSP60 (Sm)  AAM69406 1b 549 N N 
ATP-diphosphohydrolase 1 (Sm)  AAP94734 1a 544 N N 
Cysteine protease inhibitor (Sm)  AAQ16180 1c 101 N N 
Actin-binding/filamin-like protein (Sm)  AAR26703 3 984 N N 
70,000 molecular weight antigen/hsp70 homolog (Sm)  CAA28976 1a 619 N N 
Elongation factor 1 (Sm)  CAA69721 1a 465 N N 
Glutathione S-transferase, 28 kDa (GST 28) (Sm)  P09792 3 211 N N 
ATP:guanidino kinase SMC74 (Sm)  P16641 1c 675 N N 
GAPDH (major larval surface antigen) (P-37) (Sm)  P20287 1b 338 N N 
Ferritin-2 heavy chain (Sm)  P25319 3 173 N N 
Phosphoglycerate kinase (Sm)  P41759 1b 416 N N 
Triose-phosphate isomerase (TIM) (Sm)  P48501 2 253 N N 
Fructose-bisphosphate aldolase (Sm)  P53442 2 363 N N 
14-3-3 protein homolog 1 (Sm)  Q26540 2 252 N N 
Peptidyl-prolyl cis-trans isomerase B precursor (Sm)  Q26551 1b 213 Y N 
Peptidyl-prolyl cis-trans isomerase (PPIase) (Sm) 1 Q26565 1b 161 N N 
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SAMPLE SET 2:  SECRETIONS           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
6-Phosphofructokinase (Sm)  Q27778 2 781 N N 
Enolase (2-phosphoglycerate dehydratase) (Sm)  Q27877 1b 434 N N 
Probable dynein light chain (SM10) (T-cell-stimulating antigen SM10) Q94748 3 89 N N 
Similar to nucleoside-diphosphate kinase (Sm)  TC11413 1c 149 N N 
Similar to muscle glycogen phosphorylase (Sm)  TC13591 1a 847 N N 
Similar to ATP synthase _-chain mito (Sm)  TC13604 3 517 N N 
Homolog to H2B histone (Sm)  TC13606 1b 122 N N 
Similar to histone H3 (Sm)  TC13658 1a 136 N N 
Similar to histone H4 (Sm)  TC14578 1a 103 N N 
Weakly similar to lactate dehydrogenase (Sm)  TC16735 1c 332 N N 
Homolog to calmodulin (Sm)  TC16812 1a 149 N N 
Similar to malate dehydrogenase, mito (Sm)  TC16844 2 341 N N 
Similar to malate dehydrogenase, cytosolic (Sm)  TC17066 2 329 N N 
Homolog to tubulin _-2 chain (Sm)  TC7336 1a 443 N N 
Similar to pyruvate kinase (Sm)  TC7454 1a 572 N N 
Homolog to phosphoglycerate mutase (Sm)  TC7546 2 250 N N 
 
SAMPLE SET 3:  TEGUMENT           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
no significant homology found AI882660 3 99 N N 
no significant homology found BF936329 1b 31 N N 
annexin 11a isoform 2 CD098410 1b 90 N N 
Amidase CD156396 1c 59 N N 
Dysferlin CD157335 1b 71 N N 
LIM and SH3 protein 1b CD182193 1a 75 N N 
no significant homology found CD192195 1a 79 N N 
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SAMPLE SET 3:  TEGUMENT           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 CD194580 2 47 N N 
SCP-like extracellular proteinb TC10634 1a 189 N N 
SCP-like extracellular proteinb TC10635 1a 303 N N 
aquaporin-3 TC10637 1a 304 N N 
22K surface membrane antigen TC10917 1b 182 N N 
similar to Pcmt1-prov protein TC11206 1b 237 N N 
Exocyst complex component Sec10 (hSec10) TC11347 3 267 N N 
ATP-diphosphohydrolase 1a TC11432 2 545 N N 
putative related to F3G5b TC11571 1b 203 N N 
ubiquitin/ribosomal fusion proteinb TC11590 1b 128 N N 
phosphatidylinositol transfer protein TC12230 2 119 N N 
no significant homology found TC13203 1a 91 N N 
Nebulette TC13379 3 47 Y N 
breast adenocarcinoma marker like (26.0 kD) (2N58) TC13662 3 237 N N 
CD63-like protein Sm-TSP-2a TC13732 1c 219 Y N 
Myosin D TC13851 3 274 N N 
Alpha-actinin, sarcomeric (F-actin cross linking protein) TC14047 3 288 N N 
thioredoxin peroxidase 1a TC14049 1c 185 N Y 
no significant homology found TC14238 1a 277 N N 
ectonucleotide pyrophosphatase/phosphodiesterase 5 TC14339 3 271 N N 
syntenin TC14697 1a 225 N N 
filamin isoform A TC17006 3 472 N N 
SGTP4 TC17442 2 458 N N 
fatty acid coenzyme A ligase 5 TC17495 1c 262 N N 
no significant homology found TC18339 1c 236 N N 
no significant homology found TC19226 2 165 N N 
HLA-B associated transcript 1b TC7459 1c 440 N N 
major egg antigen TC7485 1a 366 N N 
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SAMPLE SET 3:  TEGUMENT           
Description 
Accession 
number Phylo 
length 
(aa) S? 
xKxGE 
Motif? 
fimbrin TC7585 1a 651 N N 
rat coatamer beta subunit TC7811 1b 460 N N 
hypothetical proteinb TC7948 1a 394 N N 
actin-binding and severin family group-protein TC8208 1a 68 N N 
adenylyl cyclase-associated proteinb TC8265 2 234 N N 
no significant homology found TC8556 1a 203 Y N 
no significant homology found TC9174 1c 55 N N 
no significant homology found TC9780 3 37 N N 
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Appendix B:  Control Data Set 
This data set was obtained as described in Methods- Samples and Subjects. 
155 Background/Control Sequences (source: NCBI's nonredundant protein database)  
accession number description Length
>gi_1002620_gb_AAC46888.1_ unknown         98 
>gi_1002624_gb_AAC46890.1_ similar to synaptobrevin 102 
>gi_1002666_gb_AAC46893.1_ unknown         78 
>gi_1002668_gb_AAC46894.1_ unknown         239 
>gi_1002670_gb_AAC46895.1_ unknown         236 
>gi_1002674_gb_AAC46897.1_ similar to E. coli phosphoserine phosphohydrolase 223 
>gi_1002676_gb_AAC46898.1_ similar to human carbonyl reductase (NADPH) 276 
>gi_1002682_gb_AAC46900.1_ similar to mitochondrial ATPase inhibitor 63 
>gi_1002684_gb_AAC46901.1_ similar to synaptobrevin       54 
>gi_1016750_gb_AAA79138.1_ rab-related GTP-binding protein       205 
>gi_10281265_gb_AAG15509.1_AF301004_1 thioredoxin peroxidase 3 [Sm]     219 
>gi_10442652_gb_AAG17406.1_AF283511_1 receptor kinase I-interacting protein SIP [Sm]   455 
>gi_1090775_prf__2019440B Sm65 antigen        369 
>gi_10953801_gb_AAG25600.1_AF297468_1 chromatin assembly factor 1 small subunit-like protein [Sm] 308 
>gi_11464653_gb_AAG35265.1_AF215933_1 Smad1 [Sm]       455 
>gi_115391_sp_P13566_CABP_SCHMA Calcium-binding protein (CaBP)       69 
>gi_11596371_gb_AAG38588.1_AF316828_1 zinc finger protein SmZF1 [Sm]    164 
>gi_119756_sp_P16463_F801_SCHMA Female specific 800 protein (FS800)     238 
>gi_12248339_gb_AAG13165.2_ NADH dehydrogenase subunit 4L [Sm]    86 
>gi_12249163_ref_NP_066213.2_ NADH dehydrogenase subunit 4L [Sm]    86 
>gi_12958632_gb_AAK09382.1_AF321922_1 purine-nucleoside phosphorylase [Sm]      287 
>gi_1354127_gb_AAC47216.1_ gynecophoral canal protein       688 
>gi_13958030_gb_AAK50768.1_AF361357_1 Ca-ATPase-like protein SMA3 [Sm]     1035 
>gi_14192680_gb_AAC16404.3_ receptor kinase-1 precursor [Sm]     780 
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155 Background/Control Sequences (source: NCBI's nonredundant protein database)  
accession number description Length
>gi_1449406_gb_AAC37263.1_ NF-YA subunit        268 
>gi_15127836_gb_AAK84311.1_AF361883_1 high voltage-activated calcium channel Cav2A [Sm]   2203 
>gi_15127838_gb_AAK84312.1_AF361884_1 high voltage-activated calcium channel Cav1 [Sm]   1776 
>gi_15149312_gb_AAK85233.1_AF395822_1 thioredoxin glutathione reductase [Sm]     598 
>gi_15420528_gb_AAK97376.1_AF358445_1 glutaminyl-tRNA synthetase [Sm]      531 
>gi_1575028_gb_AAB09439.1_ Psmras1 [Sm]       184 
>gi_1580810_emb_CAA67208.1_ T-cell-stimulating antigen [Sm]      89 
>gi_15808978_gb_AAL08579.1_AF418550_1 albumin precursor [Sm]      608 
>gi_15824396_gb_AAL09322.1_AF303222_1 SNaK1 [Sm]       1007 
>gi_15986653_gb_AAL11699.1_AF375996_1 14-3-3 epsilon 2 [Sm]     249 
>gi_15986655_gb_AAL11700.1_AF376135_1 eukaryotic translation initiation factor 2 alpha subunit [Sm] 328 
>gi_160941_gb_AAA29861.1_ calcium binding protein       69 
>gi_161050_gb_AAA29908.1_ p48 eggshell protein       414 
>gi_161052_gb_AAA29910.1_ ORF 2        382 
>gi_1619614_emb_CAA69721.1_ elongation factor 1-alpha [Sm]     465 
>gi_1620592_gb_AAC47307.1_ dynein light chain       89 
>gi_16876479_gb_AAF21638.2_AF031196_1 histamine-responsive G-protein coupled receptor [Sm]    560 
>gi_17907114_emb_CAD13249.1_ tyrosine kinase [Sm]      1264 
>gi_18181863_emb_CAC85211.2_ cathepsin B endopeptidase [Sm]     347 
>gi_18369833_gb_AAL67949.1_ receptor tyrosine kinase [Sm]     1559 
>gi_1841843_gb_AAB47536.1_ calponin homolog [Sm]      361 
>gi_18874552_gb_AAL79841.1_AF473536_1 thioredoxin [Sm]       106 
>gi_19071249_gb_AAL84173.1_AF422164_1 receptor for activated PKC [Sm]    315 
>gi_20270936_gb_AAM18481.1_AF492390_1 Sm14 fatty acid-binding protein delta E3 variant [Sm] 98 
>gi_20384923_gb_AAM09083.1_ 
Na+/Cl- dependent neurotransmitter transporter-like protein 
[Sm]   761 
>gi_21217531_gb_AAM43941.1_AF510339_1 elastase 2a [Sm]      263 
>gi_21217533_gb_AAM43942.1_AF510340_1 elastase 2b [Sm]      263 
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155 Background/Control Sequences (source: NCBI's nonredundant protein database)  
accession number description Length
>gi_2131129_emb_CAA73329.1_ amidase [Sm]       691 
>gi_21436485_gb_AAM51567.1_ immunophilin FK506 binding protein FKBP12 [Sm]   108 
>gi_22074178_gb_AAK98796.1_ ferredoxin NADP+ reductase [Sm]     522 
>gi_2246652_gb_AAC62254.1_ lysophospholipase homolog [Sm]      239 
>gi_22531389_emb_CAD44625.1_ cathepsin B1 isotype 2 [Sm]    340 
>gi_23094378_emb_CAB93676.2_ calcineurin A [Sm]      644 
>gi_23305770_gb_AAN17275.1_ unknown [Sm]       114 
>gi_23305772_gb_AAN17276.1_ CD63-like protein Sm-TSP-2 [Sm]     239 
>gi_23305778_gb_AAN17279.1_ unknown [Sm]       156 
>gi_2345100_gb_AAC02298.1_ Pad1 homolog [Sm]      313 
>gi_2345102_gb_AAC02299.1_ trans-spliced variant protein [Sm]     167 
>gi_23663956_gb_AAN39120.1_AF314754_1 insulin receptor protein kinase RTK-2 [Sm]   1499 
>gi_24415108_gb_AAN59790.1_ trimeric G-protein alpha o subunit [Sm]   328 
>gi_24415111_gb_AAN59791.1_ trimeric G-protein gamma subunit [Sm]    66 
>gi_2494322_sp_Q26571_IF5A_SCHMA Eukaryotic translation initiation factor 5A-2 (eIF-5A)    52 
>gi_2623840_gb_AAB86568.1_ unknown [Sm]       406 
>gi_26245438_gb_AAN77581.1_ Rho3 GTPase [Sm]      242 
>gi_2665824_gb_AAB88508.1_ ribosomal protein L37 [Sm]     88 
>gi_27657926_gb_AAO18222.1_ peptidylglycine alpha hydroxylating mono-oxygenase [Sm]    350 
>gi_27699497_gb_AAN17278.2_ CD9-like protein Sm-TSP-1 [Sm]     247 
>gi_28192573_gb_AAO21365.1_ leucine-rich protein [Sm]      296 
>gi_28261409_tpg_DAA00890.1_ TPA: reverse transcriptase [Sm]     789 
>gi_2842736_sp_Q94748_DYL2_SCHMA Probable dynein light chain (T-cell-stimulating antigen SM10)   89 
>gi_2842737_sp_Q94758_DYL1_SCHMA Dynein light chain       89 
>gi_28628851_gb_AAO49385.1_AF484940_1 glutathione S-transferase omega [Sm]     241 
>gi_30142122_gb_AAP13803.1_ developmentally regulated antigen 10.3 precursor [Sm]   200 
>gi_31746497_gb_AAP68901.1_AF515706_1 Fes-like tyrosine kinase protein [Sm]    1259 
>gi_3282676_gb_AAC28780.1_ nuclear factor Y transcription factor subunit B homolog [Sm] 242 
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155 Background/Control Sequences (source: NCBI's nonredundant protein database)  
accession number description Length
>gi_3283986_gb_AAC25419.1_ 13 kDa tegumental antigen Sm13 [Sm]   104 
>gi_33089916_gb_AAP93838.1_ tyrosinase 1 precursor [Sm]     481 
>gi_33114187_gb_AAP94734.1_ ATP-diphosphohydrolase 1 [Sm]      544 
>gi_33242492_gb_AAQ00945.1_ general control nonrepressed 5 [Sm]    899 
>gi_33339659_gb_AAQ14321.1_ acetylcholinesterase [Sm]       687 
>gi_33355623_gb_AAQ16180.1_ cysteine protease inhibitor [Sm]     101 
>gi_3337405_gb_AAC27440.1_ alpha-(1 3)-fucosyltransferase VII; SmFuct [Sm]    351 
>gi_34099845_gb_AAQ57211.1_ putative neuropeptide receptor [Sm]     492 
>gi_35187018_gb_AAQ84177.1_ Smad4 [Sm]       738 
>gi_37029992_gb_AAQ88098.1_ hox protein Dfd [Sm]     543 
>gi_37702159_gb_AAR00731.1_ protein kinase C type beta [Sm]   618 
>gi_37722427_gb_AAN72832.1_ LOK-like protein kinase [Sm]     1056 
>gi_37776869_emb_CAE51198.1_ src tyrosine kinase [Sm]     647 
>gi_37982950_gb_AAR06260.1_ heat shock transcription factor [Sm]    154 
>gi_38004412_gb_AAR07505.1_ Abd-A-like protein [Sm]      718 
>gi_3859490_gb_AAC72756.1_ calcium ATPase 2 [Sm]     1011 
>gi_38683290_gb_AAR26703.1_ actin-binding/filamin-like protein [Sm]      984 
>gi_3907627_gb_AAC78683.1_ G-box binding factor homolog [Sm]    214 
>gi_40317595_gb_AAR84361.1_ nicotinic acetylcholine receptor alpha subunit precursor [Sm]  686 
>gi_40317597_gb_AAR84362.1_ 
nicotinic acetylcholine receptor non-alpha subunit precursor 
[Sm]  731 
>gi_40365359_gb_AAR85353.1_ high mobility group B1 protein [Sm]   176 
>gi_40365361_gb_AAR85354.1_ ubiquitin [Sm]       103 
>gi_407047_gb_AAB39265.1_ amino acid permease       503 
>gi_40743702_gb_AAR89512.1_ ankyrin-like protein [Sm]      181 
>gi_4090941_gb_AAC98911.1_ Sm29 [Sm]       191 
>gi_4104017_gb_AAD01923.1_ tryptophan hydroxylase; SmTPH [Sm]     497 
>gi_41393747_gb_AAP94031.1_ arginase [Sm]       364 
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155 Background/Control Sequences (source: NCBI's nonredundant protein database)  
accession number description Length
>gi_42405318_gb_AAS13487.1_ Ftz-F1 interacting protein [Sm]     788 
>gi_425474_gb_AAA66476.1_ SMDR1         691 
>gi_4322668_gb_AAD16119.1_ retinoic acid receptor RXR [Sm]    743 
>gi_44829165_tpg_DAA04496.1_ TPA: gag protein [Sm]     277 
>gi_44829167_tpg_DAA04497.1_ TPA: pol polyprotein [Sm]     1227 
>gi_44829169_tpg_DAA04498.1_ TPA: pol polyprotein [Sm]     1680 
>gi_44829171_tpg_DAA04499.1_ TPA: pol polyprotein [Sm]     1382 
>gi_44829173_tpg_DAA04500.1_ TPA: pol polyprotein [Sm]     1166 
>gi_44829174_tpg_DAA04501.1_ TPA: gag protein [Sm]     288 
>gi_44829175_tpg_DAA04502.1_ TPA: ORF3 [Sm]      232 
>gi_454258_emb_CAA82848.1_ unnamed protein product [Sm]     98 
>gi_4581919_gb_AAD24794.1_AF120929_1 phosphoenolpyruvate carboxykinase [Sm]      626 
>gi_4753140_gb_AAC79802.3_ annexin [Sm]       365 
>gi_477295_pir__A48570 cystatin homolog - fluke (Sm)    89 
>gi_48475044_gb_AAR84066.2_ putative seven transmembrane receptor [Sm]    366 
>gi_49473446_gb_AAT66412.1_ polyprotein [Sm]       201 
>gi_495668_gb_AAA29882.1_ fimbrin         651 
>gi_499349_gb_AAA19024.1_ calreticulin         373 
>gi_50402589_gb_AAT76629.1_ thioredoxin 2 [Sm]      104 
>gi_50429226_gb_AAT77204.1_ neuropeptide F precursor [Sm]     147 
>gi_50442714_gb_AAT77263.1_ methionine sulfoxide reductase B2a [Sm]    175 
>gi_50442729_gb_AAT77264.1_ methionine sulfoxide reductase B2b [Sm]    137 
>gi_510098_gb_AAC37227.1_ potassium channel protein       512 
>gi_514912_gb_AAB81008.1_ LGG         196 
>gi_51988420_emb_CAH04147.1_ P2X ATP gated ion channel [Sm]   437 
>gi_52222500_gb_AAU34080.1_ glutathione peroxidase-2 [Sm]      179 
>gi_5305329_gb_AAD41591.1_ myosin light chain [Sm]     160 
>gi_542452_pir__S42030 hypothetical protein - fluke (Sm)    98 
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155 Background/Control Sequences (source: NCBI's nonredundant protein database)  
accession number description Length
>gi_55139749_gb_AAV41489.1_ Sm50 protein [Sm]      466 
>gi_552247_gb_AAA29913.1_ phosphagen kinase [Sm]      52 
>gi_55274739_gb_AAV49163.1_ polo-like kinase [Sm]      618 
>gi_5566124_gb_AAD45325.1_AF158102_1 retinoid-x-receptor [Sm]       784 
>gi_55793504_gb_AAV65746.1_ glycerol 3-phosphate dehydrogenase [Sm]     350 
>gi_60172784_gb_AAX14497.1_ hox protein Smox1 [Sm]     745 
>gi_61660998_gb_AAX51223.1_ mitochondrial thioredoxin precursor [Sm]     147 
>gi_62114973_gb_AAX63737.1_ carbohydrate-binding calcium-dependent lectin precursor [Sm]    409 
>gi_6649234_gb_AAF21436.1_AF195529_1 14-3-3 epsilon [Sm]      249 
>gi_6650016_gb_AAF21676.1_AF051138_1 trispanning orphan receptor; TORE [Sm]    281 
>gi_6841028_gb_AAF28867.1_ cyclophilin [Sm]       181 
>gi_732959_emb_CAA88616.1_ eukaryotic translation initiation factor 5A [Sm]   52 
>gi_7595982_gb_AAF64527.1_AF254148_1 PUR-alpha-like protein [Sm]      267 
>gi_7673568_gb_AAF66929.1_AF217404_1 endoplasmin [Sm]       796 
>gi_7960045_gb_AAF71198.1_AF183577_1 alpha 38720 fucosyltransferase [Sm]     426 
>gi_808821_gb_AAA96714.1_ ATPase         1022 
>gi_8132429_gb_AAF73286.1_AF155134_1 RHO G-protein coupled receptor [Sm]    381 
>gi_8250653_emb_CAB93677.1_ calcineurin B [Sm]      169 
>gi_9081807_gb_AAF82607.1_ AUT1 [Sm]       349 
>gi_951431_gb_AAA74696.1_ ORF-RF2; putative        186 
>gi_9828608_gb_AAG00234.1_AF283817_1 dolichol phosphate mannose synthase [Sm]    237 
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Appendix C:  Sequence Homology Within Sample Sets 
Vesicle proteins with homology to other vesicle proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better.) 
accession description length 
num 
hits hit accession hit description 
hit 
significance 
hsp 
length 
% 
identity 
A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke (Sm) 264 8 AAC46967 elastase 1.00E-144 275 92.36 
AAC46967 elastase 274 4 A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke 
(Sm) 1.00E-144 275 92.36 
A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke (Sm) 264 8 AAM43941 elastase 2a [Sm] 1.00E-124 259 82.24 
AAM43941 elastase 2a [Sm] 263 6 A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke 
(Sm) 1.00E-124 259 82.24 
AAC46967 elastase 274 4 AAM43941 elastase 2a [Sm] 1.00E-124 274 79.93 
AAM43941 elastase 2a [Sm] 263 6 AAC46967 elastase 1.00E-124 274 79.93 
P42637 
Tropomyosin 1 (TMI) 
(Polypeptide 49) 284 17 P42638 Tropomyosin 2 (TMII) 1.00E-101 283 66.08 
P42638 Tropomyosin 2 (TMII) 284 13 P42637 
Tropomyosin 1 (TMI) 
(Polypeptide 49) 1.00E-101 283 66.08 
AAD17299 thioredoxin peroxidase [Sm] 185 4 TC10839 ORF 71..729 frame +2 7.00E-63 179 59.78 
TC10839 ORF 71..729 frame +2 219 2 AAD17299 thioredoxin peroxidase [Sm] 8.00E-63 179 59.78 
Q26540 14-3-3 protein homolog 1 252 7 AAF21436 14-3-3 epsilon [Sm] 1.00E-69 239 54.81 
AAF21436 14-3-3 epsilon [Sm] 249 10 Q26540 14-3-3 protein homolog 1 1.00E-69 239 54.81 
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Secretion proteins with homology to other secretion proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better) 
accession description length 
num 
hits hit accession hit description 
hit 
significance hsp length 
% 
identity 
A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke 
(Sm) 264 6 AAC46967 elastase 1.00E-144 275 92.36 
AAC46967 elastase 274 5 A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke (Sm) 1.00E-144 275 92.36 
A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke 
(Sm) 264 6 AAM43941 elastase 2a [Sm] 1.00E-125 259 82.24 
AAM43941 elastase 2a [Sm] 263 6 A28942 
pancreatic elastase (EC 
3.4.21.36) precursor - fluke (Sm) 1.00E-125 259 82.24 
AAC46967 elastase 274 5 AAM43941 elastase 2a [Sm] 1.00E-124 274 79.93 
AAM43941 elastase 2a [Sm] 263 6 AAC46967 elastase 1.00E-124 274 79.93 
Q26551 
Peptidyl-prolyl cis-trans 
isomerase B precursor 
(PPIase) (Rotamase) 
(Cyclophilin B) (S-
cyclophilin) 213 5 Q26565 
Peptidyl-prolyl cis-trans 
isomerase (PPIase) (Rotamase) 
(Cyclophilin) (Cyclosporin A-
binding protein) (p17.7) 
(Smp17.7) 1.00E-45 164 56.71 
Q26565 
Peptidyl-prolyl cis-trans 
isomerase (PPIase) (Rotamase) 
(Cyclophilin) (Cyclosporin A-
binding protein)  161 6 Q26551 
Peptidyl-prolyl cis-trans 
isomerase B precursor (PPIase) 
(Rotamase) (Cyclophilin B) (S-
cyclophilin) 1.00E-45 164 56.71 
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Tegument proteins with homology to other tegument proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better) 
accession Description length 
num 
hits hit accession hit description hit significance 
hsp 
length 
% 
identity 
TC10635 
TC2046 TC2168 TC558 
TC722 TC3699 TC4460 
TC6565 frame +1 303 6 TC10634 frame +1 9.00E-42 109 74.31 
TC10634 frame +1 189 9 TC10635 
TC2046 TC2168 TC558 
TC722 TC3699 TC4460 
TC6565 frame +1 5.00E-42 109 74.31 
 
Control proteins with homology to other control proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better) 
accession description length 
num 
hits hit accession hit description hit sig 
hsp 
len 
% 
identity 
gi_2345102_gb_AAC02299.1_ 
trans-spliced 
variant protein 
[Sm] 167 4 gi_2345100_gb_AAC02298.1_ 
Pad1 homolog 
[Sm] 7.00E-62 121 92.56 
gi_2345100_gb_AAC02298.1_ 
Pad1 homolog 
[Sm] 313 7 gi_2345102_gb_AAC02299.1_ 
trans-spliced 
variant protein 
[Sm] 2.00E-61 121 92.56 
gi_3859490_gb_AAC72756.1_ 
calcium ATPase 
2 [Sm] 1011 8 gi_808821_gb_AAA96714.1_ ATPase 0 1002 69.66 
gi_808821_gb_AAA96714.1_ ATPase 1022 7 gi_3859490_gb_AAC72756.1_ 
calcium ATPase 
2 [Sm] 0 1002 69.66 
gi_21217533_gb_AAM43942.1_AF510340_1 elastase 2b [Sm] 263 4 gi_21217531_gb_AAM43941.1_AF510339_1 elastase 2a [Sm] 1.00E-88 263 58.56 
gi_21217531_gb_AAM43941.1_AF510339_1 elastase 2a [Sm] 263 2 gi_21217533_gb_AAM43942.1_AF510340_1 elastase 2b [Sm] 1.00E-88 263 58.56 
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accession description length 
num 
hits hit accession hit description hit sig 
hsp 
len 
% 
identity 
gi_15986653_gb_AAL11699.1_AF375996_1 
14-3-3 epsilon 2 
[Sm] 249 5 gi_6649234_gb_AAF21436.1_AF195529_1 
14-3-3 epsilon 
[Sm] 8.00E-72 246 57.32 
gi_6649234_gb_AAF21436.1_AF195529_1 
14-3-3 epsilon 
[Sm] 249 7 gi_15986653_gb_AAL11699.1_AF375996_1 
14-3-3 epsilon 2 
[Sm] 8.00E-72 246 57.32 
gi_11464653_gb_AAG35265.1_AF215933_1 Smad1 [Sm] 455 11 gi_35187018_gb_AAQ84177.1_ Smad4 [Sm] 9.00E-38 122 52.46 
gi_35187018_gb_AAQ84177.1_ Smad4 [Sm] 738 12 gi_11464653_gb_AAG35265.1_AF215933_1 Smad1 [Sm] 1.00E-37 122 52.46 
gi_22531389_emb_CAD44625.1_ 
cathepsin B1 
isotype 2 [Sm] 340 3 gi_18181863_emb_CAC85211.2_ 
cathepsin B 
endopeptidase 
[Sm] 
1.00E-
100 311 51.77 
gi_18181863_emb_CAC85211.2_ 
cathepsin B 
endopeptidase 
[Sm] 347 4 gi_22531389_emb_CAD44625.1_ 
cathepsin B1 
isotype 2 [Sm] 
1.00E-
100 311 51.77 
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Appendix D:  Sequence Homology Between Sample Sets 
 
Secretion proteins with homology to tegument proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better) 
accession description length 
num 
hits 
hit 
accession hit description 
hit 
significance 
hsp 
length 
% 
identity 
AAD17299.1 thioredoxin peroxidase [Sm] 185 3 TC14049 
TC2639 TC288 TC3226 
TC3474 TC5109 frame +3 1.00E-110 185 99.46 
AAP94734.1 
ATP-diphosphohydrolase 1 
[Sm] 544 4 TC11432 
TC2288 TC3771 TC6362 
frame +1 0 545 98.90 
 
Vesicle proteins with homology to tegument proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better) 
accession description length 
num 
hits 
hit 
accession hit description 
hit 
significance 
hsp 
length 
% 
identity 
AAD17299.1 
thioredoxin peroxidase 
[Schistosoma mansoni] 185 3 TC14049 
TC2639 TC288 TC3226 
TC3474 TC5109 frame +3 1E-110 185 99.46 
AAA29882.1 fimbrin 651 5 TC7585 
TC2210 TC341 TC3368 
TC6464 frame +2 0 651 99.08 
TC10839 thioredoxin peroxidase 219 5 TC14049 
TC2639 TC288 TC3226 
TC3474 TC5109 frame +3 3E-63 179 59.78 
P12812 Major egg antigen (p40) 354 4 TC7485 TC5509 frame +1 1E-111 353 54.11 
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Secretion proteins with homology to vesicle proteins 
(More than 50% homology over at least 100 residues with an expectation value of 1x10-5 or better) 
Accession description length 
num 
hits 
hit 
accession hit description 
hit 
significance 
hsp 
length 
% 
identity 
P48501 Triosephosphate isomerase (TIM) 253 7 P48501 Triosephosphate isomerase (TIM)  1.00E-148 253 100.00 
TC7546 ORF 25..776 frame +1 250 3 TC7546 ORF 25..776 frame +1 1E-148 250 100.00 
TC7454 
TC1083 TC1563 TC2625 TC526 
TC3281 TC4409 TC4966 TC5646 
frame is 3 572 3 TC7454 
TC1083 TC1563 TC2625 TC526 
TC3281 TC4409 TC4966 TC5646 
frame is 3 0 572 100 
TC7336 ORF 106..1460 frame +1 443 7 TC7336 ORF 106..1460 frame +1 0 443 100 
TC16844 ORF 109..1133 frame +1 341 7 TC16844 ORF 109..1133 frame +1 0 341 100 
TC16812 ORF 74..522 frame +2 149 15 TC16812 ORF 74..522 frame +2 1E-83 149 100 
TC16735 ORF 98..1095 frame +2 332 6 TC16735 ORF 98..1095 frame +2 0 332 100 
TC14578 ORF 95..405 frame +2 103 13 TC14578 ORF 95..405 frame +2 2E-56 103 100 
TC13658 ORF 30..439 frame +3 136 8 TC13658 ORF 30..439 frame +3 7E-74 136 100 
TC13606 ORF 24..391 frame +3 122 3 TC13606 ORF 24..391 frame +3 2E-65 122 100 
TC13604 ORF 280..1832 frame +1 517 4 TC13604 ORF 280..1832 frame +1 0 517 100 
TC13591 
TC1613 TC1618 TC219 TC707 
TC3313 TC4136 TC4992 TC6430 
frame is 1 847 6 TC13591 
TC1613 TC1618 TC219 TC707 
TC3313 TC4136 TC4992 TC6430 
frame is 1 0 847 100 
TC11413 ORF 38..486 frame +2 149 6 TC11413 ORF 38..486 frame +2 1E-86 149 100 
P16641 
ATP:guanidino kinase SMC74 
(ATP:guanidino 
phosphotransferase) 675 3 P16641 
ATP:guanidino kinase SMC74 
(ATP:guanidino phosphotransferase) 0 675 100 
Q26565| 
Peptidyl-prolyl cis-trans 
isomerase (PPIase) (Rotamase) 
(Cyclophilin) (Cyclosporin A-
binding protein) (p17.7) 
(Smp17.7) 161 5 Q26565 
Peptidyl-prolyl cis-trans isomerase 
(PPIase) (Rotamase) (Cyclophilin) 
(Cyclosporin A-binding protein) 
(p17.7) (Smp17.7) 1E-96 161 100 
P41759 Phosphoglycerate kinase 416 5 P41759 Phosphoglycerate kinase 0 416 100 
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Accession description length 
num 
hits 
hit 
accession hit description 
hit 
significance 
hsp 
length 
% 
identity 
P09792 
Glutathione S-transferase 28 kDa 
(GST 28) (SM28 antigen) 
(Protective 28 kDa antigen) (GST 
class-mu) 211 8 P09792 
Glutathione S-transferase 28 kDa 
(GST 28) (SM28 antigen) 
(Protective 28 kDa antigen) (GST 
class-mu) 1E-123 211 100 
P20287 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (Major 
larval surface antigen) (P-37) 338 6 P20287 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (Major 
larval surface antigen) (P-37) 0 338 100 
Q27877 
Enolase (2-phosphoglycerate 
dehydratase) (2-phospho-D-
glycerate hydro-lyase) 434 4 Q27877 
Enolase (2-phosphoglycerate 
dehydratase) (2-phospho-D-
glycerate hydro-lyase) 0 434 100 
CAA69721 elongation factor 1-alpha [Sm] 465 8 CAA69721 elongation factor 1-alpha [Sm] 0 465 100 
CAA28976 
70000 mol wt antigen/hsp70 
homologue (619 AA) [Sm] 619 4 CAA28976 
70000 mol wt antigen/hsp70 
homologue (619 AA) [Sm] 0 619 100 
P53442 Fructose-bisphosphate aldolase 363 5 P53442 Fructose-bisphosphate aldolase 0 363 100 
AAM43941 elastase 2a [Sm] 263 6 AAM43941 elastase 2a [Sm] 1E-153 263 100 
AAL79841 thioredoxin [Sm] 106 11 AAL79841 thioredoxin [Sm] 3E-58 106 100 
AAM69406 heat shock protein HSP60 [Sm] 549 13 AAM69406 heat shock protein HSP60 [Sm] 0 549 100 
AAD24794 
phosphoenolpyruvate 
carboxykinase [Sm] 626 2 AAD24794 
phosphoenolpyruvate carboxykinase 
[Sm] 0 626 100 
AAD26122 SPO-1 protein [Sm] 117 8 AAD26122 SPO-1 protein [Sm] 4E-65 117 100 
AAR26703 
actin-binding/filamin-like protein 
[Sm] 984 4 AAR26703 
actin-binding/filamin-like protein 
[Sm] 0 984 100 
AAD17299 thioredoxin peroxidase [Sm] 185 4 AAD17299 thioredoxin peroxidase [Sm] 1E-110 185 100 
AAC79131 tegumental protein Sm 20.8 [Sm] 181 10 AAC79131 tegumental protein Sm 20.8 [Sm] 1E-104 181 100 
AAC46967 elastase 274 4 AAC46967 elastase 1E-162 274 100 
AAC46966 actin 376 5 AAC46966 actin 0 376 100 
AAB86571 unknown [Sm] (serpin) 256 2 AAB86571 unknown [Sm] (serpin) 1E-148 256 100 
AAB47536 calponin homolog [Sm] 361 4 AAB47536 calponin homolog [Sm] 0 361 100 
AAB41442 
putative cytosol aminopeptidase 
[Sm] 520 6 AAB41442 
putative cytosol aminopeptidase 
[Sm] 0 520 100 
       139
Accession description length 
num 
hits 
hit 
accession hit description 
hit 
significance 
hsp 
length 
% 
identity 
AAB21173 
glutathione S-transferase GST 
[Sm Peptide 218 aa] 218 3 AAB21173 
glutathione S-transferase GST [Sm 
Peptide 218 aa] 1E-132 218 100 
AAA29921 calcium binding protein [Sm] 154 10 AAA29921 calcium binding protein [Sm] 3E-89 154 100 
A45630 
vaccine-dominant antigen Sm21.7 
- fluke (Sm) 184 10 A45630 
vaccine-dominant antigen Sm21.7 - 
fluke (Sm) 1E-107 184 100 
A45529 
heat shock protein 86 - fluke (Sm) 
(fragment) 442 8 A45529 
heat shock protein 86 - fluke (Sm) 
(fragment) 0 442 100 
A28942 
pancreatic elastase (EC 3.4.21.36) 
precursor - fluke (Sm) 264 8 A28942 
pancreatic elastase (EC 3.4.21.36) 
precursor - fluke (Sm) 1E-156 264 100 
Q26540 14-3-3 protein homolog 1 252 7 Q26540 14-3-3 protein homolog 1 1E-143 252 100 
AAC46967 elastase 274 4 A28942 
pancreatic elastase (EC 3.4.21.36) 
precursor - fluke (Sm) 1E-144 275 92.36364 
A28942 
pancreatic elastase (EC 3.4.21.36) 
precursor - fluke (Sm) 264 8 AAC46967 elastase 1E-144 275 92.36364 
AAM43941 elastase 2a [Sm] 263 6 A28942 
pancreatic elastase (EC 3.4.21.36) 
precursor - fluke (Sm) 1E-124 259 82.23938 
A28942 
pancreatic elastase (EC 3.4.21.36) 
precursor - fluke (Sm) 264 8 AAM43941 elastase 2a [Sm] 1E-124 259 82.23938 
AAM43941 elastase 2a [Sm] 263 6 AAC46967 elastase 1E-124 274 79.92701 
AAC46967 elastase 274 4 AAM43941 elastase 2a [Sm] 1E-124 274 79.92701 
AAD17299 thioredoxin peroxidase [Sm] 185 4 TC10839 ORF 71..729 frame +2 7E-63 179 59.77654 
Q26551 
Peptidyl-prolyl cis-trans 
isomerase B precursor (PPIase) 
(Rotamase) (Cyclophilin B) (S-
cyclophilin) 213 5 Q26565 
Peptidyl-prolyl cis-trans isomerase 
(PPIase) (Rotamase) (Cyclophilin) 
(Cyclosporin A-binding protein) 
(p17.7) (Smp17.7) 3E-45 164 56.70732 
Q26540 14-3-3 protein homolog 1 252 7 AAF21436 14-3-3 epsilon [Sm] 1E-69 239 54.81172 
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Appendix E:  ProP Propeptide prediction results 
Only showing results for proteins predicted to contain one or more propeptides 
 
A28942 pancreatic elastase      
MSNRWRFVVVVTLFTYCLTFERVSTWLIRSGEPVQHPAEFPFIAFLTTERTMCTGSLVSTRAVLTAGHCVCSPLPVIRVS      80 
FLTLRNGDQQGIHHQPSGVKVAPGYMPSCMSARQRRPIAQTLSGFDIAIVMLAQMVNLQSGIRVISLPQPSDIPPPGTGV     160 
FIVGYGRDDNDRDPSRKNGGILKKGRATIMECRHATNGNPICVKAGQNFGQLPAPGDSGGPLLPSLQGPVLGVVSHGVTL     240 
PNLPDIIVEYASVARMLDFVRSNI                                                             320 
sssssssssssssssssssssssss...................................P...................      80 
...................................P............................................     160 
................................................................................     240 
........................                                                             320 
  
Signal peptide cleavage site predicted: between pos. 25 and 26: VST-WL  
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 2 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
A28942           4    ---MSNR|WR  0.041    . 
A28942           6    -MSNRWR|FV  0.028    . 
A28942          22    YCLTFER|VS  0.035    . 
A28942          29    VSTWLIR|SG  0.113    . 
A28942          50    AFLTTER|TM  0.056    . 
A28942          61    GSLVSTR|AV  0.853 *ProP* 
A28942          78    SPLPVIR|VS  0.047    . 
A28942          85    VSFLTLR|NG  0.048    . 
A28942         100    HQPSGVK|VA  0.088    . 
A28942         113    PSCMSAR|QR  0.131    . 
A28942         115    CMSARQR|RP  0.040    . 
A28942         116    MSARQRR|PI  0.743 *ProP* 
A28942         143    NLQSGIR|VI  0.062    . 
A28942         167    FIVGYGR|DD  0.038    . 
A28942         172    GRDDNDR|DP  0.055    . 
A28942         176    NDRDPSR|KN  0.070    . 
A28942         177    DRDPSRK|NG  0.137    . 
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A28942         183    KNGGILK|KG  0.101    . 
A28942         184    NGGILKK|GR  0.156    . 
A28942         186    GILKKGR|AT  0.062    . 
A28942         193    ATIMECR|HA  0.031    . 
A28942         204    GNPICVK|AG  0.055    . 
A28942         255    EYASVAR|ML  0.063    . 
A28942         261    RMLDFVR|SN  0.087    . 
____________________________^_________________ 
 
AAA19024 calreticulin  
MLSILLTLLLSKYALGHEVWFSETFPNESIENWVQSTYNAEKQGEFKVEAGKSPVDPIEDLGLKTTQDARFYGIARKISE      80 
PFSNRGKTILLQFTVKFDKTVSCGGAYIKLLGSDIDPKKFHGESPYKIMFGPDICGMATKKVHVIFNYKGKNHLIKKEIP     160 
CKDDLKTHLYTLIVNPNNKYEVLVDNADPNDKKPDDWVDEQFIDDPDDKKPDNWDQPKTIPDMDAKKPDDWDDAMDGEWE     240 
RPQKDNPEYKGEWTPRRIDNPKYKGEWKPVQIDNPEYKHDPELYVLNDIGYVGFDLWQVDSGSIFDNILITDSPDFAKEE     320 
GERLWRKRYDAEVAKEQSSAKDDKEEAEETKERKELPDDAKASDEPSGDHDEL                                400 
ssssssssssssssss................................................................      80 
................................................................................     160 
................................................................................     240 
................................................................................     320 
.......P.............................................                                400 
  
Signal peptide cleavage site predicted: between pos. 16 and 17: ALG-HE 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 1 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
AAA19024        12    LTLLLSK|YA  0.075    . 
AAA19024        42    STYNAEK|QG  0.063    . 
AAA19024        47    EKQGEFK|VE  0.067    . 
AAA19024        52    FKVEAGK|SP  0.072    . 
AAA19024        64    IEDLGLK|TT  0.088    . 
AAA19024        70    KTTQDAR|FY  0.035    . 
AAA19024        76    RFYGIAR|KI  0.032    . 
AAA19024        77    FYGIARK|IS  0.076    . 
AAA19024        85    SEPFSNR|GK  0.053    . 
AAA19024        87    PFSNRGK|TI  0.101    . 
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AAA19024        96    LLQFTVK|FD  0.072    . 
AAA19024        99    FTVKFDK|TV  0.059    . 
AAA19024       109    CGGAYIK|LL  0.065    . 
AAA19024       118    GSDIDPK|KF  0.078    . 
AAA19024       119    SDIDPKK|FH  0.102    . 
AAA19024       127    HGESPYK|IM  0.097    . 
AAA19024       140    ICGMATK|KV  0.064    . 
AAA19024       141    CGMATKK|VH  0.071    . 
AAA19024       149    HVIFNYK|GK  0.083    . 
AAA19024       151    IFNYKGK|NH  0.074    . 
AAA19024       156    GKNHLIK|KE  0.090    . 
AAA19024       157    KNHLIKK|EI  0.280    . 
AAA19024       162    KKEIPCK|DD  0.063    . 
AAA19024       166    PCKDDLK|TH  0.113    . 
AAA19024       179    IVNPNNK|YE  0.270    . 
AAA19024       192    NADPNDK|KP  0.061    . 
AAA19024       193    ADPNDKK|PD  0.068    . 
AAA19024       209    IDDPDDK|KP  0.056    . 
AAA19024       210    DDPDDKK|PD  0.067    . 
AAA19024       218    DNWDQPK|TI  0.173    . 
AAA19024       226    IPDMDAK|KP  0.071    . 
AAA19024       227    PDMDAKK|PD  0.077    . 
AAA19024       241    MDGEWER|PQ  0.045    . 
AAA19024       244    EWERPQK|DN  0.109    . 
AAA19024       250    KDNPEYK|GE  0.070    . 
AAA19024       256    KGEWTPR|RI  0.056    . 
AAA19024       257    GEWTPRR|ID  0.058    . 
AAA19024       262    RRIDNPK|YK  0.083    . 
AAA19024       264    IDNPKYK|GE  0.081    . 
AAA19024       268    KYKGEWK|PV  0.051    . 
AAA19024       278    IDNPEYK|HD  0.060    . 
AAA19024       318    DSPDFAK|EE  0.106    . 
AAA19024       323    AKEEGER|LW  0.048    . 
AAA19024       326    EGERLWR|KR  0.025    . 
AAA19024       327    GERLWRK|RY  0.064    . 
AAA19024       328    ERLWRKR|YD  0.530 *ProP* 
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AAA19024       335    YDAEVAK|EQ  0.076    . 
AAA19024       341    KEQSSAK|DD  0.076    . 
AAA19024       344    SSAKDDK|EE  0.086    . 
AAA19024       351    EEAEETK|ER  0.112    . 
AAA19024       353    AEETKER|KE  0.071    . 
AAA19024       354    EETKERK|EL  0.076    . 
AAA19024       361    ELPDDAK|AS  0.099    . 
____________________________^_________________ 
 
AAA29921 calcium binding protein    
MAFKIDDFTIQEDQVKIAKDVFKRFDKRGQEKISTTDLGPAFRALNLTVKPDTLKEWADQVDDDATGFIDFNGFLICYGK      80 
KLQEDQDERDLRDAFRVLDKNKRGEIDVEDLRWILKGLGDDLTEEEIDDMIRDTDTDGSGFVDFDEFYKLMTSE           160 
...........................P....................................................      80 
......................P............................P......................           160 
  
Signal peptide cleavage site predicted: none 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 3 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
AAA29921         4    ---MAFK|ID  0.056    . 
AAA29921        16    IQEDQVK|IA  0.170    . 
AAA29921        19    DQVKIAK|DV  0.064    . 
AAA29921        23    IAKDVFK|RF  0.070    . 
AAA29921        24    AKDVFKR|FD  0.204    . 
AAA29921        27    VFKRFDK|RG  0.058    . 
AAA29921        28    FKRFDKR|GQ  0.617 *ProP* 
AAA29921        32    DKRGQEK|IS  0.071    . 
AAA29921        43    DLGPAFR|AL  0.051    . 
AAA29921        50    ALNLTVK|PD  0.067    . 
AAA29921        55    VKPDTLK|EW  0.122    . 
AAA29921        80    FLICYGK|KL  0.051    . 
AAA29921        81    LICYGKK|LQ  0.086    . 
AAA29921        89    QEDQDER|DL  0.070    . 
AAA29921        92    QDERDLR|DA  0.101    . 
AAA29921        96    DLRDAFR|VL  0.070    . 
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AAA29921       100    AFRVLDK|NK  0.062    . 
AAA29921       102    RVLDKNK|RG  0.074    . 
AAA29921       103    VLDKNKR|GE  0.580 *ProP* 
AAA29921       112    IDVEDLR|WI  0.044    . 
AAA29921       116    DLRWILK|GL  0.107    . 
AAA29921       132    EIDDMIR|DT  0.634 *ProP* 
AAA29921       149    DFDEFYK|LM  0.066    . 
____________________________^_________________ 
 
AAC46967 elastase 
MSNRWRFLVVTLFTYCLTFERVSTWLIRSGEPVQHRTEFPFIAFLTTERTMCTGSLVSTRAVLTAGHCVCSPLPVIRVLC      80 
LFQVSFLTLRNGDQQGIHHQPSGVKVAPGYMPSCMSARRGRPIAQTLSGFDIAIVMLAQMVNLQSGITVISLPQASDIPT     160 
PGTGVFIVGYGRDDNDRDPSRKNGGILKKGELVVGRATIMECRHATNGNPICVKAGQNFGQLPAPGDSGGPLLPSPQGPV     240 
LGVVSHGVTLPNLPDIIVEYASVARMLDFVRSNI                                                   320 
ssssssssssssssssssssssss...................................P....................      80 
................................................................................     160 
................................................................................     240 
..................................                                                   320 
  
Signal peptide cleavage site predicted: between pos. 24 and 25: VST-WL 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 1 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
AAC46967         4    ---MSNR|WR  0.036    . 
AAC46967         6    -MSNRWR|FL  0.033    . 
AAC46967        21    YCLTFER|VS  0.035    . 
AAC46967        28    VSTWLIR|SG  0.113    . 
AAC46967        36    GEPVQHR|TE  0.151    . 
AAC46967        49    AFLTTER|TM  0.056    . 
AAC46967        60    GSLVSTR|AV  0.853 *ProP* 
AAC46967        77    SPLPVIR|VL  0.136    . 
AAC46967        90    VSFLTLR|NG  0.048    . 
AAC46967       105    HQPSGVK|VA  0.088    . 
AAC46967       118    PSCMSAR|RG  0.054    . 
AAC46967       119    SCMSARR|GR  0.045    . 
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AAC46967       121    MSARRGR|PI  0.392    . 
AAC46967       172    FIVGYGR|DD  0.038    . 
AAC46967       177    GRDDNDR|DP  0.055    . 
AAC46967       181    NDRDPSR|KN  0.070    . 
AAC46967       182    DRDPSRK|NG  0.137    . 
AAC46967       188    KNGGILK|KG  0.083    . 
AAC46967       189    NGGILKK|GE  0.117    . 
AAC46967       196    GELVVGR|AT  0.093    . 
AAC46967       203    ATIMECR|HA  0.031    . 
AAC46967       214    GNPICVK|AG  0.055    . 
AAC46967       265    EYASVAR|ML  0.063    . 
AAC46967       271    RMLDFVR|SN  0.087    . 
____________________________^_________________ 
 
AAD17299 thioredoxin peroxidase 2    
MVLLPNRPAPEFKGQAVINGEFKEICLKDYRGKYVVLFFYPADFTFVCPTEIIAFSDQVEEFNSRNCQVIACSTDSQYSH      80 
LAWDNLDRKSGGLGHMKIPLLADRKQEISKAYGVFDEEDGNAFRGLFIIDPNGILRQITINDKPVGRSVDETLRLLDAFQ     160 
FVEKHGEVCPVNWKRGQHGIKVNQK                                                            240 
................................................................................      80 
..................................................................P.............     160 
.........................                                                            240 
  
Signal peptide cleavage site predicted: none 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 1 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
AAD17299         7    MVLLPNR|PA  0.126    . 
AAD17299        13    RPAPEFK|GQ  0.066    . 
AAD17299        23    VINGEFK|EI  0.089    . 
AAD17299        28    FKEICLK|DY  0.062    . 
AAD17299        31    ICLKDYR|GK  0.034    . 
AAD17299        33    LKDYRGK|YV  0.087    . 
AAD17299        65    VEEFNSR|NC  0.101    . 
AAD17299        88    AWDNLDR|KS  0.023    . 
AAD17299        89    WDNLDRK|SG  0.155    . 
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AAD17299        97    GGLGHMK|IP  0.070    . 
AAD17299       104    IPLLADR|KQ  0.037    . 
AAD17299       105    PLLADRK|QE  0.069    . 
AAD17299       110    RKQEISK|AY  0.080    . 
AAD17299       124    EDGNAFR|GL  0.048    . 
AAD17299       136    DPNGILR|QI  0.043    . 
AAD17299       143    QITINDK|PV  0.051    . 
AAD17299       147    NDKPVGR|SV  0.634 *ProP* 
AAD17299       154    SVDETLR|LL  0.135    . 
AAD17299       164    AFQFVEK|HG  0.075    . 
AAD17299       174    VCPVNWK|RG  0.062    . 
AAD17299       175    CPVNWKR|GQ  0.373    . 
AAD17299       181    RGQHGIK|VN  0.066    . 
AAD17299       185    GIKVNQK|--  0.080    . 
____________________________^_________________ 
 
AAF82607 AUT1   
MAGVDHAYQYSVEVKSRFSLFLDDTLNSEDPDILLSKLQSKRGEKTKKDKPHLQQQHVAPTKADTITKSEVKLDTATPKA      80 
GSRVSKTPNSTEPPPVPPEDVQITSAKGTDEPISTFXRGRGSGRGTPRGMRVGRGQGPRIAPTEAPQDSVSDLNAPRGSS     160 
FEPRGRGRGRGRGMFGRGRGMPFNSNRDFENQDGPDRQGPRQYGRRDGNWNSQDVDGLIMPESGDSEQVVRFADDRNEVE     240 
DQPEHATAENEEGVVVGTETPVEEEPKSYTLEGYKAMRQSSKPAVLLNNKGLRKANDGKDVFANMVAHRKLQEVSEDVYE     320 
VEERKTSLTYVSFLCIYTRFHLGASVDRY                                                        400 
................................................................................      80 
.....................................................P..........................     160 
................................................................................     240 
................................................................................     320 
.............................                                                        400 
  
Signal peptide cleavage site predicted: none 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 1 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
AAF82607        15    QYSVEVK|SR  0.070    . 
AAF82607        17    SVEVKSR|FS  0.142    . 
AAF82607        37    PDILLSK|LQ  0.084    . 
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AAF82607        41    LSKLQSK|RG  0.088    . 
AAF82607        42    SKLQSKR|GE  0.185    . 
AAF82607        45    QSKRGEK|TK  0.062    . 
AAF82607        47    KRGEKTK|KD  0.076    . 
AAF82607        48    RGEKTKK|DK  0.176    . 
AAF82607        50    EKTKKDK|PH  0.060    . 
AAF82607        62    QHVAPTK|AD  0.085    . 
AAF82607        68    KADTITK|SE  0.155    . 
AAF82607        72    ITKSEVK|LD  0.098    . 
AAF82607        79    LDTATPK|AG  0.073    . 
AAF82607        83    TPKAGSR|VS  0.048    . 
AAF82607        86    AGSRVSK|TP  0.211    . 
AAF82607       107    VQITSAK|GT  0.081    . 
AAF82607       118    PISTFXR|GR  0.100    . 
AAF82607       120    STFXRGR|GS  0.037    . 
AAF82607       124    RGRGSGR|GT  0.062    . 
AAF82607       128    SGRGTPR|GM  0.054    . 
AAF82607       131    GTPRGMR|VG  0.083    . 
AAF82607       134    RGMRVGR|GQ  0.722 *ProP* 
AAF82607       139    GRGQGPR|IA  0.166    . 
AAF82607       157    SDLNAPR|GS  0.094    . 
AAF82607       164    GSSFEPR|GR  0.269    . 
AAF82607       166    SFEPRGR|GR  0.236    . 
AAF82607       168    EPRGRGR|GR  0.046    . 
AAF82607       170    RGRGRGR|GR  0.056    . 
AAF82607       172    RGRGRGR|GM  0.038    . 
AAF82607       177    GRGMFGR|GR  0.113    . 
AAF82607       179    GMFGRGR|GM  0.038    . 
AAF82607       187    MPFNSNR|DF  0.048    . 
AAF82607       197    NQDGPDR|QG  0.041    . 
AAF82607       201    PDRQGPR|QY  0.038    . 
AAF82607       205    GPRQYGR|RD  0.032    . 
AAF82607       206    PRQYGRR|DG  0.080    . 
AAF82607       231    DSEQVVR|FA  0.046    . 
AAF82607       236    VRFADDR|NE  0.037    . 
AAF82607       267    PVEEEPK|SY  0.074    . 
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AAF82607       275    YTLEGYK|AM  0.064    . 
AAF82607       278    EGYKAMR|QS  0.038    . 
AAF82607       282    AMRQSSK|PA  0.066    . 
AAF82607       290    AVLLNNK|GL  0.093    . 
AAF82607       293    LNNKGLR|KA  0.043    . 
AAF82607       294    NNKGLRK|AN  0.159    . 
AAF82607       299    RKANDGK|DV  0.066    . 
AAF82607       309    ANMVAHR|KL  0.038    . 
AAF82607       310    NMVAHRK|LQ  0.069    . 
AAF82607       324    VYEVEER|KT  0.034    . 
AAF82607       325    YEVEERK|TS  0.076    . 
AAF82607       339    FLCIYTR|FH  0.033    . 
AAF82607       348    LGASVDR|Y-  0.033    . 
____________________________^_________________ 
 
AAM43941 elastase 2a    
MLNGRTFLMVTLFTYCLTFERVSTWLVRKGEPVQDRTEFPYIAFVRTERTMCTGSLVSTRAVLTAGHCVCSPMPVVQVSF      80 
LTLRNGDQQGIHHQPSGVKVAPEYMPSCTASRQRRRIRQTLSGFDIATVMLAQMVNLQSGIRVISLPQASDIPTPGTDVF     160 
IVGYGRDDNDRDPSRRAGGILKKGRATVMECKHSTTGNPICVQAAYVFGQITAPGDSGGPLLRSPQGPVLGVVSHGVTLS     240 
NRLDVLVEYASVARMLGFVSSNI                                                              320 
ssssssssssssssssssssssss...................................P....................      80 
................................................................................     160 
...............P................................................................     240 
.......................                                                              320 
  
Signal peptide cleavage site predicted: between pos. 24 and 25: VST-WL 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 2 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
AAM43941         5    --MLNGR|TF  0.050    . 
AAM43941        21    YCLTFER|VS  0.037    . 
AAM43941        28    VSTWLVR|KG  0.040    . 
AAM43941        29    STWLVRK|GE  0.138    . 
AAM43941        36    GEPVQDR|TE  0.053    . 
AAM43941        46    PYIAFVR|TE  0.042    . 
       149
AAM43941        49    AFVRTER|TM  0.113    . 
AAM43941        60    GSLVSTR|AV  0.853 *ProP* 
AAM43941        84    VSFLTLR|NG  0.048    . 
AAM43941        99    HQPSGVK|VA  0.104    . 
AAM43941       112    PSCTASR|QR  0.059    . 
AAM43941       114    CTASRQR|RR  0.045    . 
AAM43941       115    TASRQRR|RI  0.222    . 
AAM43941       116    ASRQRRR|IR  0.207    . 
AAM43941       118    RQRRRIR|QT  0.130    . 
AAM43941       142    NLQSGIR|VI  0.062    . 
AAM43941       166    FIVGYGR|DD  0.038    . 
AAM43941       171    GRDDNDR|DP  0.052    . 
AAM43941       175    NDRDPSR|RA  0.076    . 
AAM43941       176    DRDPSRR|AG  0.849 *ProP* 
AAM43941       182    RAGGILK|KG  0.102    . 
AAM43941       183    AGGILKK|GR  0.271    . 
AAM43941       185    GILKKGR|AT  0.098    . 
AAM43941       192    ATVMECK|HS  0.056    . 
AAM43941       223    SGGPLLR|SP  0.166    . 
AAM43941       242    GVTLSNR|LD  0.046    . 
AAM43941       254    EYASVAR|ML  0.081    . 
____________________________^_________________ 
 
TC14049 thioredoxin peroxidase 1a     
MVLLPNRPAPEFKGQAVINGEFKEICLKDYRGKYVVLFFYPSDFTFVCPTEIIAFSDQVEEFNSRNCQVIACSTDSQYSH      80 
LAWDNLDRKSGGLGHMKIPLLADRKQEISKAYGVFDEEDGNAFRGLFIIDPNGILRQITINDKPVGRSVDETLRLLDAFQ     160 
FVEKHGEVCPVNWKRGQHGIKVNQK                                                            240 
................................................................................      80 
..................................................................P.............     160 
.........................                                                            240 
  
Signal peptide cleavage site predicted: none 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 1 
 
Name           Pos    Context     Score  Pred 
____________________________v_________________ 
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TC14049          7    MVLLPNR|PA  0.126    . 
TC14049         13    RPAPEFK|GQ  0.066    . 
TC14049         23    VINGEFK|EI  0.089    . 
TC14049         28    FKEICLK|DY  0.062    . 
TC14049         31    ICLKDYR|GK  0.034    . 
TC14049         33    LKDYRGK|YV  0.087    . 
TC14049         65    VEEFNSR|NC  0.101    . 
TC14049         88    AWDNLDR|KS  0.023    . 
TC14049         89    WDNLDRK|SG  0.155    . 
TC14049         97    GGLGHMK|IP  0.070    . 
TC14049        104    IPLLADR|KQ  0.037    . 
TC14049        105    PLLADRK|QE  0.069    . 
TC14049        110    RKQEISK|AY  0.080    . 
TC14049        124    EDGNAFR|GL  0.048    . 
TC14049        136    DPNGILR|QI  0.043    . 
TC14049        143    QITINDK|PV  0.051    . 
TC14049        147    NDKPVGR|SV  0.634 *ProP* 
TC14049        154    SVDETLR|LL  0.135    . 
TC14049        164    AFQFVEK|HG  0.075    . 
TC14049        174    VCPVNWK|RG  0.062    . 
TC14049        175    CPVNWKR|GQ  0.373    . 
TC14049        181    RGQHGIK|VN  0.066    . 
TC14049        185    GIKVNQK|--  0.080    . 
____________________________^_________________ 
 
TC7546 phosphoglycerate mutase      
MAPYRIVFIRHGESVYNEENRFCGWHDADLSGQGITEAKQAGQLLRQNHFTFDIAYTSVLKRAIKTLNFVLDELDLNWIP      80 
VTKTWRLNERMYGALQGLNKSETAAKHGEEQVKIWRRAYDIPPPPVDISDPRFPGNEPKYALLDSSCIPRTECLKDTVQR     160 
VLPFWFDTISASIKRREQVLIVAHGNSLRALIKYLDNTSDSDIVELNIPTGIPLVYELDANLKPTKHYYLADEATVAAAI     240 
ARVANQGKKK                                                                           320 
.............................................................P..................      80 
................................................................................     160 
................................................................................     240 
..........                                                                           320 
Signal peptide cleavage site predicted: none 
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 1 
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Name           Pos    Context     Score  Pred 
____________________________v_________________ 
TC7546           5    --MAPYR|IV  0.033    . 
TC7546          10    YRIVFIR|HG  0.030    . 
TC7546          21    VYNEENR|FC  0.146    . 
TC7546          39    QGITEAK|QA  0.067    . 
TC7546          46    QAGQLLR|QN  0.086    . 
TC7546          61    AYTSVLK|RA  0.067    . 
TC7546          62    YTSVLKR|AI  0.753 *ProP* 
TC7546          65    VLKRAIK|TL  0.119    . 
TC7546          83    NWIPVTK|TW  0.056    . 
TC7546          86    PVTKTWR|LN  0.030    . 
TC7546          90    TWRLNER|MY  0.033    . 
TC7546         100    ALQGLNK|SE  0.073    . 
TC7546         106    KSETAAK|HG  0.061    . 
TC7546         113    HGEEQVK|IW  0.091    . 
TC7546         116    EQVKIWR|RA  0.042    . 
TC7546         117    QVKIWRR|AY  0.079    . 
TC7546         132    VDISDPR|FP  0.079    . 
TC7546         139    FPGNEPK|YA  0.099    . 
TC7546         150    DSSCIPR|TE  0.058    . 
TC7546         155    PRTECLK|DT  0.084    . 
TC7546         160    LKDTVQR|VL  0.104    . 
TC7546         174    TISASIK|RR  0.076    . 
TC7546         175    ISASIKR|RE  0.063    . 
TC7546         176    SASIKRR|EQ  0.365    . 
TC7546         189    AHGNSLR|AL  0.051    . 
TC7546         193    SLRALIK|YL  0.067    . 
TC7546         223    ELDANLK|PT  0.061    . 
TC7546         226    ANLKPTK|HY  0.069    . 
TC7546         242    VAAAIAR|VA  0.068    . 
TC7546         248    RVANQGK|KK  0.068    . 
TC7546         249    VANQGKK|K-  0.060    . 
TC7546         250    ANQGKKK|--  0.075    . 
____________________________^_________________ 
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Appendix F:  Gene Ontology Annotation 
VESICLES   TEGUMENT 
Biological Process    Biological Process 
10 12.35% GO:0006457   protein folding     3 6.98% GO:0006810   transport   
8 9.88% GO:0006096   glycolysis     2 4.65% GO:0006464   protein modification   
6 7.41% GO:0044267   cellular protein metabolism     1 2.33% GO:0006887   exocytosis   
4 4.94% GO:0006508   proteolysis     1 2.33% GO:0048278   vesicle docking   
3 3.70% GO:0007001  
 chromosome organization and biogenesis [sensu 
Eukaryota]     1 2.33% GO:0006412   protein biosynthesis   
3 3.70% GO:0006118   electron transport     1 2.33% GO:0009117   nucleotide metabolism   
3 3.70% GO:0008152   metabolism     1 2.33% GO:0008643   carbohydrate transport   
3 3.70% GO:0006334   nucleosome assembly     1 2.33% GO:0008152   metabolism   
2 2.47% GO:0006754   ATP biosynthesis     1 2.33% GO:0006605   protein targeting   
2 2.47% GO:0015986   ATP synthesis coupled proton transport      Cellular Component 
2 2.47% GO:0005975   carbohydrate metabolism     4 9.30% GO:0016021   integral to membrane   
2 2.47% GO:0006812   cation transport     3 6.98% GO:0016020   membrane   
2 2.47% GO:0007018   microtubule-based movement     2 4.65% GO:0005622   intracellular   
2 2.47% GO:0006412   protein biosynthesis     1 2.33% GO:0005576   extracellular region   
2 2.47% GO:0051258   protein polymerization     1 2.33% GO:0005737   cytoplasm   
2 2.47% GO:0006100   tricarboxylic acid cycle intermediate metabolism     1 2.33% GO:0005840   ribosome   
1 1.23% GO:0031032   actomyosin structure organization and biogenesis    1 2.33% GO:0005795   Golgi stack   
1 1.23% GO:0019642   anaerobic glycolysis      Molecular Function 
1 1.23% GO:0006527   arginine catabolism     2 4.65% GO:0005509   calcium ion binding   
1 1.23% GO:0007155   cell adhesion     2 4.65% GO:0005215   transporter activity   
1 1.23% GO:0001539   ciliary or flagellar motility     2 4.65% GO:0016787   hydrolase activity   
1 1.23% GO:0006241   CTP biosynthesis     1 2.33% GO:0005544   calcium-dependent phospholipid binding   
1 1.23% GO:0006094   gluconeogenesis     1 2.33% GO:0004040   amidase activity   
1 1.23% GO:0006183   GTP biosynthesis     1 2.33% GO:0004719  
 protein-L-isoaspartate [D-aspartate] O-
methyltransferase activity   
1 1.23% GO:0006092   main pathways of carbohydrate metabolism     1 2.33% GO:0003735   structural constituent of ribosome   
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1 1.23% GO:0006108   malate metabolism     1 2.33% GO:0005554   molecular function unknown   
1 1.23% GO:0007017   microtubule-based process     1 2.33% GO:0005515   protein binding   
1 1.23% GO:0045978   negative regulation of nucleoside metabolism     1 2.33% GO:0005351   sugar porter activity   
1 1.23% GO:0006807   nitrogen compound metabolism     1 2.33% GO:0003824   catalytic activity   
1 1.23% GO:0006468   protein amino acid phosphorylation     1 2.33% GO:0003676   nucleic acid binding   
1 1.23% GO:0019538   protein metabolism     1 2.33% GO:0004386   helicase activity   
1 1.23% GO:0009209  
 pyrimidine ribonucleoside triphosphate 
biosynthesis     1 2.33% GO:0005524   ATP binding   
1 1.23% GO:0006810   transport     CONTROLS 
1 1.23% GO:0006099   tricarboxylic acid cycle      Biological Process 
1 1.23% GO:0006228   UTP biosynthesis     11 7.10% GO:0006355   regulation of transcription  
Cellular Component   9 5.81% GO:0006468   protein amino acid phosphorylation   
5 6.17% GO:0005737   cytoplasm     8 5.16% GO:0008152   metabolism   
3 3.70% GO:0016020   membrane     7 4.52% GO:0006812   cation transport   
3 3.70% GO:0000786   nucleosome     7 4.52% GO:0006810   transport   
3 3.70% GO:0005634   nucleus     6 3.87% GO:0006811   ion transport   
2 2.47% GO:0005622   intracellular     6 3.87% GO:0006508   proteolysis   
2 2.47% GO:0005874   microtubule     5 3.23% GO:0006816   calcium ion transport   
2 2.47% GO:0016459   myosin     5 3.23% GO:0006118   electron transport   
2 2.47% GO:0043234   protein complex     5 3.23% GO:0007186  
 G-protein coupled receptor protein signaling 
pathway   
2 2.47% GO:0016469   proton-transporting two-sector ATPase complex     5 3.23% GO:0006457   protein folding   
1 1.23% GO:0005884   actin filament     4 2.58% GO:0007242   intracellular signaling cascade   
1 1.23% GO:0005783   endoplasmic reticulum     4 2.58% GO:0007017   microtubule-based process   
1 1.23% GO:0009288   flagellum    4 2.58% GO:0006412   protein biosynthesis   
1 1.23% GO:0045255   hydrogen-translocating F-type ATPase complex     4 2.58% GO:0006278   RNA-dependent DNA replication   
1 1.23% GO:0016021   integral to membrane     3 1.94% GO:0006310   DNA recombination   
1 1.23% GO:0005875   microtubule associated complex     3 1.94% GO:0045449   regulation of transcription   
1 1.23% GO:0005743   mitochondrial inner membrane     3 1.94% GO:0007264   small GTPase mediated signal transduction   
1 1.23% GO:0005739   mitochondrion     2 1.29% GO:0006486   protein amino acid glycosylation   
1 1.23% GO:0000015   phosphopyruvate hydratase complex     2 1.29% GO:0006413   translational initiation   
1 1.23% GO:0005840   ribosome     2 1.29% GO:0016192   vesicle-mediated transport   
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Molecular Function   1 0.65% GO:0031032   actomyosin structure organization and biogenesis   
16 19.75% GO:0005524   ATP binding     1 0.65% GO:0006865   amino acid transport   
9 11.11% GO:0051082   unfolded protein binding     1 0.65% GO:0006527   arginine catabolism   
7 8.64% GO:0005509   calcium ion binding     1 0.65% GO:0009072   aromatic amino acid family metabolism   
7 8.64% GO:0005515   protein binding     1 0.65% GO:0015986   ATP synthesis coupled proton transport   
4 4.94% GO:0005525   GTP binding     1 0.65% GO:0005975   carbohydrate metabolism   
3 3.70% GO:0003824   catalytic activity     1 0.65% GO:0007155   cell adhesion   
3 3.70% GO:0003677   DNA binding     1 0.65% GO:0045454   cell redox homeostasis   
3 3.70% GO:0016820   hydrolase activity    1 0.65% GO:0006633   fatty acid biosynthesis   
3 3.70% GO:0003774   motor activity     1 0.65% GO:0006094   gluconeogenesis   
3 3.70% GO:0000166   nucleotide binding     1 0.65% GO:0006424   glutamyl-tRNA aminoacylation   
3 3.70% GO:0016491   oxidoreductase activity     1 0.65% GO:0046168   glycerol-3-phosphate catabolism   
3 3.70% GO:0004252   serine-type endopeptidase activity     1 0.65% GO:0006072   glycerol-3-phosphate metabolism   
2 2.47% GO:0003779   actin binding     1 0.65% GO:0006629   lipid metabolism   
2 2.47% GO:0015662   ATPase activity    1 0.65% GO:0015672   monovalent inorganic cation transport   
2 2.47% GO:0005489   electron transporter activity     1 0.65% GO:0045978   negative regulation of nucleoside metabolism   
2 2.47% GO:0003924   GTPase activity     1 0.65% GO:0006836   neurotransmitter transport   
2 2.47% GO:0046933   hydrogen-transporting ATP synthase activity    1 0.65% GO:0006139   nucleobase  
2 2.47% GO:0046961   hydrogen-transporting ATPase activity    1 0.65% GO:0009405   pathogenesis   
2 2.47% GO:0016868   intramolecular transferase activity    1 0.65% GO:0006518   peptide metabolism   
2 2.47% GO:0004459   L-lactate dehydrogenase activity     1 0.65% GO:0006813   potassium ion transport   
2 2.47% GO:0003676   nucleic acid binding     1 0.65% GO:0006464   protein modification   
2 2.47% GO:0017111   nucleoside-triphosphatase activity     1 0.65% GO:0015031   protein transport   
2 2.47% GO:0019904   protein domain specific binding     1 0.65% GO:0015992   proton transport   
2 2.47% GO:0005198   structural molecule activity     1 0.65% GO:0006979   response to oxidative stress   
1 1.23% GO:0004177   aminopeptidase activity     1 0.65% GO:0042427   serotonin biosynthesis   
1 1.23% GO:0004053   arginase activity     1 0.65% GO:0007165   signal transduction   
1 1.23% GO:0005488   binding     1 0.65% GO:0006414   translational elongation   
1 1.23% GO:0004108   citrate [Si]-synthase activity     1 0.65% GO:0006418   tRNA aminoacylation for protein translation   
1 1.23% GO:0004857   enzyme inhibitor activity     1 0.65% GO:0000160  
 two-component signal transduction system 
[phosphorelay]   
       155
1 1.23% GO:0004332   fructose-bisphosphate aldolase activity     1 0.65% GO:0007601   visual perception   
1 1.23% GO:0004356   glutamate-ammonia ligase activity      Cellular Component 
1 1.23% GO:0004365  
 glyceraldehyde-3-phosphate dehydrogenase 
[phosphorylating] activity     18 11.61% GO:0016020   membrane   
1 1.23% GO:0004386   helicase activity     16 10.32% GO:0016021   integral to membrane   
1 1.23% GO:0008553   hydrogen-exporting ATPase activity    12 7.74% GO:0005634   nucleus   
1 1.23% GO:0016787   hydrolase activity     5 3.23% GO:0005622   intracellular   
1 1.23% GO:0016301   kinase activity     4 2.58% GO:0005875   microtubule associated complex   
1 1.23% GO:0004178   leucyl aminopeptidase activity     3 1.94% GO:0005737   cytoplasm   
1 1.23% GO:0030060   L-malate dehydrogenase activity     2 1.29% GO:0045211   postsynaptic membrane   
1 1.23% GO:0000287   magnesium ion binding     2 1.29% GO:0005840   ribosome   
1 1.23% GO:0016615   malate dehydrogenase activity     2 1.29% GO:0005891   voltage-gated calcium channel complex   
1 1.23% GO:0030145   manganese ion binding     1 0.65% GO:0000785   chromatin   
1 1.23% GO:0003777   microtubule motor activity     1 0.65% GO:0005783   endoplasmic reticulum   
1 1.23% GO:0005554   molecular function unknown     1 0.65% GO:0005850   eukaryotic translation initiation factor 2 complex   
1 1.23% GO:0051287   NAD binding     1 0.65% GO:0005576   extracellular region   
1 1.23% GO:0004550   nucleoside diphosphate kinase activity     1 0.65% GO:0005615   extracellular space   
1 1.23% GO:0004611   phosphoenolpyruvate carboxykinase activity     1 0.65% GO:0009331   glycerol-3-phosphate dehydrogenase complex   
1 1.23% GO:0004618   phosphoglycerate kinase activity     1 0.65% GO:0005834   heterotrimeric G-protein complex   
1 1.23% GO:0004634   phosphopyruvate hydratase activity     1 0.65% GO:0005887   integral to plasma membrane   
1 1.23% GO:0004645   phosphorylase activity     1 0.65% GO:0005739   mitochondrion   
1 1.23% GO:0004672   protein kinase activity     1 0.65% GO:0016469   proton-transporting two-sector ATPase complex   
1 1.23% GO:0030170   pyridoxal phosphate binding     1 0.65% GO:0008076   voltage-gated potassium channel complex   
1 1.23% GO:0004743   pyruvate kinase activity      Molecular Function 
1 1.23% GO:0004867   serine-type endopeptidase inhibitor activity     18 11.61% GO:0005524   ATP binding   
1 1.23% GO:0008236   serine-type peptidase activity     12 7.74% GO:0003677   DNA binding   
1 1.23% GO:0005200   structural constituent of cytoskeleton     9 5.81% GO:0003824   catalytic activity   
1 1.23% GO:0003735   structural constituent of ribosome     9 5.81% GO:0004672   protein kinase activity   
1 1.23% GO:0046912   transferase activity    8 5.16% GO:0005509   calcium ion binding   
1 1.23% GO:0016772   transferase activity    7 4.52% GO:0003700   transcription factor activity   
1 1.23% GO:0004802   transketolase activity     6 3.87% GO:0005525   GTP binding   
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1 1.23% GO:0005215   transporter activity     6 3.87% GO:0005216   ion channel activity   
1 1.23% GO:0004807   triose-phosphate isomerase activity     5 3.23% GO:0003676   nucleic acid binding   
SECRETIONS   5 3.23% GO:0004713   protein-tyrosine kinase activity   
Biological Process   5 3.23% GO:0003723   RNA binding   
10 18.87% GO:0006096   glycolysis     4 2.58% GO:0015662   ATPase activity  
5 9.43% GO:0006508   proteolysis     4 2.58% GO:0005489   electron transporter activity   
4 7.55% GO:0006457   protein folding     4 2.58% GO:0016820   hydrolase activity  
3 5.66% GO:0006334   nucleosome assembly     4 2.58% GO:0003777   microtubule motor activity   
3 5.66% GO:0007001   chromosome organization and biogenesis     4 2.58% GO:0016491   oxidoreductase activity   
3 5.66% GO:0006100   tricarboxylic acid cycle intermediate metabolism     4 2.58% GO:0004674   protein serine/threonine kinase activity   
2 3.77% GO:0008152   metabolism     4 2.58% GO:0003964   RNA-directed DNA polymerase activity   
2 3.77% GO:0006108   malate metabolism     3 1.94% GO:0005388   calcium-transporting ATPase activity   
1 1.89% GO:0001539   ciliary or flagellar motility     3 1.94% GO:0005261   cation channel activity   
1 1.89% GO:0031032   actomyosin structure organization and biogenesis    3 1.94% GO:0001584   rhodopsin-like receptor activity   
1 1.89% GO:0006801   superoxide metabolism     3 1.94% GO:0003743   translation initiation factor activity   
1 1.89% GO:0006094   gluconeogenesis     3 1.94% GO:0051082   unfolded protein binding   
1 1.89% GO:0006810   transport     3 1.94% GO:0008270   zinc ion binding   
1 1.89% GO:0006118   electron transport     2 1.29% GO:0003779   actin binding   
1 1.89% GO:0044267   cellular protein metabolism     2 1.29% GO:0004190   aspartic-type endopeptidase activity   
1 1.89% GO:0006412   protein biosynthesis     2 1.29% GO:0004197   cysteine-type endopeptidase activity   
1 1.89% GO:0006826   iron ion transport     2 1.29% GO:0008234   cysteine-type peptidase activity   
1 1.89% GO:0006879   iron ion homeostasis     2 1.29% GO:0005230   extracellular ligand-gated ion channel activity   
1 1.89% GO:0007017   microtubule-based process     2 1.29% GO:0008417   fucosyltransferase activity   
1 1.89% GO:0006183   GTP biosynthesis     2 1.29% GO:0016787   hydrolase activity   
1 1.89% GO:0006228   UTP biosynthesis     2 1.29% GO:0004879   ligand-dependent nuclear receptor activity   
1 1.89% GO:0006241   CTP biosynthesis     2 1.29% GO:0004497   monooxygenase activity   
1 1.89% GO:0009209  
 pyrimidine ribonucleoside triphosphate 
biosynthesis     2 1.29% GO:0030594   neurotransmitter receptor activity   
1 1.89% GO:0005975   carbohydrate metabolism     2 1.29% GO:0004889  
 nicotinic acetylcholine-activated cation-selective 
channel activity   
1 1.89% GO:0006754   ATP biosynthesis     2 1.29% GO:0005515   protein binding   
1 1.89% GO:0015986   ATP synthesis coupled proton transport     2 1.29% GO:0019904   protein domain specific binding   
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1 1.89% GO:0019642   anaerobic glycolysis     2 1.29% GO:0004252   serine-type endopeptidase activity   
1 1.89% GO:0007018   microtubule-based movement     2 1.29% GO:0004871   signal transducer activity   
1 1.89% GO:0051258   protein polymerization     2 1.29% GO:0003707   steroid hormone receptor activity   
Cellular Component   2 1.29% GO:0003735   structural constituent of ribosome   
3 5.66% GO:0005622   intracellular     2 1.29% GO:0005245   voltage-gated calcium channel activity   
3 5.66% GO:0005737   cytoplasm     1 0.65% GO:0004040   amidase activity   
3 5.66% GO:0000786   nucleosome     1 0.65% GO:0015359   amino acid permease activity   
3 5.66% GO:0005634   nucleus     1 0.65% GO:0005279   amino acid-polyamine transporter activity   
1 1.89% GO:0009288   flagellum    1 0.65% GO:0004053   arginase activity   
1 1.89% GO:0005884   actin filament     1 0.65% GO:0042626   ATPase activity  
1 1.89% GO:0005945   6-phosphofructokinase complex     1 0.65% GO:0016887   ATPase activity   
1 1.89% GO:0000015   phosphopyruvate hydratase complex     1 0.65% GO:0005488   binding   
1 1.89% GO:0005875   microtubule associated complex     1 0.65% GO:0005544   calcium-dependent phospholipid binding   
1 1.89% GO:0016021   integral to membrane     1 0.65% GO:0005386   carrier activity   
1 1.89% GO:0045255   hydrogen-translocating F-type ATPase complex     1 0.65% GO:0004104   cholinesterase activity   
1 1.89% GO:0016469   proton-transporting two-sector ATPase complex     1 0.65% GO:0005507   copper ion binding   
1 1.89% GO:0005874   microtubule     1 0.65% GO:0004869   cysteine protease inhibitor activity   
1 1.89% GO:0043234   protein complex     1 0.65% GO:0015036   disulfide oxidoreductase activity   
Molecular Function   1 0.65% GO:0004866   endopeptidase inhibitor activity   
5 9.43% GO:0005509   calcium ion binding     1 0.65% GO:0004857   enzyme inhibitor activity   
4 7.55% GO:0016491   oxidoreductase activity     1 0.65% GO:0005006   epidermal growth factor receptor activity   
4 7.55% GO:0005524   ATP binding     1 0.65% GO:0050660   FAD binding   
3 5.66% GO:0004252   serine-type endopeptidase activity     1 0.65% GO:0015018  
 galactosylgalactosylxylosylprotein 3-beta-
glucuronosyltransferase activity   
3 5.66% GO:0005525   GTP binding     1 0.65% GO:0004818   glutamate-tRNA ligase activity   
3 5.66% GO:0003677   DNA binding     1 0.65% GO:0004819   glutamine-tRNA ligase activity   
3 5.66% GO:0004459   L-lactate dehydrogenase activity     1 0.65% GO:0004602   glutathione peroxidase activity   
2 3.77% GO:0051082   unfolded protein binding     1 0.65% GO:0004367  
 glycerol-3-phosphate dehydrogenase [NAD+] 
activity   
2 3.77% GO:0003779   actin binding     1 0.65% GO:0019001   guanyl nucleotide binding   
2 3.77% GO:0005515   protein binding     1 0.65% GO:0031072   heat shock protein binding   
2 3.77% GO:0005488   binding     1 0.65% GO:0046933   hydrogen-transporting ATP synthase activity  
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2 3.77% GO:0030060   L-malate dehydrogenase activity     1 0.65% GO:0046961   hydrogen-transporting ATPase activity  
2 3.77% GO:0016615   malate dehydrogenase activity     1 0.65% GO:0005506   iron ion binding   
1 1.89% GO:0004198   calpain activity     1 0.65% GO:0016301   kinase activity   
1 1.89% GO:0004197   cysteine-type endopeptidase activity     1 0.65% GO:0008289   lipid binding   
1 1.89% GO:0004177   aminopeptidase activity     1 0.65% GO:0015077   monovalent inorganic cation transporter activity   
1 1.89% GO:0004867   serine-type endopeptidase inhibitor activity     1 0.65% GO:0008080   N-acetyltransferase activity   
1 1.89% GO:0004785   copper, zinc superoxide dismutase activity     1 0.65% GO:0051287   NAD binding   
1 1.89% GO:0046872   metal ion binding     1 0.65% GO:0004983   neuropeptide Y receptor activity   
1 1.89% GO:0003774   motor activity     1 0.65% GO:0005328   neurotransmitter-sodium symporter activity   
1 1.89% GO:0005200   structural constituent of cytoskeleton     1 0.65% GO:0017111   nucleoside-triphosphatase activity   
1 1.89% GO:0004611   phosphoenolpyruvate carboxykinase activity     1 0.65% GO:0000166   nucleotide binding   
1 1.89% GO:0008289   lipid binding     1 0.65% GO:0016654   oxidoreductase activity  
1 1.89% GO:0005489   electron transporter activity     1 0.65% GO:0016616   oxidoreductase activity  
1 1.89% GO:0008236   serine-type peptidase activity     1 0.65% GO:0016614   oxidoreductase activity  
1 1.89% GO:0016787   hydrolase activity     1 0.65% GO:0004504   peptidylglycine monooxygenase activity   
1 1.89% GO:0004869   cysteine protease inhibitor activity     1 0.65% GO:0004611   phosphoenolpyruvate carboxykinase activity   
1 1.89% GO:0004866   endopeptidase inhibitor activity     1 0.65% GO:0016791   phosphoric monoester hydrolase activity   
1 1.89% GO:0016301   kinase activity     1 0.65% GO:0005267   potassium channel activity   
1 1.89% GO:0016772   transferase activity    1 0.65% GO:0004731   purine-nucleoside phosphorylase activity   
1 1.89% GO:0004365  
 glyceraldehyde-3-phosphate dehydrogenase, 
phosphorylating activity     1 0.65% GO:0004872   receptor activity   
1 1.89% GO:0051287   NAD binding     1 0.65% GO:0008236   serine-type peptidase activity   
1 1.89% GO:0008199   ferric iron binding     1 0.65% GO:0005198   structural molecule activity   
1 1.89% GO:0004618   phosphoglycerate kinase activity     1 0.65% GO:0005529   sugar binding   
1 1.89% GO:0004807   triose-phosphate isomerase activity     1 0.65% GO:0016772   transferase activity  
1 1.89% GO:0004332   fructose-bisphosphate aldolase activity     1 0.65% GO:0016763   transferase activity, transferring pentosyl groups   
1 1.89% GO:0019904   protein domain specific binding     1 0.65% GO:0003746   translation elongation factor activity   
1 1.89% GO:0003872   6-phosphofructokinase activity     1 0.65% GO:0004675  
 transmembrane receptor protein serine/threonine 
kinase activity   
1 1.89% GO:0004634   phosphopyruvate hydratase activity     1 0.65% GO:0004714  
 transmembrane receptor protein tyrosine kinase 
activity   
1 1.89% GO:0003777   microtubule motor activity     1 0.65% GO:0005215   transporter activity   
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1 1.89% GO:0004550   nucleoside diphosphate kinase activity     1 0.65% GO:0004812   tRNA ligase activity   
1 1.89% GO:0000287   magnesium ion binding     1 0.65% GO:0004510   tryptophan 5-monooxygenase activity   
1 1.89% GO:0004645   phosphorylase activity     1 0.65% GO:0005249   voltage-gated potassium channel activity   
1 1.89% GO:0030170   pyridoxal phosphate binding         
1 1.89% GO:0008553   hydrogen-exporting ATPase activity        
1 1.89% GO:0046933   hydrogen-transporting ATP synthase activity        
1 1.89% GO:0046961   hydrogen-transporting ATPase activity        
1 1.89% GO:0000166   nucleotide binding         
1 1.89% GO:0017111   nucleoside-triphosphatase activity         
1 1.89% GO:0005198   structural molecule activity         
1 1.89% GO:0003924   GTPase activity         
1 1.89% GO:0004743   pyruvate kinase activity         
1 1.89% GO:0016868   intramolecular transferase activity        
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Appendix G:  Protein Domain Annotation 
VESICLES  CONTROLS   
6 7.41% IPR002423   Chaperonin Cpn60/TCP-1    9 20.93% IPR000719   Protein kinase  
6 7.41% IPR008950   GroEL-like chaperone, ATPase    8 18.60% IPR011009   Protein kinase-like  
6 7.41% IPR011992   EF-Hand type    7 16.28% IPR012335   Thioredoxin fold  
6 7.41% IPR012335   Thioredoxin fold    6 13.95% IPR011992   EF-Hand type  
5 6.17% IPR001844   Chaperonin Cpn60    5 11.63% IPR005834   Haloacid dehalogenase-like hydrolase  
4 4.94% IPR002194   Chaperonin TCP-1    5 11.63% IPR002048   Calcium-binding EF-hand  
4 4.94% IPR002048   Calcium-binding EF-hand    5 11.63% IPR001245   Tyrosine protein kinase  
3 3.70% IPR007125   Histone core    4 9.30% IPR004014   Cation transporting ATPase, N-terminal  
3 3.70% IPR009072   Histone-fold    4 9.30% IPR008250   E1-E2 ATPase-associated region  
3 3.70% IPR001314   Peptidase S1A, chymotrypsin    4 9.30% IPR001757   ATPase, E1-E2 type  
3 3.70% IPR001254   Peptidase S1 and S6, chymotrypsin/Hap    4 9.30% IPR006068   Cation transporting ATPase, C-terminal  
3 3.70% IPR009003   Peptidase, trypsin-like serine and cysteine    4 9.30% IPR006663   Thioredoxin domain 2  
2 2.47% IPR008280   Tubulin/FtsZ, C-terminal    4 9.30% IPR006662   Thioredoxin-related  
2 2.47% IPR000217   Tubulin    4 9.30% IPR001372   Dynein light chain, type 1  
2 2.47% IPR003008   Tubulin/FtsZ, GTPase    4 9.30% IPR008266   Tyrosine protein kinase, active site  
2 2.47% IPR001557   L-lactate/malate dehydrogenase    4 9.30% IPR000477   RNA-directed DNA polymerase Reverse transcriptase  
2 2.47% IPR001236   Lactate/malate dehydrogenase    3 6.98% IPR005225   Small GTP-binding protein domain  
2 2.47% IPR000194  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, central region    3 6.98% IPR001806   Ras GTPase  
2 2.47% IPR003593   AAA ATPase    3 6.98% IPR007087   Zinc finger, C2H2-type  
2 2.47% IPR004100  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, N-terminal    3 6.98% IPR008271   Serine/threonine protein kinase, active site  
2 2.47% IPR000793  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, C-terminal    3 6.98% IPR005821   Ion transport  
2 2.47% IPR000866  
 Alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen    3 6.98% IPR005820   Cation channel, non-ligand gated  
2 2.47% IPR000308   14-3-3 protein    3 6.98% IPR012336   Thioredoxin-like fold  
2 2.47% IPR000533   Tropomyosin    3 6.98% IPR000276   Rhodopsin-like GPCR superfamily  
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2 2.47% IPR010987   Glutathione S-transferase, C-terminal-like    3 6.98% IPR000980   SH2 motif  
2 2.47% IPR004046   Glutathione S-transferase, C-terminal    3 6.98% IPR001611   Leucine-rich repeat  
2 2.47% IPR004045   Glutathione S-transferase, N-terminal    3 6.98% IPR001356   Homeobox  
2 2.47% IPR002928   Myosin tail    3 6.98% IPR009057   Homeodomain-like  
2 2.47% IPR006662   Thioredoxin-related    3 6.98% IPR012287   Homeodomain-related  
2 2.47% IPR000886   Endoplasmic reticulum targeting sequence    3 6.98% IPR002290   Serine/threonine protein kinase  
2 2.47% IPR005834   Haloacid dehalogenase-like hydrolase    3 6.98% IPR001584   Integrase, catalytic region  
2 2.47% IPR004014   Cation transporting ATPase, N-terminal    2 4.65% IPR001388   Synaptobrevin  
2 2.47% IPR001757   ATPase, E1-E2 type    2 4.65% IPR001452   Src homology-3  
2 2.47% IPR006068   Cation transporting ATPase, C-terminal    2 4.65% IPR001680   WD-40 repeat  
2 2.47% IPR008250   E1-E2 ATPase-associated region    2 4.65% IPR013019   MAD homology, MH1  
2 2.47% IPR009079   Four-helical cytokine    2 4.65% IPR008984   SMAD/FHA  
2 2.47% IPR001404   Heat shock protein Hsp90    2 4.65% IPR003619   Dwarfin protein, A  
2 2.47% IPR001715   Calponin-like actin-binding    2 4.65% IPR001132   Dwarfin protein  
1 1.23% IPR013078   Phosphoglycerate mutase    2 4.65% IPR009356   NADH dehydrogenase subunit 4L  
1 1.23% IPR005952   Phosphoglycerate mutase 1    2 4.65% IPR001682   Ca2+/Na+ channel, pore region  
1 1.23% IPR001650   Helicase, C-terminal    2 4.65% IPR002111   Cation not K+ channel, TM region  
1 1.23% IPR011545   DEAD/DEAH box helicase, N-terminal    2 4.65% IPR002077   Ca2+ channel, alpha subunit  
1 1.23% IPR001697   Pyruvate kinase    2 4.65% IPR013027  
 FAD-dependent pyridine nucleotide-disulphide 
oxidoreductase  
1 1.23% IPR001978   Troponin    2 4.65% IPR000308   14-3-3 protein  
1 1.23% IPR000158   Cell division protein FtsZ    2 4.65% IPR013128   Peptidase C1A, papain  
1 1.23% IPR002453   Beta tubulin    2 4.65% IPR000668   Peptidase C1A, papain C-terminal  
1 1.23% IPR012718   T-complex protein 1, epsilon subunit    2 4.65% IPR000169   Peptidase, cysteine peptidase active site  
1 1.23% IPR007648   Mitochondrial ATPase inhibitor, IATP    2 4.65% IPR012599   Peptidase C1, propeptide  
1 1.23% IPR012722   T-complex protein 1, zeta subunit    2 4.65% IPR001715   Calponin-like actin-binding  
1 1.23% IPR001993   Mitochondrial substrate carrier    2 4.65% IPR005746   Thioredoxin  
1 1.23% IPR002113   Adenine nucleotide translocator 1    2 4.65% IPR009003   Peptidase, trypsin-like serine and cysteine  
1 1.23% IPR002067   Mitochondrial carrier protein    2 4.65% IPR001314   Peptidase S1A, chymotrypsin  
1 1.23% IPR001252   Malate dehydrogenase, active site    2 4.65% IPR001254   Peptidase S1 and S6, chymotrypsin/Hap  
1 1.23% IPR010097  
 Malate dehydrogenase, NAD-dependent, eukaryotes 
and gamma proteobacteria    2 4.65% IPR000379   Esterase/lipase/thioesterase  
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1 1.23% IPR001125   Recoverin    2 4.65% IPR008139   Saposin B  
1 1.23% IPR011304   L-lactate dehydrogenase    2 4.65% IPR011001   Saposin-like  
1 1.23% IPR005475   Transketolase, central region    2 4.65% IPR000301   CD9/CD37/CD63 antigen  
1 1.23% IPR009014   Transketolase, C-terminal-like    2 4.65% IPR008952   Tetraspanin  
1 1.23% IPR005476   Transketolase, C-terminal    2 4.65% IPR000555   Mov34/MPN/PAD-1  
1 1.23% IPR005474   Transketolase, N-terminal    2 4.65% IPR008991   Translation protein SH3-like  
1 1.23% IPR005478   Bacterial transketolase    2 4.65% IPR001884   Eukaryotic initiation factor 5A hypusine eIF-5A  
1 1.23% IPR001951   Histone H4    2 4.65% IPR005824   KOW  
1 1.23% IPR003953  
 Fumarate reductase/succinate dehydrogenase 
flavoprotein, N-terminal    2 4.65% IPR013032   EGF-like region  
1 1.23% IPR004112  
 Fumarate reductase/succinate dehydrogenase 
flavoprotein, C-terminal    2 4.65% IPR001503   Glycosyl transferase, family 10  
1 1.23% IPR012719   T-complex protein 1, gamma subunit    2 4.65% IPR001827   Homeobox protein, antennapedia type  
1 1.23% IPR000164   Histone H3    2 4.65% IPR005782   Calcium ATPase  
1 1.23% IPR012716   T-complex protein 1, beta subunit    2 4.65% IPR006202   Neurotransmitter-gated ion-channel ligand-binding  
1 1.23% IPR000558   Histone H2B    2 4.65% IPR006029  
 Neurotransmitter-gated ion-channel transmembrane 
region  
1 1.23% IPR005722   ATP synthase F1, beta subunit    2 4.65% IPR006201   Neurotransmitter-gated ion-channel  
1 1.23% IPR000811   Glycosyl transferase, family 35    2 4.65% IPR002394   Nicotinic acetylcholine receptor  
1 1.23% IPR011833   Glycogen/starch/alpha-glucan phosphorylase    2 4.65% IPR008946   Steroid nuclear receptor, ligand-binding  
1 1.23% IPR001564   Nucleoside diphosphate kinase    2 4.65% IPR001628   Nuclear hormone receptor, DNA-binding  
1 1.23% IPR012005   Nucleoside-diphosphate kinase    2 4.65% IPR000536   Nuclear hormone receptor, ligand-binding  
1 1.23% IPR012336   Thioredoxin-like fold    2 4.65% IPR001723   Steroid hormone receptor  
1 1.23% IPR000911   Ribosomal protein L11    2 4.65% IPR000324   Vitamin D receptor  
1 1.23% IPR001107   Band 7 protein    2 4.65% IPR008042   Retrotransposon, Pao  
1 1.23% IPR000163   Prohibitin    2 4.65% IPR001995   Peptidase A2A, retrovirus, catalytic  
1 1.23% IPR002020   Citrate synthase    2 4.65% IPR009007   Peptidase aspartic, catalytic  
1 1.23% IPR010109   Citrate synthase, eukaryotic    2 4.65% IPR000886   Endoplasmic reticulum targeting sequence  
1 1.23% IPR005841   Phosphoglucomutase/phosphomannomutase    2 4.65% IPR002579   Methionine sulfoxide reductase B  
1 1.23% IPR005843  
 Phosphoglucomutase/phosphomannomutase C 
terminal    2 4.65% IPR011057   Mss4-like  
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1 1.23% IPR005845  
 Phosphoglucomutase/phosphomannomutase 
alpha/beta/alpha domain II    1 2.33% IPR005027   Glycosyl transferase, family 43  
1 1.23% IPR005846  
 Phosphoglucomutase/phosphomannomutase 
alpha/beta/alpha domain III    1 2.33% IPR006383   HAD-superfamily hydrolase subfamily IB, PSPase-like 
1 1.23% IPR005844  
 Phosphoglucomutase/phosphomannomutase 
alpha/beta/alpha domain I    1 2.33% IPR002347   Glucose/ribitol dehydrogenase  
1 1.23% IPR003960   AAA-protein subdomain    1 2.33% IPR002198   Short-chain dehydrogenase/reductase SDR  
1 1.23% IPR003338   AAA ATPase VAT, N-terminal    1 2.33% IPR007648   Mitochondrial ATPase inhibitor, IATP  
1 1.23% IPR009010   Aspartate decarboxylase-like fold    1 2.33% IPR003579   Ras small GTPase, Rab type  
1 1.23% IPR003959   AAA ATPase, central region    1 2.33% IPR002078   Sigma-54 factor, interaction region  
1 1.23% IPR005938   AAA ATPase, CDC48    1 2.33% IPR000866  
 Alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen  
1 1.23% IPR005294   ATP synthase F1, alpha subunit    1 2.33% IPR011511   Variant SH3  
1 1.23% IPR000504   RNA-binding region RNP-1 RNA recognition motif    1 2.33% IPR012615   Trematode Eggshell Synthesis  
1 1.23% IPR012677   Nucleotide-binding, alpha-beta plait    1 2.33% IPR001369   Purine phosphorylase, family 2  
1 1.23% IPR001372   Dynein light chain, type 1    1 2.33% IPR011270  
 Purine nucleoside phosphorylase I, inosine and 
guanosine-specific  
1 1.23% IPR000941   Enolase    1 2.33% IPR011268   Inosine guanosine and xanthosine phosphorylase  
1 1.23% IPR002130   Peptidyl-prolyl cis-trans isomerase, cyclophilin type    1 2.33% IPR000782   Beta-Ig-H3/fasciclin  
1 1.23% IPR000741   Fructose-bisphosphate aldolase, class-I    1 2.33% IPR006413   Calcium-transporting P-type ATPase, PMR1-type  
1 1.23% IPR000652   Triosephosphate isomerase    1 2.33% IPR000695   H+ transporting ATPase, proton pump  
1 1.23% IPR001576   Phosphoglycerate kinase    1 2.33% IPR003605   TGF beta receptor, GS motif  
1 1.23% IPR000173   Glyceraldehyde 3-phosphate dehydrogenase    1 2.33% IPR001289   CCAAT-binding transcription factor, subunit B  
1 1.23% IPR000749   ATP:guanido phosphotransferase    1 2.33% IPR002086   Aldehyde dehydrogenase  
1 1.23% IPR008978   HSP20-like chaperone    1 2.33% IPR005829   Sugar transporter superfamily  
1 1.23% IPR001436   Alpha crystallin    1 2.33% IPR005446  
 L-type voltage-dependent calcium channel alpha 1 
subunit  
1 1.23% IPR002068   Heat shock protein Hsp20    1 2.33% IPR000205   NAD-binding site  
1 1.23% IPR000719   Protein kinase    1 2.33% IPR001327  
 Pyridine nucleotide-disulphide oxidoreductase, NAD-
binding region  
1 1.23% IPR011009   Protein kinase-like    1 2.33% IPR012999  
 Pyridine nucleotide-disulphide oxidoreductase, class I, 
active site  
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1 1.23% IPR004161   Elongation factor Tu, domain 2    1 2.33% IPR011767   Glutaredoxin active site  
1 1.23% IPR009000   Translation factor    1 2.33% IPR011899   Glutaredoxin, eukaryotic and viruses  
1 1.23% IPR000795   Protein synthesis factor, GTP-binding    1 2.33% IPR006338   Thioredoxin and glutathione reductase selenoprotein  
1 1.23% IPR009001   EF-Tu/eEF-1alpha/eIF2-gamma, C-terminal    1 2.33% IPR002109   Glutaredoxin  
1 1.23% IPR004160   Elongation factor Tu, C-terminal    1 2.33% IPR004099  
 Pyridine nucleotide-disulphide oxidoreductase 
dimerisation region  
1 1.23% IPR013126   Heat shock protein 70    1 2.33% IPR001100   Pyridine nucleotide-disulphide oxidoreductase, class I  
1 1.23% IPR001023   Heat shock protein Hsp70    1 2.33% IPR000815   Mercuric reductase  
1 1.23% IPR001298   Filamin/ABP280 repeat    1 2.33% IPR001412   Aminoacyl-tRNA synthetase, class I  
1 1.23% IPR002173   Carbohydrate kinase, PfkB    1 2.33% IPR000924   Glutamyl-tRNA synthetase, class Ic  
1 1.23% IPR005924   Arginase    1 2.33% IPR011035   Ribosomal protein L25-like  
1 1.23% IPR006035   Arginase/agmatinase/formiminoglutamase    1 2.33% IPR007638  
 Glutaminyl-tRNA synthetase, non-specific RNA-
binding region part 2  
1 1.23% IPR008256   Peptidase S1B, glutamyl endopeptidase I    1 2.33% IPR004514   Glutaminyl-tRNA synthetase  
1 1.23% IPR001983   Translationally controlled tumor protein    1 2.33% IPR003577   Ras small GTPase, Ras type  
1 1.23% IPR011057   Mss4-like    1 2.33% IPR000264   Serum albumin  
1 1.23% IPR006069   Cation transporting ATPase    1 2.33% IPR001703   Alpha-fetoprotein  
1 1.23% IPR008209   Phosphoenolpyruvate carboxykinase GTP    1 2.33% IPR006069   Cation transporting ATPase  
1 1.23% IPR000782   Beta-Ig-H3/fasciclin    1 2.33% IPR005775   Na+/K+ ATPase, alpha subunit  
1 1.23% IPR004001   Actin    1 2.33% IPR012340   Nucleic acid-binding, OB-fold, subgroup  
1 1.23% IPR004000   Actin/actin-like    1 2.33% IPR003029   RNA binding S1  
1 1.23% IPR000215   Proteinase inhibitor I4, serpin    1 2.33% IPR011488   Eukaryotic translation initiation factor 2, alpha subunit  
1 1.23% IPR000557   Calponin repeat    1 2.33% IPR008994   Nucleic acid-binding, OB-fold  
1 1.23% IPR001997   Calponin    1 2.33% IPR001623   Heat shock protein DnaJ, N-terminal  
1 1.23% IPR003096   SM22/calponin    1 2.33% IPR004160   Elongation factor Tu, C-terminal  
1 1.23% IPR000819   Peptidase M17, leucyl aminopeptidase, C-terminal    1 2.33% IPR004161   Elongation factor Tu, domain 2  
1 1.23% IPR011356   Peptidase M17, leucyl aminopeptidase    1 2.33% IPR009001   EF-Tu/eEF-1alpha/eIF2-gamma, C-terminal  
1 1.23% IPR003299   Flagellar calcium-binding protein calflagin    1 2.33% IPR000795   Protein synthesis factor, GTP-binding  
1 1.23% IPR001589   Actin-binding, actinin-type    1 2.33% IPR009000   Translation factor  
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1 1.23% IPR001580   Calreticulin/calnexin    1 2.33% IPR004539   Translation elongation factor EF-1, alpha subunit  
1 1.23% IPR013320   Concanavalin A-like lectin/glucanase, subgroup    1 2.33% IPR009068   S15/NS1, RNA-binding  
1 1.23% IPR008985   Concanavalin A-like lectin/glucanase    1 2.33% IPR001828   Extracellular ligand-binding receptor  
1 1.23% IPR009169   Calreticulin    1 2.33% IPR001997   Calponin  
1 1.23% IPR007420   Protein of unknown function DUF465    1 2.33% IPR000557   Calponin repeat  
1 1.23% IPR004009   Myosin, N-terminal, SH3-like    1 2.33% IPR003096   SM22/calponin  
1 1.23% IPR001609   Myosin head, motor region    1 2.33% IPR011045   Nitrous oxide reductase, N-terminal  
1 1.23% IPR001637   Glutamine synthetase class-I, adenylation site    1 2.33% IPR000463   Cytosolic fatty-acid binding  
1 1.23% IPR002452   Alpha tubulin    1 2.33% IPR000566   Lipocalin-related protein and Bos/Can/Equ allergen  
SECRETIONS  1 2.33% IPR012674   Calycin  
5 9.43% IPR011992   EF-Hand type   1 2.33% IPR011038   Calycin-like  
4 7.55% IPR012335   Thioredoxin fold   1 2.33% IPR000175   Sodium:neurotransmitter symporter  
3 5.66% IPR009003   Peptidase, trypsin-like serine and cysteine   1 2.33% IPR000911   Ribosomal protein L11  
3 5.66% IPR001314   Peptidase S1A, chymotrypsin   1 2.33% IPR008256   Peptidase S1B, glutamyl endopeptidase I  
3 5.66% IPR001254   Peptidase S1 and S6, chymotrypsin/Hap   1 2.33% IPR000120   Amidase  
3 5.66% IPR001557   L-lactate/malate dehydrogenase   1 2.33% IPR001179   Peptidylprolyl isomerase, FKBP-type  
3 5.66% IPR001236   Lactate/malate dehydrogenase   1 2.33% IPR000759   Adrenodoxin reductase  
3 5.66% IPR009072   Histone-fold   1 2.33% IPR003140   Phospholipase/Carboxylesterase  
3 5.66% IPR007125   Histone core   1 2.33% IPR004843   Metallophosphoesterase  
3 5.66% IPR002048   Calcium-binding EF-hand   1 2.33% IPR006186  
 Serine/threonine-specific protein phosphatase and bis5-
nucleosyl-tetraphosphatase  
2 3.77% IPR002130   Peptidyl-prolyl cis-trans isomerase, cyclophilin type   1 2.33% IPR011002   Flagellar motor switch protein FliG-like  
2 3.77% IPR001252   Malate dehydrogenase, active site   1 2.33% IPR006212   Furin-like repeat  
2 3.77% IPR004045   Glutathione S-transferase, N-terminal   1 2.33% IPR000494   EGF receptor, L domain  
2 3.77% IPR010987   Glutathione S-transferase, C-terminal-like   1 2.33% IPR003961   Fibronectin, type III  
2 3.77% IPR004046   Glutathione S-transferase, C-terminal   1 2.33% IPR000585   Hemopexin  
2 3.77% IPR001715   Calponin-like actin-binding   1 2.33% IPR009030   Growth factor, receptor  
1 1.89% IPR003008   Tubulin/FtsZ, GTPase   1 2.33% IPR001019  
 Guanine nucleotide binding protein G-protein, alpha 
subunit  
1 1.89% IPR008280   Tubulin/FtsZ, C-terminal   1 2.33% IPR001408   G-protein alpha subunit, group I  
1 1.89% IPR000217   Tubulin   1 2.33% IPR011025   G protein alpha subunit, helical insertion  
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1 1.89% IPR000652   Triosephosphate isomerase   1 2.33% IPR001770   G-protein, gamma subunit  
1 1.89% IPR009000   Translation factor   1 2.33% IPR003578   Ras small GTPase, Rho type  
1 1.89% IPR006662   Thioredoxin-related   1 2.33% IPR001569   Ribosomal protein L37e  
1 1.89% IPR001424   Superoxide dismutase, copper/zinc binding   1 2.33% IPR008977   PHM/PNGase F Fold  
1 1.89% IPR003096   SM22/calponin   1 2.33% IPR000323   Copper type II, ascorbate-dependent monooxygenase  
1 1.89% IPR001125   Recoverin   1 2.33% IPR000720   Peptidyl-glycine alpha-amidating monooxygenase  
1 1.89% IPR001697   Pyruvate kinase   1 2.33% IPR000408   Regulator of chromosome condensation, RCC1  
1 1.89% IPR000215   Proteinase inhibitor I4, serpin   1 2.33% IPR010987   Glutathione S-transferase, C-terminal-like  
1 1.89% IPR001713   Proteinase inhibitor I25A, stefin A   1 2.33% IPR004045   Glutathione S-transferase, N-terminal  
1 1.89% IPR000010   Proteinase inhibitor I25, cystatin   1 2.33% IPR003957  
 Histone-like transcription factor/archaeal 
histone/topoisomerase  
1 1.89% IPR000795   Protein synthesis factor, GTP-binding   1 2.33% IPR007124   Histone-fold/TFIID-TAF/NF-Y  
1 1.89% IPR005952   Phosphoglycerate mutase 1   1 2.33% IPR009072   Histone-fold  
1 1.89% IPR013078   Phosphoglycerate mutase   1 2.33% IPR003958   Transcription factor CBF/NF-Y/archaeal histone  
1 1.89% IPR001576   Phosphoglycerate kinase   1 2.33% IPR008922   Di-copper centre-containing  
1 1.89% IPR000023   Phosphofructokinase   1 2.33% IPR002227   Tyrosinase  
1 1.89% IPR008209   Phosphoenolpyruvate carboxykinase GTP   1 2.33% IPR002049   EGF-like, laminin  
1 1.89% IPR000169   Peptidase, cysteine peptidase active site   1 2.33% IPR000407   Nucleoside phosphatase GDA1/CD39  
1 1.89% IPR008256   Peptidase S1B, glutamyl endopeptidase I   1 2.33% IPR000182   GCN5-related N-acetyltransferase  
1 1.89% IPR000819   Peptidase M17, leucyl aminopeptidase, C-terminal   1 2.33% IPR009464   PCAF, N-terminal  
1 1.89% IPR001300   Peptidase C2, calpain   1 2.33% IPR001487   Bromodomain  
1 1.89% IPR012005   Nucleoside-diphosphate kinase   1 2.33% IPR002018   Carboxylesterase, type B  
1 1.89% IPR000407   Nucleoside phosphatase GDA1/CD39   1 2.33% IPR000997   Cholinesterase  
1 1.89% IPR001564   Nucleoside diphosphate kinase   1 2.33% IPR001713   Proteinase inhibitor I25A, stefin A  
1 1.89% IPR010097  
 Malate dehydrogenase, NAD-dependent, eukaryotes 
and gamma proteobacteria   1 2.33% IPR000010   Proteinase inhibitor I25, cystatin  
1 1.89% IPR011274   Malate dehydrogenase, NAD-dependent, cytosolic   1 2.33% IPR008967   p53-like transcription factor, DNA-binding  
1 1.89% IPR010945   Malate dehydrogenase, NAD or NADP   1 2.33% IPR000611   Neuropeptide Y receptor  
1 1.89% IPR008267   Malate dehydrogenase   1 2.33% IPR000794   Beta-ketoacyl synthase  
1 1.89% IPR011304   L-lactate dehydrogenase   1 2.33% IPR002219   Protein kinase C, phorbol ester/diacylglycerol binding  
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1 1.89% IPR000566   Lipocalin-related protein and Bos/Can/Equ allergen   1 2.33% IPR008973   C2 calcium/lipid-binding region, CaLB  
1 1.89% IPR001951   Histone H4   1 2.33% IPR000008   C2  
1 1.89% IPR000164   Histone H3   1 2.33% IPR000961   Protein kinase, C-terminal  
1 1.89% IPR000558   Histone H2B   1 2.33% IPR011991   Winged helix repressor DNA-binding  
1 1.89% IPR001404   Heat shock protein Hsp90   1 2.33% IPR002341   HSF/ETS, DNA-binding  
1 1.89% IPR001023   Heat shock protein Hsp70   1 2.33% IPR000232   Heat shock factor HSF-type, DNA-binding  
1 1.89% IPR013126   Heat shock protein 70   1 2.33% IPR001298   Filamin/ABP280 repeat  
1 1.89% IPR004100  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, N-terminal   1 2.33% IPR002173   Carbohydrate kinase, PfkB  
1 1.89% IPR000793  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, C-terminal   1 2.33% IPR000194  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, central region  
1 1.89% IPR000194  
 H+-transporting two-sector ATPase, alpha/beta 
subunit, central region   1 2.33% IPR009071   High mobility group box  
1 1.89% IPR008950   GroEL-like chaperone, ATPase   1 2.33% IPR000910   HMG1/2 high mobility group box  
1 1.89% IPR000811   Glycosyl transferase, family 35   1 2.33% IPR000135   High mobility group proteins HMG1 and HMG2  
1 1.89% IPR011833   Glycogen/starch/alpha-glucan phosphorylase   1 2.33% IPR000626   Ubiquitin  
1 1.89% IPR000173   Glyceraldehyde 3-phosphate dehydrogenase   1 2.33% IPR002293   Amino acid/polyamine transporter I  
1 1.89% IPR002347   Glucose/ribitol dehydrogenase   1 2.33% IPR004841   Amino acid permease-associated region  
1 1.89% IPR000741   Fructose-bisphosphate aldolase, class-I   1 2.33% IPR004760   L-type amino acid transporter  
1 1.89% IPR009079   Four-helical cytokine   1 2.33% IPR002110   Ankyrin  
1 1.89% IPR003299   Flagellar calcium-binding protein calflagin   1 2.33% IPR003571   Snake toxin  
1 1.89% IPR001298   Filamin/ABP280 repeat   1 2.33% IPR001273   Aromatic amino acid hydroxylase  
1 1.89% IPR012347   Ferritin-related   1 2.33% IPR005963   Tyrosine 5-monooxygenase  
1 1.89% IPR009078   Ferritin/ribonucleotide reductase-like   1 2.33% IPR006035   Arginase/agmatinase/formiminoglutamase  
1 1.89% IPR008331   Ferritin and Dps   1 2.33% IPR005924   Arginase  
1 1.89% IPR001519   Ferritin   1 2.33% IPR003593   AAA ATPase  
1 1.89% IPR000941   Enolase   1 2.33% IPR003439   ABC transporter related  
1 1.89% IPR004161   Elongation factor Tu, domain 2   1 2.33% IPR011527   ABC transporter, transmembrane region, type 1  
1 1.89% IPR004160   Elongation factor Tu, C-terminal   1 2.33% IPR001140   ABC transporter, transmembrane region  
1 1.89% IPR009001   EF-Tu/eEF-1alpha/eIF2-gamma, C-terminal   1 2.33% IPR005135   Endonuclease/exonuclease/phosphatase  
1 1.89% IPR001372   Dynein light chain, type 1   1 2.33% IPR001878   Zinc finger, CCHC-type  
1 1.89% IPR000463   Cytosolic fatty-acid binding   1 2.33% IPR001969   Peptidase aspartic, active site  
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1 1.89% IPR002423   Chaperonin Cpn60/TCP-1   1 2.33% IPR008209   Phosphoenolpyruvate carboxykinase GTP  
1 1.89% IPR001844   Chaperonin Cpn60   1 2.33% IPR001464   Annexin  
1 1.89% IPR000158   Cell division protein FtsZ   1 2.33% IPR001589   Actin-binding, actinin-type  
1 1.89% IPR002173   Carbohydrate kinase, PfkB   1 2.33% IPR001580   Calreticulin/calnexin  
1 1.89% IPR011038   Calycin-like   1 2.33% IPR013320   Concanavalin A-like lectin/glucanase, subgroup  
1 1.89% IPR012674   Calycin   1 2.33% IPR008985   Concanavalin A-like lectin/glucanase  
1 1.89% IPR000557   Calponin repeat   1 2.33% IPR009169   Calreticulin  
1 1.89% IPR001997   Calponin   1 2.33% IPR003972   Shaker voltage-gated K+ channel  
1 1.89% IPR002453   Beta tubulin   1 2.33% IPR001622   K+ channel, pore region  
1 1.89% IPR000749   ATP:guanido phosphotransferase   1 2.33% IPR003131   K+ channel tetramerisation  
1 1.89% IPR005722   ATP synthase F1, beta subunit   1 2.33% IPR003968   Kv channel  
1 1.89% IPR000866  
 Alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen   1 2.33% IPR003091   Voltage-dependent potassium channel  
1 1.89% IPR001589   Actin-binding, actinin-type   1 2.33% IPR000210   BTB  
1 1.89% IPR004000   Actin/actin-like   1 2.33% IPR007856   Saposin-like type B, 1  
1 1.89% IPR004001   Actin   1 2.33% IPR001429   ATP P2X receptor  
1 1.89% IPR003593   AAA ATPase   1 2.33% IPR000889   Glutathione peroxidase  
1 1.89% IPR009161   6-phosphofructokinase, eukaryotic type   1 2.33% IPR007092   Leucine-rich repeat, SDS22  
1 1.89% IPR000308   14-3-3 protein   1 2.33% IPR000749   ATP:guanido phosphotransferase  
TEGUMENT  1 2.33% IPR000959   POLO box duplicated region  
2 4.65% IPR008973   C2 calcium/lipid-binding region, CaLB   1 2.33% IPR008927   6-phosphogluconate dehydrogenase, C-terminal-like  
2 4.65% IPR012336   Thioredoxin-like fold   1 2.33% IPR011128  
 NAD-dependent glycerol-3-phosphate dehydrogenase, 
N-terminal  
2 4.65% IPR000301   CD9/CD37/CD63 antigen   1 2.33% IPR006109  
 NAD-dependent glycerol-3-phosphate dehydrogenase, 
C-terminal  
2 4.65% IPR008952   Tetraspanin   1 2.33% IPR006168   NAD-dependent glycerol-3-phosphate dehydrogenase  
2 4.65% IPR001715   Calponin-like actin-binding   1 2.33% IPR001304   C-type lectin  
1 2.33% IPR001464   Annexin   1 2.33% IPR002130   Peptidyl-prolyl cis-trans isomerase, cyclophilin type  
1 2.33% IPR000120   Amidase   1 2.33% IPR006628   PUR-alpha/beta/gamma, DNA/RNA-binding  
1 2.33% IPR012968   FerI   1 2.33% IPR009079   Four-helical cytokine  
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1 2.33% IPR001283   Allergen V5/Tpx-1 related   1 2.33% IPR001404   Heat shock protein Hsp90  
1 2.33% IPR012269   Aquaporin   1 2.33% IPR003594   ATP-binding region, ATPase-like  
1 2.33% IPR000425   Major intrinsic protein   1 2.33% IPR001760   Opsin  
1 2.33% IPR000682  
 Protein-L-isoaspartateD-aspartate O-
methyltransferase   1 2.33% IPR008080   Parvalbumin  
1 2.33% IPR009976   Exocyst complex component Sec10   1 2.33% IPR001125   Recoverin  
1 2.33% IPR000407   Nucleoside phosphatase GDA1/CD39   1 2.33% IPR006861   Hyaluronan/mRNA binding protein  
1 2.33% IPR000626   Ubiquitin   1 2.33% IPR001173   Glycosyl transferase, family 2  
1 2.33% IPR001975   Ribosomal protein L40e       
1 2.33% IPR001666   Phosphatidylinositol transfer protein       
1 2.33% IPR005024   Snf7       
1 2.33% IPR002017   Spectrin repeat       
1 2.33% IPR002048   Calcium-binding EF-hand       
1 2.33% IPR011992   EF-Hand type       
1 2.33% IPR000866  
 Alkyl hydroperoxide reductase/ Thiol specific 
antioxidant/ Mal allergen       
1 2.33% IPR012335   Thioredoxin fold       
1 2.33% IPR002591  
 Type I phosphodiesterase/nucleotide 
pyrophosphatase       
1 2.33% IPR001478   PDZ/DHR/GLGF       
1 2.33% IPR001298   Filamin/ABP280 repeat       
1 2.33% IPR005828   General substrate transporter       
1 2.33% IPR003663   Sugar transporter       
1 2.33% IPR005829   Sugar transporter superfamily       
1 2.33% IPR000873   AMP-dependent synthetase and ligase       
1 2.33% IPR011545   DEAD/DEAH box helicase, N-terminal       
1 2.33% IPR001650   Helicase, C-terminal       
1 2.33% IPR008978   HSP20-like chaperone       
1 2.33% IPR002068   Heat shock protein Hsp20       
1 2.33% IPR001436   Alpha crystallin       
1 2.33% IPR011710   Protein of unknown function DUF1606       
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1 2.33% IPR009028  
 AP2 clathrin adaptor, alpha and beta chain, 
appendage       
1 2.33% IPR001837   CAP protein       
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Appendix H:  GO Entropy Calculations 
 (only showing attributes with highest information gain) 
 
GO terms- Entropy: Vesicles vs. Controls 
70 vesicle proteins vs. 118 control proteins 
Total Information Gain = 9.52E-01 
attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Biological Process: glycolysis GO:0006096 8 0 118 62 8.89E-01 6.30E-02 
Biological Process: cellular protein metabolism GO:0044267 6 0 118 64 9.06E-01 4.68E-02 
Biological Process: regulation of transcription GO:0006355 0 11 107 70 9.12E-01 4.09E-02 
Cellular Component: integral to membrane GO:0016021 1 16 102 69 9.14E-01 3.83E-02 
Molecular Function: unfolded protein binding GO:0051082 9 3 115 61 9.23E-01 2.91E-02 
Molecular Function: transcription factor activity GO:0003700 0 7 111 70 9.27E-01 2.56E-02 
Molecular Function: protein binding GO:0005515 7 2 116 63 9.28E-01 2.49E-02 
Cellular Component: membrane GO:0016020 3 18 100 67 9.29E-01 2.32E-02 
Cellular Component: nucleosome GO:0000786 3 0 118 67 9.29E-01 2.31E-02 
Biological Process: nucleosome assembly GO:0006334 3 0 118 67 9.29E-01 2.31E-02 
Biological Process: chromosome organization and 
biogenesis [sensu Eukaryota] GO:0007001 3 0 118 67 9.29E-01 2.31E-02 
Molecular Function: motor activity GO:0003774 3 0 118 67 9.29E-01 2.31E-02 
Biological Process: protein folding GO:0006457 10 5 113 60 9.30E-01 2.23E-02 
Molecular Function: ion channel activity GO:0005216 0 6 112 70 9.31E-01 2.19E-02 
Biological Process: ion transport GO:0006811 0 6 112 70 9.31E-01 2.19E-02 
Biological Process: calcium ion transport GO:0006816 0 5 113 70 9.34E-01 1.82E-02 
Molecular Function: RNA binding GO:0003723 0 5 113 70 9.34E-01 1.82E-02 
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attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Biological Process: G-protein coupled receptor protein 
signaling pathway GO:0007186 0 5 113 70 9.34E-01 1.82E-02 
Molecular Function: protein-tyrosine kinase activity GO:0004713 0 5 113 70 9.34E-01 1.82E-02 
 
GO terms- Entropy:  Secretions vs. Controls  
48 secretion proteins vs. 118 control proteins. 
Total Information Gain = 8.68E-01 
attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Biological Process: glycolysis GO:0006096 10 0 118 38 7.53E-01 1.15E-01 
Cellular Component: membrane GO:0016020 0 18 100 48 8.10E-01 5.72E-02 
Biological Process: regulation of transcription GO:0006355 0 11 107 48 8.34E-01 3.40E-02 
Cellular Component: nucleosome GO:0000786 3 0 118 45 8.35E-01 3.29E-02 
Biological Process: nucleosome assembly GO:0006334 3 0 118 45 8.35E-01 3.29E-02 
Biological Process: chromosome organization and biogenesis GO:0007001 3 0 118 45 8.35E-01 3.29E-02 
Molecular Function: L-lactate dehydrogenase activity GO:0004459 3 0 118 45 8.35E-01 3.29E-02 
Biological Process: tricarboxylic acid cycle intermediate 
metabolism GO:0006100 3 0 118 45 8.35E-01 3.29E-02 
Molecular Function: catalytic activity GO:0003824 0 9 109 48 8.40E-01 2.76E-02 
Molecular Function: protein kinase activity GO:0004672 0 9 109 48 8.40E-01 2.76E-02 
Biological Process: protein amino acid phosphorylation GO:0006468 0 9 109 48 8.40E-01 2.76E-02 
Cellular Component: integral to membrane GO:0016021 1 16 102 47 8.40E-01 2.73E-02 
Biological Process: malate metabolism GO:0006108 2 0 118 46 8.46E-01 2.18E-02 
Molecular Function: L-malate dehydrogenase activity GO:0030060 2 0 118 46 8.46E-01 2.18E-02 
Molecular Function: malate dehydrogenase activity GO:0016615 2 0 118 46 8.46E-01 2.18E-02 
Biological Process: cation transport GO:0006812 0 7 111 48 8.46E-01 2.13E-02 
Molecular Function: transcription factor activity GO:0003700 0 7 111 48 8.46E-01 2.13E-02 
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GO terms- Entropy:  Tegument vs. Controls 
21 tegument proteins vs. 118 control proteins. 
Total Information Gain = 6.43E-01 
attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Molecular Function: transporter activity GO:0005215 2 1 117 19 5.91E-01 2.18E-02 
Biological Process: protein modification GO:0006464 2 1 117 19 5.91E-01 2.18E-02 
Molecular Function: DNA binding GO:0003677 0 12 106 21 5.91E-01 2.14E-02 
Cellular Component: nucleus GO:0005634 0 12 106 21 5.91E-01 2.14E-02 
Molecular Function: protein-L-isoaspartate [D-aspartate] O-methyltransferase 
activity GO:0004719 1 0 118 20 5.93E-01 1.98E-02 
Biological Process: exocytosis GO:0006887 1 0 118 20 5.93E-01 1.98E-02 
Biological Process: vesicle docking GO:0048278 1 0 118 20 5.93E-01 1.98E-02 
Molecular Function: molecular function unknown GO:0005554 1 0 118 20 5.93E-01 1.98E-02 
Biological Process: nucleotide metabolism GO:0009117 1 0 118 20 5.93E-01 1.98E-02 
Molecular Function: sugar porter activity GO:0005351 1 0 118 20 5.93E-01 1.98E-02 
Biological Process: carbohydrate transport GO:0008643 1 0 118 20 5.93E-01 1.98E-02 
Molecular Function: helicase activity GO:0004386 1 0 118 20 5.93E-01 1.98E-02 
Cellular Component: Golgi stack GO:0005795 1 0 118 20 5.93E-01 1.98E-02 
Biological Process: protein targeting GO:0006605 1 0 118 20 5.93E-01 1.98E-02 
Biological Process: regulation of transcription GO:0006355 0 11 107 21 5.93E-01 1.96E-02 
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GO terms- Entropy:  Secretions vs. Vesicles 
48 secretion proteins vs. 69 vesicle proteins. 
Total Information Gain = 9.77E-01 
attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Molecular Function: ATP binding GO:0005524 4 16 53 44 9.47E-01 2.93E-02 
Cellular Component: membrane GO:0016020 0 3 66 48 9.57E-01 1.99E-02 
Molecular Function: hydrolase activity GO:0016820 0 3 66 48 9.57E-01 1.99E-02 
Molecular Function: catalytic activity GO:0003824 0 3 66 48 9.57E-01 1.99E-02 
Molecular Function: unfolded protein binding GO:0051082 2 9 60 46 9.59E-01 1.78E-02 
Biological Process: cellular protein metabolism GO:0044267 1 6 63 47 9.61E-01 1.55E-02 
Molecular Function: nucleic acid binding GO:0003676 0 2 67 48 9.63E-01 1.32E-02 
Cellular Component: myosin GO:0016459 0 2 67 48 9.63E-01 1.32E-02 
Biological Process: cation transport GO:0006812 0 2 67 48 9.63E-01 1.32E-02 
Molecular Function: ATPase activity GO:0015662 0 2 67 48 9.63E-01 1.32E-02 
 
GO terms- Entropy:  Tegument vs. Vesicles 
21 tegument proteins vs. 69 vesicle proteins. 
Total Information Gain = 7.84E-01 
attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Molecular Function: ATP binding GO:0005524 0 16 53 21 7.08E-01 7.62E-02 
Cellular Component: integral to membrane GO:0016021 4 1 68 17 7.22E-01 6.18E-02 
Biological Process: protein modification GO:0006464 2 0 69 19 7.36E-01 4.79E-02 
Biological Process: protein folding GO:0006457 0 10 59 21 7.38E-01 4.56E-02 
Molecular Function: unfolded protein binding GO:0051082 0 9 60 21 7.43E-01 4.07E-02 
Biological Process: transport GO:0006810 3 1 68 18 7.43E-01 4.05E-02 
Biological Process: glycolysis GO:0006096 0 8 61 21 7.48E-01 3.59E-02 
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attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Biological Process: cellular protein metabolism GO:0044267 0 6 63 21 7.57E-01 2.66E-02 
Molecular Function: calcium-dependent phospholipid binding GO:0005544 1 0 69 20 7.60E-01 2.36E-02 
Molecular Function: amidase activity GO:0004040 1 0 69 20 7.60E-01 2.36E-02 
Cellular Component: extracellular region GO:0005576 1 0 69 20 7.60E-01 2.36E-02 
Molecular Function: protein-L-isoaspartate [D-aspartate] O-methyltransferase 
activity GO:0004719 1 0 69 20 7.60E-01 2.36E-02 
Biological Process: exocytosis GO:0006887 1 0 69 20 7.60E-01 2.36E-02 
Biological Process: vesicle docking GO:0048278 1 0 69 20 7.60E-01 2.36E-02 
Biological Process: nucleotide metabolism GO:0009117 1 0 69 20 7.60E-01 2.36E-02 
Molecular Function: sugar porter activity GO:0005351 1 0 69 20 7.60E-01 2.36E-02 
Biological Process: carbohydrate transport GO:0008643 1 0 69 20 7.60E-01 2.36E-02 
Cellular Component: Golgi stack GO:0005795 1 0 69 20 7.60E-01 2.36E-02 
Biological Process: protein targeting GO:0006605 1 0 69 20 7.60E-01 2.36E-02 
Molecular Function: transporter activity GO:0005215 2 1 68 19 7.63E-01 2.12E-02 
Molecular Function: hydrolase activity GO:0016787 2 1 68 19 7.63E-01 2.12E-02 
 
GO terms- Entropy: Tegument vs. Secretions 
21 tegument proteins vs. 48 secretion proteins. 
Total Information Gain = 8.87E-01 
attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Biological Process: glycolysis GO:0006096 0 10 38 21 8.03E-01 8.34E-02 
Cellular Component: membrane GO:0016020 3 0 48 18 8.09E-01 7.79E-02 
Cellular Component: integral to membrane GO:0016021 4 1 47 17 8.27E-01 5.96E-02 
Molecular Function: transporter activity GO:0005215 2 0 48 19 8.35E-01 5.12E-02 
Biological Process: protein modification GO:0006464 2 0 48 19 8.35E-01 5.12E-02 
Biological Process: proteolysis GO:0006508 0 5 43 21 8.47E-01 3.97E-02 
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attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Biological Process: transport GO:0006810 3 1 47 18 8.49E-01 3.76E-02 
Biological Process: protein folding GO:0006457 0 4 44 21 8.55E-01 3.15E-02 
Molecular Function: oxidoreductase activity GO:0016491 0 4 44 21 8.55E-01 3.15E-02 
Molecular Function: calcium-dependent phospholipid binding GO:0005544 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: amidase activity GO:0004040 1 0 48 20 8.61E-01 2.52E-02 
Cellular Component: extracellular region GO:0005576 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: protein-L-isoaspartate [D-aspartate] O-methyltransferase 
activity GO:0004719 1 0 48 20 8.61E-01 2.52E-02 
Biological Process: exocytosis GO:0006887 1 0 48 20 8.61E-01 2.52E-02 
Biological Process: vesicle docking GO:0048278 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: structural constituent of ribosome GO:0003735 1 0 48 20 8.61E-01 2.52E-02 
Cellular Component: ribosome GO:0005840 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: molecular function unknown GO:0005554 1 0 48 20 8.61E-01 2.52E-02 
Biological Process: nucleotide metabolism GO:0009117 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: sugar porter activity GO:0005351 1 0 48 20 8.61E-01 2.52E-02 
Biological Process: carbohydrate transport GO:0008643 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: catalytic activity GO:0003824 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: nucleic acid binding GO:0003676 1 0 48 20 8.61E-01 2.52E-02 
Molecular Function: helicase activity GO:0004386 1 0 48 20 8.61E-01 2.52E-02 
Cellular Component: Golgi stack GO:0005795 1 0 48 20 8.61E-01 2.52E-02 
Biological Process: protein targeting GO:0006605 1 0 48 20 8.61E-01 2.52E-02 
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Appendix I:  Protein Domain Entropy Calculations 
(only showing attributes with highest information gain) 
 
Protein Domains- Entropy:  Vesicles vs. Controls 
79 vesicle proteins vs. 148 control proteins 
Total Information Gain = 9.32E-01 
attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Chaperonin Cpn60/TCP-1 IPR002423 6 0 148 73 8.91E-01 4.12E-02 
GroEL-like chaperone, ATPase IPR008950 6 0 148 73 8.91E-01 4.12E-02 
Chaperonin Cpn60 IPR001844 5 0 148 74 8.98E-01 3.42E-02 
Chaperonin TCP-1 IPR002194 4 0 148 75 9.05E-01 2.73E-02 
Histone core IPR007125 3 0 148 76 9.12E-01 2.04E-02 
 
Protein Domains- Entropy:  Secretions vs. Controls 
52 secretion proteins vs. 148 control proteins 
Total Information Gain = 8.27E-01 
attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Histone core IPR007125 3 0 148 49 7.97E-01 2.96E-02 
Lactate/malate dehydrogenase IPR001236 3 0 148 49 7.97E-01 2.96E-02 
L-lactate/malate dehydrogenase IPR001557 3 0 148 49 7.97E-01 2.96E-02 
Protein kinase IPR000719 0 9 139 52 8.07E-01 2.01E-02 
Glutathione S-transferase, C-terminal IPR004046 2 0 148 50 8.07E-01 1.96E-02 
Malate dehydrogenase, active site IPR001252 2 0 148 50 8.07E-01 1.96E-02 
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attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Protein kinase-like IPR011009 0 8 140 52 8.09E-01 1.78E-02 
Histone-fold IPR009072 3 1 147 49 8.11E-01 1.55E-02 
 
Protein Domains- Entropy:  Tegument vs. Controls 
29 tegument proteins vs. 148 control proteins 
Total Information Gain = 6.43E-01 
attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
C2 calcium/lipid-binding region, CaLB IPR008973 2 1 147 27 6.28E-01 1.58E-02 
FerI IPR012968 1 0 148 28 6.29E-01 1.49E-02 
Allergen V5/Tpx-1 related IPR001283 1 0 148 28 6.29E-01 1.49E-02 
Aquaporin IPR012269 1 0 148 28 6.29E-01 1.49E-02 
Major intrinsic protein IPR000425 1 0 148 28 6.29E-01 1.49E-02 
Protein-L-isoaspartateD-aspartate O-methyltransferase IPR000682 1 0 148 28 6.29E-01 1.49E-02 
Exocyst complex component Sec10 IPR009976 1 0 148 28 6.29E-01 1.49E-02 
Ribosomal protein L40e IPR001975 1 0 148 28 6.29E-01 1.49E-02 
Phosphatidylinositol transfer protein IPR001666 1 0 148 28 6.29E-01 1.49E-02 
Snf7 IPR005024 1 0 148 28 6.29E-01 1.49E-02 
Spectrin repeat IPR002017 1 0 148 28 6.29E-01 1.49E-02 
Type I phosphodiesterase/nucleotide pyrophosphatase IPR002591 1 0 148 28 6.29E-01 1.49E-02 
PDZ/DHR/GLGF IPR001478 1 0 148 28 6.29E-01 1.49E-02 
General substrate transporter IPR005828 1 0 148 28 6.29E-01 1.49E-02 
Sugar transporter IPR003663 1 0 148 28 6.29E-01 1.49E-02 
AMP-dependent synthetase and ligase IPR000873 1 0 148 28 6.29E-01 1.49E-02 
DEAD/DEAH box helicase, N-terminal IPR011545 1 0 148 28 6.29E-01 1.49E-02 
Helicase, C-terminal IPR001650 1 0 148 28 6.29E-01 1.49E-02 
HSP20-like chaperone IPR008978 1 0 148 28 6.29E-01 1.49E-02 
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attribute description attribute 
 
yy 
 
ny  nn 
 
yn 
 
E_attribute  Gain 
Heat shock protein Hsp20 IPR002068 1 0 148 28 6.29E-01 1.49E-02 
Alpha crystallin IPR001436 1 0 148 28 6.29E-01 1.49E-02 
Protein of unknown function DUF1606 IPR011710 1 0 148 28 6.29E-01 1.49E-02 
AP2 clathrin adaptor, alpha and beta chain, appendage IPR009028 1 0 148 28 6.29E-01 1.49E-02 
CAP protein IPR001837 1 0 148 28 6.29E-01 1.49E-02 
 
Protein Domains- Entropy:  Secretions vs. Vesicles 
53 secretion proteins vs. 78 vesicle proteins 
Total Information Gain = 9.74E-01 
attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Chaperonin TCP-1 IPR002194 0 4 74 53 9.50E-01 2.33E-02 
Chaperonin Cpn60/TCP-1 IPR002423 1 6 72 52 9.60E-01 1.32E-02 
GroEL-like chaperone, ATPase IPR008950 1 6 72 52 9.60E-01 1.32E-02 
Tropomyosin IPR000533 0 2 76 53 9.62E-01 1.15E-02 
Myosin tail IPR002928 0 2 76 53 9.62E-01 1.15E-02 
Endoplasmic reticulum targeting sequence IPR000886 0 2 76 53 9.62E-01 1.15E-02 
Haloacid dehalogenase-like hydrolase IPR005834 0 2 76 53 9.62E-01 1.15E-02 
Cation transporting ATPase, N-terminal IPR004014 0 2 76 53 9.62E-01 1.15E-02 
ATPase, E1-E2 type IPR001757 0 2 76 53 9.62E-01 1.15E-02 
Cation transporting ATPase, C-terminal IPR006068 0 2 76 53 9.62E-01 1.15E-02 
E1-E2 ATPase-associated region IPR008250 0 2 76 53 9.62E-01 1.15E-02 
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Protein Domains- Entropy:  Tegument vs. Vesicles 
29 tegument proteins vs. 78 vesicle proteins 
Total Information Gain = 8.43E-01 
attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
C2 calcium/lipid-binding region, CaLB IPR008973 2 0 78 27 8.07E-01 3.59E-02 
CD9/CD37/CD63 antigen IPR000301 2 0 78 27 8.07E-01 3.59E-02 
Tetraspanin IPR008952 2 0 78 27 8.07E-01 3.59E-02 
Chaperonin Cpn60/TCP-1 IPR002423 0 6 72 29 8.16E-01 2.65E-02 
GroEL-like chaperone, ATPase IPR008950 0 6 72 29 8.16E-01 2.65E-02 
Chaperonin Cpn60 IPR001844 0 5 73 29 8.21E-01 2.19E-02 
Annexin IPR001464 1 0 78 28 8.25E-01 1.78E-02 
Amidase IPR000120 1 0 78 28 8.25E-01 1.78E-02 
FerI IPR012968 1 0 78 28 8.25E-01 1.78E-02 
Allergen V5/Tpx-1 related IPR001283 1 0 78 28 8.25E-01 1.78E-02 
Aquaporin IPR012269 1 0 78 28 8.25E-01 1.78E-02 
 
Protein Domains- Entropy:  Tegument vs. Secretions 
30 tegument proteins vs. 51 secretion proteins 
Total Information Gain = 9.51E-01 
attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
C2 calcium/lipid-binding region, CaLB IPR008973 2 0 51 28 9.15E-01 3.62E-02 
Thioredoxin-like fold IPR012336 2 0 51 28 9.15E-01 3.62E-02 
CD9/CD37/CD63 antigen IPR000301 2 0 51 28 9.15E-01 3.62E-02 
Tetraspanin IPR008952 2 0 51 28 9.15E-01 3.62E-02 
Peptidase S1 and S6, chymotrypsin/Hap IPR001254 0 3 48 30 9.26E-01 2.53E-02 
Peptidase, trypsin-like serine and cysteine IPR009003 0 3 48 30 9.26E-01 2.53E-02 
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attribute description attribute 
 
yy 
 
ny 
 
nn 
 
yn 
 
E_attribute  Gain 
Peptidase S1A, chymotrypsin IPR001314 0 3 48 30 9.26E-01 2.53E-02 
Histone-fold IPR009072 0 3 48 30 9.26E-01 2.53E-02 
Histone core IPR007125 0 3 48 30 9.26E-01 2.53E-02 
Lactate/malate dehydrogenase IPR001236 0 3 48 30 9.26E-01 2.53E-02 
L-lactate/malate dehydrogenase IPR001557 0 3 48 30 9.26E-01 2.53E-02 
Phosphoglycerate mutase 1 IPR005952 1 0 51 29 9.33E-01 1.79E-02 
Phosphoglycerate mutase IPR013078 1 0 51 29 9.33E-01 1.79E-02 
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Appendix J:  Perl And Matlab Scripts 
 
#parse_nonred_seqs.pl 
#This script was used in creating a control data set; given a file #containing a list of sequence ids 
#corresponding entries that need to be eliminated from a fasta file, it will run through the fasta file 
#and create two new files- one with eliminated sequences and one with  
#the desired sequences 
 
#usage: parse_nonredundant_seqs.pl 
 
use strict; 
use Bio::SeqIO; 
open(INFILE, "s:\\sm_to_eliminate_new.txt"); 
local($/) = undef; 
my $line = <INFILE>; 
 
my $in  = Bio::SeqIO->new('-file' => "s:\\NRSm_455.fasta" , 
       '-format' => 'Fasta'); 
my $out = Bio::SeqIO->new('-file' => ">s:\\NRSm_455_eliminated.fasta" , 
        '-format' => 'Fasta'); 
my $out2 = Bio::SeqIO->new('-file' => ">s:\\NRSm_455_nonred.fasta" , 
        '-format' => 'Fasta'); 
 
while ( my $seq = $in->next_seq() ) { 
    my $a = $seq->id; 
    if ($line =~ /$a/){ 
        $out->write_seq($seq);} 
     else { 
 $out2->write_seq($seq); }} 
 
#blastparser.pl 
#written by Amy Schmidbauer 
#This script will take a blast results file (standard long format) and parse 
#specified results into table format 
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use strict; 
use Bio::SearchIO; 
 
my $outfile = "NRSm_155_blast_parsed.out"; 
 
open (OUTFILE, ">$outfile") or die "Can't open outfile"; 
 
    my $in = new Bio::SearchIO(-format => 'blast', 
                               -file   => "NRSm_155_blast.out"); 
    while( my $result = $in->next_result ) { 
      while( my $hit = $result->next_hit ) { 
        while( my $hsp = $hit->next_hsp ) { 
          if( $hsp->length('total') > 100 ) { 
            #if ( $hsp->percent_identity >= 75 ) { 
  if ($result->query_accession ne $hit->accession){ 
              print OUTFILE $result->query_accession, 
         ",", $result->query_description, 
         ",", $result->query_length, 
         ",", $result->num_hits, 
         ",", $hit->accession, 
         ",", $hit->description, 
                ",", $hit->significance, 
                       ",", $hsp->length('total'), 
                       ",", $hsp->percent_identity, "\n"; 
            } 
          } 
        } 
      } 
    } 
 
 
       184
#parse_iprscan.pl 
#This script takes as input an InterPro scan file ("raw" format) and creates 
#1- a matrix of seq_id vs. protein domain ids and descriptions 
#2- a matrix of seq_id vs. GO ids and terms 
#3- a file containing a count of seq ids corresponding to each protein domain 
#4- a file containing a count of seq ids corresponding to each GO id 
#could be split into 2 scripts or modularized for creating GO data vs. domain data 
 
#input file must be sorted by protein_id 
 
use Tie::IxHash; 
 
open(INFILE1, "s:\\secretions_&_tegument_iprscan_cleaned.raw"); 
open(OUTFILE1, ">s:\\domains_matrix.out"); 
open(OUTFILE2, ">s:\\domain_id_counts.out"); 
 
my %HoH = (); 
tie %HoH, "Tie::IxHash"; 
my %domain_ids = (); 
tie %domain_ids, "Tie::IxHash"; 
my %domain_descr = (); 
tie %domain_descr, "Tie::IxHash"; 
 
my $count=0; 
#load protein->domain hash, domain_id->count hash, 
#and domain_id->descr hash 
while(<INFILE1>){ 
     if (/NULL/){ 
  @line = split("\t", $_); 
      $prot_id = $line[0]; 
      $domain_id = "NULL"; 
       $HoH{$prot_id}->{$domain_id} = 1;} 
 else { 
  @line = split("\t", $_); 
      $prot_id      = $line[0]; 
  $domain_id    = $line[11]; 
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  $domain_descr = $line[12]; 
  $domain_descr =~ tr/("|')//d; 
  $HoH{$prot_id}->{$domain_id} = 1; 
      $domain_ids{$domain_id} = $count; 
  $domain_descr{$domain_id} = $domain_descr;}} 
 
#print domain_ids as headers in domain_matrix output 
printf OUTFILE1 '%20s'," "; 
print OUTFILE1 "\t"; 
foreach my $a (keys %domain_ids){ 
 print OUTFILE1 "$a\t"; } 
print OUTFILE1 "\n"; 
 
#print domain descriptions as headers in domain_matrix output 
foreach my $a1 (keys %domain_descr) 
    { 
    my $domain_descr = $domain_descr{$a1}; 
    print OUTFILE1 "$domain_descr\t"; 
    } 
print OUTFILE1 "\n"; 
 
#print protein->domain matrix data and load domain_id->count hash 
foreach my $b (keys %HoH){ 
    #print $b; 
    print OUTFILE1 "$b\t\t\t"; 
    foreach my $c (keys %domain_ids){ 
     #print "$c\n"; 
        if ($HoH{$b}->{$c}){ 
           #print "$b\t$c\n"; 
           print OUTFILE1 "1         \t"; 
           $domain_ids{$c} = ($domain_ids{$c} + 1);} 
        else{ 
            #print "no $c\n"; 
            print OUTFILE1 "0         \t"; }} 
    print OUTFILE1 "\n"; } 
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#print domain_id->description->count to output file 
while ( my ($domain_id, $count) = each(%domain_ids) ){ 
    my $domain_descr = $domain_descr{$domain_id}; 
    print OUTFILE2 "$domain_id => $domain_descr => $count\n";} 
 
close INFILE1; 
close OUTFILE1; 
close OUTFILE2; 
 
open(INFILE1, "s:\\secretions_&_tegument_iprscan_cleaned.raw"); 
open(OUTFILE3, ">s:\\goids_matrix.out"); 
open(OUTFILE4, ">s:\\go_id_counts.out"); 
 
my %go_ids = ();  #hash 
tie %go_ids, "Tie::IxHash"; 
my %go_descr = (); #hash 
tie %go_descr, "Tie::IxHash"; 
my %prot_go = (); #hash of hashes 
tie %prot_go, "Tie::IxHash"; 
 
my @line; 
my $go_id; 
my $size=0; 
my $size2=0; 
my @go_fields; 
my $count2; 
my $descr_long; 
my $descr_go; 
my $descr; 
 
while(<INFILE1>) { 
    @line = split("\t", $_); 
    $size = @line; 
    if ($size ==14){ #if GO column isn't empty 
      $prot_id = $line[0]; 
      $go_line = $line[13]; 
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      @go_fields = split(/\(/,$go_line); 
      $size2 = @go_fields; 
      for ($i=0; $i<$size2; $i++){ 
            if ($go_fields[$i] =~ /GO:\d{7}/){ 
             #print "yes\n"; 
             $go_id = $&; 
                $count2 = 0; 
                $descr_long = $go_fields[$i-1]; 
                if ($descr_long =~ /^GO:\d{7}/){ 
                 ($descr_go, $descr) = split(/,\s/,$descr_long);} 
                else{ 
                 $descr = $descr_long; 
                 $descr =~ tr/"//d;} 
                #print "$descr\n\n"; 
                $go_ids{$go_id} = $count2; 
                $go_descr{$go_id} = $descr; 
                $prot_go{$prot_id} -> {$go_id} = 1;}}} 
    else  #if GO column is empty{ 
        $prot_id = $line[0]; 
        $go_id = "NULL"; 
        $prot_go{$prot_id} -> {$go_id} = 1; }} 
 
printf OUTFILE3 '%20s'," "; 
print OUTFILE3 "\t"; 
foreach my $d (keys %go_ids){ 
 print OUTFILE3 "$d\t";} 
print OUTFILE3 "\n"; 
printf OUTFILE3 '%20s'," "; 
print OUTFILE3 "\t"; 
foreach my $e (keys %go_ids){ 
    my $go_descr = $go_descr{$e}; 
    print OUTFILE3 "$go_descr\t";} 
print OUTFILE3 "\n"; 
 
#print protein->domain matrix data and load domain_id->count hash 
foreach my $f (keys %prot_go){ 
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    #print $f; 
    print OUTFILE3 "$f\t\t\t"; 
    foreach my $g (keys %go_ids){ 
     #print "$g\n"; 
        if ($prot_go{$f}->{$g}){ 
            #print "yes $g\t$g\n"; 
            print OUTFILE3 "1         \t"; 
            $go_ids{$g} = ($go_ids{$g} + 1);} 
        else{            
  #print "no $f\t$g\n"; 
            print OUTFILE3 "0         \t"; } } 
    print OUTFILE3 "\n"; } 
 
#print domain_id->count hash 
while ( ($go_id, $count2) = each(%go_ids )){ 
    my $go_descr = $go_descr{$go_id}; 
    print OUTFILE4 "$go_id => $go_descr => $count2\n"; } 
 
close INFILE1; 
close OUTFILE3; 
close OUTFILE4; 
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#append_labels_to_matrix.pl 
#Can be used to in conjunction with parse_iprscan.pl to prepare matrics for Matlab. 
#Matrix files were openened in Excel so that a column containing class labels could 
#be appended to the beginning of the matrix and all seq_ids and column headings could 
#be deleted (so that matrix contained only 0s and 1s for use in Matlab).  Sometimes the 
#matrix cannot be opened in Excel because it has too many columns.  This script is used to 
#append a column of class labels to the beginning of the matrix. 
    
use strict; 
 
open(INFILE1, "s:\\secretions_&_tegument_domains_matrix.out"); 
open(OUTFILE1, ">s:\\secretions_&_tegument_domains_matrix2.out"); 
 
my $i = 1; 
while(<INFILE1>){ 
 if ($i < 52){ 
  print OUTFILE1 "0\t$_";} 
 else{ 
  print OUTFILE1 "1\t$_";} 
 $i++; } 
 
close INFILE1; 
close OUTFILE1; 
 
 
 
 
 
 
 
 
 
 
 
#Entropy.m 
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#Matlab script used to calculate Entropy 
 
clear all 
   
D = load('secretions_&_tegument_domains_matrix2.out'); 
fid = fopen('secretions_&_tegument_domain_entropy.txt','w'); 
  
fprintf(fid, '%s, %s, %s, %s\n', 'label_yes', 'label_no','total', 'I'); 
    label_yes = 0; 
    label_no = 0; 
    total = 0; 
    for x = 1 : size(D,1) 
        if (D(x,1)==1) 
            label_yes = label_yes + 1; 
        end 
        if (D(x,1)==0) 
            label_no = label_no + 1; 
        end  
    end 
  
    if (label_yes + label_no) == 0  
        I = 0; 
    elseif (label_yes == 0 && label_no ~= 0) 
        I = -(((label_no/(label_yes + label_no)) *log2(label_no)/(label_yes + label_no))); 
    elseif (label_no == 0 && label_yes ~= 0) 
        I = -(((label_yes/(label_yes + label_no))*log2(label_yes)/(label_yes + label_no))); 
    else 
        I = -((label_yes/(label_yes + label_no))*log2(label_yes/(label_yes + label_no)))-
((label_no/(label_yes + label_no))*log2(label_no/(label_yes + label_no))); 
    end 
    total = label_yes + label_no; 
    fprintf(fid,'%d, %d, %d, %d\n', label_yes, label_no, total, I); 
   
 fprintf(fid, '%s, %s, %s, %s, %s, %s, %s\n','attribute','yy', 'ny', 'nn', 'yn','E_attribute','Gain');    
 for i = 2 : size(D,2)   
    attribute = i-1; 
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    yy = 0; 
    yn = 0;  
    ny = 0; 
    nn = 0; 
    E_attribute = 0; 
    Gain = 0; 
    for x = 1 : size(D,1) 
        if (D(x,1)==1) && (D(x,i)==1) 
            yy = yy + 1; 
        end 
        if (D(x,1)==1) && (D(x,i)~=1) 
            yn = yn + 1; 
        end  
        if (D(x,1)==0) && (D(x,i)==0) 
            nn = nn + 1; 
        end 
        if (D(x,1)==0) && (D(x,i)~=0) 
            ny = ny + 1; 
        end 
    end 
    if total == 0 
        E_attribute = 0; 
    elseif ((yy == 0) && (ny ~= 0) && (nn ~= 0) && (yn ~= 0)) 
        E_attribute = (((ny+yy)/total) * (-(ny/(yy+ny))*log2(ny/(yy+ny)))) + (((yn+nn)/total) * (-
(yn/(yn+nn))*log2(yn/(yn+nn)) - (nn/(yn+nn))*log2(nn/(yn+nn)))); 
    elseif ((yy == 0) && (ny == 0) && (nn ~= 0) && (yn ~= 0)) 
        E_attribute = (((yn+nn)/total) * (-(yn/(yn+nn))*log2(yn/(yn+nn)) - (nn/(yn+nn))*log2(nn/(yn+nn)))); 
    elseif ((ny == 0) && (yy ~= 0) && (nn ~= 0) && (yn ~= 0)) 
        E_attribute = (((ny+yy)/total) * (-(yy/(yy+ny))*log2(yy/(yy+ny)))) + (((yn+nn)/total) * (-
(yn/(yn+nn))*log2(yn/(yn+nn)) - (nn/(yn+nn))*log2(nn/(yn+nn)))); 
    else 
        E_attribute = (((ny+yy)/total) * (-(yy/(yy+ny))*log2(yy/(yy+ny)) - (ny/(yy+ny))*log2(ny/(yy+ny)))) 
+ (((yn+nn)/total) * (-(yn/(yn+nn))*log2(yn/(yn+nn)) - (nn/(yn+nn))*log2(nn/(yn+nn)))); 
    end 
    Gain = I-E_attribute; 
    fprintf(fid,'%d, %d, %d, %d, %d, %d, %d\n', attribute, yy, ny, nn, yn, E_attribute, Gain); 
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 end 
  
    fclose(fid); 
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Appendix K:  Permission To Use Figures 
Permission to use figures 2, 3, 4 (Dorsey, Cousin et al. 2002): 
From:  "Jones, Jennifer (ELS-OXF)" <J.Jones@elsevier.co.uk>  
To:  "'schmidbauer2@comcast.net'" <schmidbauer2@comcast.net>  
Subject:  RE: Obtain Permission  
Date:  Monday, June 05, 2006 3:50:26 AM 
 
Dear Amy Schmidbauer 
 
We hereby grant you permission to reproduce the material detailed below at no 
charge in your thesis subject to the following conditions: 
1.      If any part of the material to be used (for example, figures) has appeared in 
our publication with credit or acknowledgement to another source, permission must 
also be sought from that source.  If such permission is not obtained then that 
material may not be included in your publication/copies. 
2.      Suitable acknowledgment to the source must be made, either as a footnote or 
in a reference list at the end of your publication, as follows: 
"Reprinted from Publication title, Vol number, Author(s), Title of article, Pages 
No., Copyright (Year), with permission from Elsevier". 
3.      Reproduction of this material is confined to the purpose for which permission 
is hereby given.  
4.      This permission is granted for non-exclusive world English rights only.  For 
other languages please reapply separately for each one required.  Permission 
excludes use in an electronic form.  Should you have a specific electronic project in 
mind please reapply for permission. 
5.      This includes permission for UMI to supply single copies, on demand, of the 
complete thesis.  Should your thesis be published commercially, please reapply for 
permission. 
Yours sincerely 
Jennifer Jones 
Rights Assistant  
-----Original Message----- 
     194
From: schmidbauer2@comcast.net [mailto:schmidbauer2@comcast.net] 
Sent: 04 June 2006 23:27 
To: permissions@elsevier.com 
Subject: Obtain Permission 
 
This Email was sent from the Elsevier Corporate Web Site  and is related to Obtain 
Permission form: 
---------------------------------------------------------------- 
Product:       Customer Support 
Component:     Obtain Permission  
Web server:    http://www.elsevier.com 
IP address:    10.10.24.149 
Client:        Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1; .NET CLR 
1.0.3705; .NET CLR 1.1.4322) 
Invoked from: 
http://www.elsevier.com/wps/find/obtainpermissionform.cws_home?isSubmitted=y
es&navigateXmlFileName=/store/prod_webcache_act/framework_support/obtainpe
rmission.xml 
Request From: 
Ms Amy Schmidbauer 
Indiana University Purdue University Indianapolis 
4720 Stoughton Ct. 
46254 
Indianapolis 
United States 
Contact Details: 
Telephone:             317-250-3071 
Fax:                    
Email Address:         schmidbauer2@comcast.net 
To use the following material: 
ISSN/ISBN:              
Title:                 Micron 
Author(s):          Dorsey, C., Cousin, C., Lewis, F., Stirewalt, M. 
Volume:            33 
Issue:                3 
Year:                2002 
Pages:              279 - 323 
Article title:     Ultrastructure of the S. mansoni cercaria 
How much of the requested material is to be used:   Figures 1, 10, and 23a   
Are you the author:    No  
Author at institute:   No 
How/where will the requested material be used:  
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In a graduate thesis through IUPUI on cercarial secretions of the parasite S. 
mansoni. 
 
For further info regarding this automatic email, please contact: 
WEB APPLICATIONS TEAM  ( esweb.admin@elsevier.co.uk ) 
----------------------------------------------------------- 
From:  "Cousin, Carolyn" <ccousin@udc.edu>  
To:  <schmidbauer2@comcast.net>  
Subject:  RE: RE: permission to use figure  
Date:  Tuesday, May 16, 2006 12:22:23 PM     
 
I would be willing to grant permission for you to use the requested figures from the 
publication.  If you need my signature on a letter, I can supply it via e-mail. 
Best of luck on your project and manuscript. 
Carolyn Cousin 
-----Original Message----- 
From: schmidbauer2@comcast.net [mailto:schmidbauer2@comcast.net] 
Sent: Tuesday, May 16, 2006 10:28 AM 
To: Cousin, Carolyn 
Subject: FW: RE: permission to use figure 
 
Dear Dr. Cousin, 
 
Dr. Fred Lewis advised me to seek your permission, in addition to his and the 
publisher's, to use figures 1, 10, and 23a from the publication "Ultrastructure of the 
S. mansoni cercaria" (Micron Vol. 33, pages 279-323).  I am doing a thesis project 
at Indiana University that is a proteomic study of the S. mansoni secretome. Would 
you be willing to grant this permission? 
thank you, 
Amy Schmidbauer 
-----Original Message----- 
From: "Fred Lewis" <flewis@afbr-bri.com>  
To: <schmidbauer2@comcast.net>  
Subject: RE: permission to use figure  
Date: Tuesday, May 16, 2006 9:21:39 AM  
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Amy,  
You have my permission to use those figures, but I may not have the final say on 
the subject. You will also need to contact the publisher, Pergamon Press, which 
produces the journal Micron in which the article appears. Although unlikely, there 
may be some copyright issues involved. Also, please contact Carolyn Cousin at 
ccousin@udc.edu for her consent as well. Dr. Stirewalt is no longer alive, and 
Charles Dorsey is in very ill health.  
Fred  
Fred Lewis, Ph.D.  
Head, Schistosomiasis Laboratory  
Biomedical Research Institute  
12111 Parklawn Dr, Rockville MD 20852  
phone (301)881-3300 ext 25 or ext 27  
fax (301) 770-4756 
 
 -----Original Message-----  
From: schmidbauer2@comcast.net [mailto:schmidbauer2@comcast.net]  
Sent: Monday, May 15, 2006 5:12 PM  
To: flewis@afbr-bri.com  
Subject: permission to use figure  
 
Dear Dr. Lewis,  
I am doing a thesis project at Indiana University that is a proteomic study of the S. 
mansoni secretome. I am writing to seek permission to use figures 1, 10, and 23a 
from the publication "Ultrastructure of the S. mansoni cercaria" (Micron Vol. 33, 
pages 279-323) in my thesis. This paper was extremely helpful to me in gaining an 
understanding of the morphology of this parasite. Would you be willing to grant 
this permission?  
thank you,  
Amy Schmidbauer 
 
Permission to use figure 5 (Jones, Gobert et al. 2004): 
From:  "Malcolm Jones" Malcolm.Jones@qimr.edu.au 
To:  schmidbauer2@comcast.net 
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Subject:  Re: permission to use figure  
Date:  Sunday, May 14, 2006 5:42:45 PM     
 
Dear Ms Schmidbauer,  
Very happy to grant the permission.  Thanks indeed for asking.  Would you prefer 
the original digital image, or will you make a copy from the published article?   
Best wishes 
Malcolm  
 -----Original Message----- 
From:  schmidbauer2@comcast.net  
To:  malcolmJ@qimr.edu.au  
Subject:  permission to use figure  
Date:  Sunday, May 14, 2006 10:11:31 AM 
  
Dear Dr. Malcolm Jones, 
I am doing a thesis project at Indiana University that is a proteomic study of the S. 
mansoni secretome. I am writing to seek permission to use a figure from one of 
your publication in my thesis- Figure 2 from "The cytoskeleton and motor proteins 
of human schistosomes and their role in surface maintenance and host-parasite 
interactions" from Bioessays Vol. 26 No. 7 pages 752-765 2004. 
thank you, 
Amy Schmidbauer  
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